sampleid	submitted_name	run_prefix	experimental_strategy	cgc_base_name	filename	analyte_amount	analyte_A260A280Ratio	aliquot_concentration	cgc_id	cgc_filename	vital_status	gender	race	ethnicity	disease_type	data_subtype	tcga_sample_id	cgc_case_uuid	sample_type	cgc_platform	gdc_file_uuid	primary_site	age_at_diagnosis	cgc_sample_uuid	cgc_aliquot_uuid	tcga_aliquot_id	reference_genome	tcga_case_id	investigation	days_to_death	knightlabID	data_submitting_center_label	tissue_source_site_label	country_of_sample_procurement	portion_is_ffpe	pathologic_t_label	pathologic_n_label	histological_diagnosis_label	pathologic_stage_label	PlateCenter	PlateCenterFlag
13722.58cfa82de4b0c9d6adf6a710	58cfa82de4b0c9d6adf6a710	G12519.TCGA-34-2600-01A-01D-0963-08.5.filtered.	WGS	G12519.TCGA-34-2600-01A-01D-0963-08.5	G12519.TCGA-34-2600-01A-01D-0963-08.5.bam	626	1.9	0.16	58cfa82de4b0c9d6adf6a710	G12519.TCGA-34-2600-01A-01D-0963-08.5.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-34-2600-01A	DA61857A-B00E-4A19-AB02-8FBB2EE56BEA	Primary Tumor	Illumina HiSeq	c9a14cf5-32b5-43f5-991f-26b83b6a7727	Lung	76	B0C827C6-B7EF-420B-9A6F-7E8B79C320CC	E9CB8877-8E83-46C0-93F0-EA20530C9400	TCGA-34-2600-01A-01D-0963-08	HG19_Broad_variant	TCGA-34-2600	TCGA-LUSC	1874	s10072	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	0963-08	FALSE
13722.58cfa82de4b0c9d6adf6a71a	58cfa82de4b0c9d6adf6a71a	G14855.TCGA-05-4389-01A-01D-1931-08.4.filtered.	WGS	G14855.TCGA-05-4389-01A-01D-1931-08.4	G14855.TCGA-05-4389-01A-01D-1931-08.4.bam	372.53	1.9	0.14	58cfa82de4b0c9d6adf6a71a	G14855.TCGA-05-4389-01A-01D-1931-08.4.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4389-01A	A3DE401D-91FE-49A2-BB07-81C1A06506E6	Primary Tumor	Illumina HiSeq	0979871e-d324-4f7e-98da-f65ff17a74d7	Lung	70	ED61AC6A-F21F-4B88-928A-029340D4AEBD	14BF9BFB-14D6-4CAC-A556-828F680E8A15	TCGA-05-4389-01A-01D-1931-08	HG19_Broad_variant	TCGA-05-4389	TCGA-LUAD	NA	s11426	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T1	N0	Lung Adenocarcinoma Mixed Subtype	Stage IA	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a728	58cfa82de4b0c9d6adf6a728	G14857.TCGA-73-4666-01A-01D-1931-08.4.filtered.	WGS	G14857.TCGA-73-4666-01A-01D-1931-08.4	G14857.TCGA-73-4666-01A-01D-1931-08.4.bam	375.23	1.9	0.16	58cfa82de4b0c9d6adf6a728	G14857.TCGA-73-4666-01A-01D-1931-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4666-01A	4C31127E-D095-4978-9DAC-35153C27F6ED	Primary Tumor	Illumina HiSeq	16906318-0783-402c-9f2c-b8e22348748c	Lung	52	5BAE2E45-6DBC-458C-A66F-702EB1AF7357	9FFCB7FA-424C-4F93-87A7-CE5E9053C613	TCGA-73-4666-01A-01D-1931-08	HG19_Broad_variant	TCGA-73-4666	TCGA-LUAD	NA	s10758	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IV	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a72c	58cfa82de4b0c9d6adf6a72c	G14858.TCGA-73-4659-01A-01D-1931-08.3.filtered.	WGS	G14858.TCGA-73-4659-01A-01D-1931-08.3	G14858.TCGA-73-4659-01A-01D-1931-08.3.bam	665.52	1.9	0.15	58cfa82de4b0c9d6adf6a72c	G14858.TCGA-73-4659-01A-01D-1931-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4659-01A	CD0DC947-B708-464E-BEB7-954C9D4583E7	Primary Tumor	Illumina HiSeq	967b7c80-0ec2-4e5f-81fd-07bffeeeaa7f	Lung	66	C35A5ED1-1821-4077-BA1E-B972DFA3233B	53D32D8B-5649-42B0-8C52-2C39AF2A961B	TCGA-73-4659-01A-01D-1931-08	HG19_Broad_variant	TCGA-73-4659	TCGA-LUAD	711	s10973	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a73a	58cfa82de4b0c9d6adf6a73a	G14847.TCGA-05-4397-01A-01D-1931-08.6.filtered.	WGS	G14847.TCGA-05-4397-01A-01D-1931-08.6	G14847.TCGA-05-4397-01A-01D-1931-08.6.bam	573.23	1.9	0.14	58cfa82de4b0c9d6adf6a73a	G14847.TCGA-05-4397-01A-01D-1931-08.6.bam	Dead	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4397-01A	6DFD47D2-831A-4386-9051-F78199A16BB5	Primary Tumor	Illumina HiSeq	48ff480a-fd08-4db2-8ba6-ce90769d4811	Lung	65	C4C061CD-E926-400B-B18C-B47C234337CA	0B19BEE7-5281-4915-9D98-C20EB3E84ECF	TCGA-05-4397-01A-01D-1931-08	HG19_Broad_variant	TCGA-05-4397	TCGA-LUAD	731	s11424	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N1	Lung Adenocarcinoma Mixed Subtype	Stage IIB	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a780	58cfa82de4b0c9d6adf6a780	G16920.TCGA-CZ-4856-01A-02D-2048-08.1.filtered.	WGS	G16920.TCGA-CZ-4856-01A-02D-2048-08.1	G16920.TCGA-CZ-4856-01A-02D-2048-08.1.bam	34.73	1.9	0.15	58cfa82de4b0c9d6adf6a780	G16920.TCGA-CZ-4856-01A-02D-2048-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-4856-01A	FCECAFA8-8B8B-4AE6-81BC-73ACF05B211A	Primary Tumor	Illumina HiSeq	11912043-5f81-4764-94e5-b6a0218a906c	Kidney	62	6F6C9F00-D6E5-452F-BA04-F77B146B780B	A7293FEF-B5D3-4572-A38B-5DC4F8A67C12	TCGA-CZ-4856-01A-02D-2048-08	HG19_Broad_variant	TCGA-CZ-4856	TCGA-KIRC	NA	s9935	Broad Institute of MIT and Harvard	Harvard	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	2048-08	FALSE
13722.58cfa82de4b0c9d6adf6a740	58cfa82de4b0c9d6adf6a740	G14850.TCGA-49-4486-01A-01D-1931-08.3.filtered.	WGS	G14850.TCGA-49-4486-01A-01D-1931-08.3	G14850.TCGA-49-4486-01A-01D-1931-08.3.bam	142.53	1.9	0.14	58cfa82de4b0c9d6adf6a740	G14850.TCGA-49-4486-01A-01D-1931-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4486-01A	61C655EC-52B5-453F-A6CC-B2ABA445B027	Primary Tumor	Illumina HiSeq	53a1d9af-aa10-4382-bfad-f13af3c6cab9	Lung	72	5AE9B10F-347C-48C3-90CD-9290055CFE4B	23D86395-9E20-4CF9-BF7E-F76544A1F772	TCGA-49-4486-01A-01D-1931-08	HG19_Broad_variant	TCGA-49-4486	TCGA-LUAD	2318	s10628	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a784	58cfa82de4b0c9d6adf6a784	G16922.TCGA-BP-5010-01A-02D-2048-08.1.filtered.	WGS	G16922.TCGA-BP-5010-01A-02D-2048-08.1	G16922.TCGA-BP-5010-01A-02D-2048-08.1.bam	227.73	1.9	0.14	58cfa82de4b0c9d6adf6a784	G16922.TCGA-BP-5010-01A-02D-2048-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-5010-01A	9F5C0A43-D222-484A-9249-D288387DD7A1	Primary Tumor	Illumina HiSeq	5909062c-40ed-4237-b615-c18d204060eb	Kidney	63	4057D69A-52EF-451B-BD74-6436919970C9	A4F8305F-4409-4776-B34D-4878D18C8693	TCGA-BP-5010-01A-02D-2048-08	HG19_Broad_variant	TCGA-BP-5010	TCGA-KIRC	878	s8999	Broad Institute of MIT and Harvard	MSKCC	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage III	2048-08	FALSE
13722.58cfa82ee4b0c9d6adf6a7e1	58cfa82ee4b0c9d6adf6a7e1	G25784.TCGA-91-6840-01A-11D-1945-08.3.filtered.	WGS	G25784.TCGA-91-6840-01A-11D-1945-08.3	G25784.TCGA-91-6840-01A-11D-1945-08.3.bam	315.7	1.9	0.05	58cfa82ee4b0c9d6adf6a7e1	G25784.TCGA-91-6840-01A-11D-1945-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-91-6840-01A	D5326429-9805-47F9-97B0-FBDA658E3F01	Primary Tumor	Illumina HiSeq	27c919e7-a635-4c6d-a12d-31d1ee814e12	Lung	59	AF744755-51EB-4DAF-9029-5CF88730B1DC	09BC8542-4EA1-4599-91B3-D606425B37E2	TCGA-91-6840-01A-11D-1945-08	HG19_Broad_variant	TCGA-91-6840	TCGA-LUAD	NA	s11430	Broad Institute of MIT and Harvard	ABS - IUPUI	United States	NO	T1b	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6a7ee	58cfa82ee4b0c9d6adf6a7ee	G26378.TCGA-02-2483-01A-01D-1494-08.1.filtered.	WGS	G26378.TCGA-02-2483-01A-01D-1494-08.1	G26378.TCGA-02-2483-01A-01D-1494-08.1.bam	264.7	1.9	0.05	58cfa82ee4b0c9d6adf6a7ee	G26378.TCGA-02-2483-01A-01D-1494-08.1.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-02-2483-01A	A2AC9937-F351-4D78-9261-264BF6C21E0C	Primary Tumor	Illumina HiSeq	8f0bfbe1-af94-4579-bcd2-696056315c1e	Brain	43	724D75C1-7F82-4208-8510-3E89F3679BDE	4D7F2C74-862B-4AAD-98E1-FA831F14A905	TCGA-02-2483-01A-01D-1494-08	HG19_Broad_variant	TCGA-02-2483	TCGA-GBM	NA	s14171	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6a7ec	58cfa82ee4b0c9d6adf6a7ec	G26374.TCGA-06-5415-01A-01D-1486-08.1.filtered.	WGS	G26374.TCGA-06-5415-01A-01D-1486-08.1	G26374.TCGA-06-5415-01A-01D-1486-08.1.bam	1043.73	1.9	0.05	58cfa82ee4b0c9d6adf6a7ec	G26374.TCGA-06-5415-01A-01D-1486-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-5415-01A	713190ED-C6C1-4695-814B-85CA9B95E6A0	Primary Tumor	Illumina HiSeq	ed52d6d6-fd9a-42a4-a02b-6b3a443b576e	Brain	60	E0601D4F-A1DF-4F29-BABA-F8A67556A822	FCA08EE9-B480-4DC7-BE56-F1EB03B56F7C	TCGA-06-5415-01A-01D-1486-08	HG19_Broad_variant	TCGA-06-5415	TCGA-GBM	NA	s14059	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1486-08	FALSE
13722.58cfa82ee4b0c9d6adf6a7e6	58cfa82ee4b0c9d6adf6a7e6	G25774.TCGA-05-5429-01A-01D-1625-08.2.filtered.	WGS	G25774.TCGA-05-5429-01A-01D-1625-08.2	G25774.TCGA-05-5429-01A-01D-1625-08.2.bam	670.7	1.9	0.05	58cfa82ee4b0c9d6adf6a7e6	G25774.TCGA-05-5429-01A-01D-1625-08.2.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-5429-01A	63BD2175-4B7C-44C9-AEF3-9EFC8F79837B	Primary Tumor	Illumina HiSeq	5860c273-a773-4f6a-b5a1-a2999bc37419	Lung	60	FBC90B42-7D26-456B-A166-41993A1D3F0D	37D0CF1B-1743-4852-8073-372B16B5C17D	TCGA-05-5429-01A-01D-1625-08	HG19_Broad_variant	TCGA-05-5429	TCGA-LUAD	NA	s10632	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T3	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1625-08	FALSE
13722.58cfa82ee4b0c9d6adf6a894	58cfa82ee4b0c9d6adf6a894	G26383.TCGA-02-2485-01A-01D-1494-08.1.filtered.	WGS	G26383.TCGA-02-2485-01A-01D-1494-08.1	G26383.TCGA-02-2485-01A-01D-1494-08.1.bam	521.7	1.9	0.05	58cfa82ee4b0c9d6adf6a894	G26383.TCGA-02-2485-01A-01D-1494-08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-02-2485-01A	521EA765-1BD1-423D-A75D-091243DF37A9	Primary Tumor	Illumina HiSeq	fd79ff6d-c0aa-4d12-8e39-1e3f1aab26a2	Brain	53	5B5F7C1D-8F3D-4F35-8295-58BC3EEFEAB0	0332B017-17D5-4083-8FC4-9D6F8FDBBBDE	TCGA-02-2485-01A-01D-1494-08	HG19_Broad_variant	TCGA-02-2485	TCGA-GBM	NA	s14220	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6a7ea	58cfa82ee4b0c9d6adf6a7ea	G23065.TCGA_BA_5153_01A_01D_2268_08.1.filtered.	WGS	G23065.TCGA_BA_5153_01A_01D_2268_08.1	G23065.TCGA_BA_5153_01A_01D_2268_08.1.bam	422.7	1.9	0.15	58cfa82ee4b0c9d6adf6a7ea	G23065.TCGA_BA_5153_01A_01D_2268_08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5153-01A	B3631718-9E0A-454C-BEE1-8F36EBC509D8	Primary Tumor	Illumina HiSeq	29740348-2de4-44e6-bdb0-05a2fb2fd9eb	Head and Neck	51	2DC7070A-9C70-4BB1-9634-8C934BB9C8D1	24D2B176-B1AB-4789-B394-616B722E63DF	TCGA-BA-5153-01A-01D-2268-08	HG19_Broad_variant	TCGA-BA-5153	TCGA-HNSC	1762	s15484	Broad Institute of MIT and Harvard	UNC	None	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Not available	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8c2	58cfa82ee4b0c9d6adf6a8c2	G35154.TCGA-CS-6668-01A-11D-1893-08.2.filtered.	WGS	G35154.TCGA-CS-6668-01A-11D-1893-08.2	G35154.TCGA-CS-6668-01A-11D-1893-08.2.bam	220	1.9	0.05	58cfa82ee4b0c9d6adf6a8c2	G35154.TCGA-CS-6668-01A-11D-1893-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-6668-01A	A5D3F3FB-6541-419D-B47E-720D438F1BFF	Primary Tumor	Illumina HiSeq	698a92bc-1d75-4e94-a533-d41f6a195e9b	Brain	57	C6784C8A-FA04-429D-9290-40BD95F2D94D	D414E076-DCB6-4EDF-ADEF-0ABDC57354EA	TCGA-CS-6668-01A-11D-1893-08	HG19_Broad_variant	TCGA-CS-6668	TCGA-LGG	NA	s8320	Broad Institute of MIT and Harvard	Thomas Jefferson University	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1893-08	FALSE
13722.58cfa82ee4b0c9d6adf6a950	58cfa82ee4b0c9d6adf6a950	G32522.TCGA-BJ-A191-01A-11D-A13W-08.1.filtered.	WGS	G32522.TCGA-BJ-A191-01A-11D-A13W-08.1	G32522.TCGA-BJ-A191-01A-11D-A13W-08.1.bam	110.16	1.93	0.09	58cfa82ee4b0c9d6adf6a950	G32522.TCGA-BJ-A191-01A-11D-A13W-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A191-01A	2501EE46-8D38-448B-8765-E9C9706CBBE8	Primary Tumor	Illumina HiSeq	fe7c5f35-ecea-4165-8fa8-7a178959b096	Thyroid	49	C92FC4E3-7A96-4000-A969-AA894CA58A33	64C2E6A0-2341-49C4-A6DD-656E7BB505DD	TCGA-BJ-A191-01A-11D-A13W-08	HG19_Broad_variant	TCGA-BJ-A191	TCGA-THCA	NA	s11973	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T1b	N0	Other  specify	Stage I	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8c4	58cfa82ee4b0c9d6adf6a8c4	G35154.TCGA-E1-5318-01A-01D-1468-08.1.filtered.	WGS	G35154.TCGA-E1-5318-01A-01D-1468-08.1	G35154.TCGA-E1-5318-01A-01D-1468-08.1.bam	161	1.9	0.05	58cfa82ee4b0c9d6adf6a8c4	G35154.TCGA-E1-5318-01A-01D-1468-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-E1-5318-01A	400B2FA3-BAF7-4BAA-99B4-88B9F25B5049	Primary Tumor	Illumina HiSeq	0fc8cc9a-c3ea-48d6-8f7d-18ab9b69ffb1	Brain	42	EDC32A96-F912-4348-80D4-72D08129DB53	8C46A1DF-1C10-4188-992A-A55B782494C9	TCGA-E1-5318-01A-01D-1468-08	HG19_Broad_variant	TCGA-E1-5318	TCGA-LGG	2379	s8326	Broad Institute of MIT and Harvard	Duke	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1468-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9d8	58cfa82ee4b0c9d6adf6a9d8	G25252.TCGA-CV-7416-01A-11D-2334-08.1.filtered.	WGS	G25252.TCGA-CV-7416-01A-11D-2334-08.1	G25252.TCGA-CV-7416-01A-11D-2334-08.1.bam	242.7	NA	0.05	58cfa82ee4b0c9d6adf6a9d8	G25252.TCGA-CV-7416-01A-11D-2334-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7416-01A	96415324-6859-41EB-8D07-BE4E6F7D9781	Primary Tumor	Illumina HiSeq	1374c517-8c54-4a22-80e6-0f48eb1d4de6	Head and Neck	29	2E08CFFB-DA11-40A5-81AB-3B1BFFA5E2CE	2738B06F-155B-4CB8-983B-AD61D451E5AE	TCGA-CV-7416-01A-11D-2334-08	HG19_Broad_variant	TCGA-CV-7416	TCGA-HNSC	763	s15604	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T4a	Not available	Head and Neck Squamous Cell Carcinoma	Stage IVA	2334-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9ee	58cfa82ee4b0c9d6adf6a9ee	G26398.TCGA-06-5411-01A-01D-1696-08.2.filtered.	WGS	G26398.TCGA-06-5411-01A-01D-1696-08.2	G26398.TCGA-06-5411-01A-01D-1696-08.2.bam	407.03	1.9	0.05	58cfa82ee4b0c9d6adf6a9ee	G26398.TCGA-06-5411-01A-01D-1696-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-5411-01A	3F960D3B-A58C-43D0-A8A4-F3555B399C9D	Primary Tumor	Illumina HiSeq	a5235cf1-9584-4e39-be51-b383765f3fec	Brain	51	7790FA3D-C06F-4C74-B180-CA6D4F53DC7D	2FDAB641-D73B-4F9A-AA4C-C1944F131A69	TCGA-06-5411-01A-01D-1696-08	HG19_Broad_variant	TCGA-06-5411	TCGA-GBM	254	s14170	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1696-08	FALSE
13722.58cfa82ee4b0c9d6adf6a997	58cfa82ee4b0c9d6adf6a997	G25787.TCGA-78-7156-01A-11D-2036-08.1.filtered.	WGS	G25787.TCGA-78-7156-01A-11D-2036-08.1	G25787.TCGA-78-7156-01A-11D-2036-08.1.bam	405.7	NA	0.05	58cfa82ee4b0c9d6adf6a997	G25787.TCGA-78-7156-01A-11D-2036-08.1.bam	Dead	MALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-78-7156-01A	7B0622AB-63EA-483F-AE40-D3EA587BDBBA	Primary Tumor	Illumina HiSeq	f02c1668-47cc-4ebd-a656-5c2a70f1ae9f	Lung	62	FAB452A2-A57A-4D63-80BC-2AD2B5A20F03	D17EDA6C-B986-4BA3-B0E9-BAC7A751C26A	TCGA-78-7156-01A-11D-2036-08	HG19_Broad_variant	TCGA-78-7156	TCGA-LUAD	976	s10761	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T4	N1	Lung Adenocarcinoma Mixed Subtype	Stage IV	2036-08	TRUE
13722.58cfa82ee4b0c9d6adf6a95a	58cfa82ee4b0c9d6adf6a95a	G23063.TCGA_CR_7385_01A_11D_2268_08.1.filtered.	WGS	G23063.TCGA_CR_7385_01A_11D_2268_08.1	G23063.TCGA_CR_7385_01A_11D_2268_08.1.bam	289.7	NA	0.15	58cfa82ee4b0c9d6adf6a95a	G23063.TCGA_CR_7385_01A_11D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7385-01A	9F89510C-ED07-471F-B35E-7C87C237B9FE	Primary Tumor	Illumina HiSeq	0d321573-5651-4eb3-9f8c-a11f802e5e92	Head and Neck	42	4C4A6867-BABE-4032-A639-A9B31CDDDC6C	6BBD66DD-EFEE-4D6E-B02F-F88E98526B82	TCGA-CR-7385-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-7385	TCGA-HNSC	NA	s15605	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T1	NX	Head and Neck Squamous Cell Carcinoma	Not available	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6a9f6	58cfa82ee4b0c9d6adf6a9f6	G32526.TCGA-EL-A3TB-01A-11D-A22D-08.2.filtered.	WGS	G32526.TCGA-EL-A3TB-01A-11D-A22D-08.2	G32526.TCGA-EL-A3TB-01A-11D-A22D-08.2.bam	42.57	NA	0.07	58cfa82ee4b0c9d6adf6a9f6	G32526.TCGA-EL-A3TB-01A-11D-A22D-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3TB-01A	A09D0BE0-FD41-4B30-B488-9A9F2ABEF8E7	Primary Tumor	Illumina HiSeq	3b8dc42d-2715-4480-a0f4-7595b3520131	Thyroid	47	11671156-4BBF-4A3C-B074-7D6C27EE4FEE	0567D3E6-6278-4D0A-81AE-C084D73C6DD3	TCGA-EL-A3TB-01A-11D-A22D-08	HG19_Broad_variant	TCGA-EL-A3TB	TCGA-THCA	NA	s12084	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A22D-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa58	58cfa82ee4b0c9d6adf6aa58	G32530.TCGA-EM-A3AQ-01A-11D-A20C-08.1.filtered.	WGS	G32530.TCGA-EM-A3AQ-01A-11D-A20C-08.1	G32530.TCGA-EM-A3AQ-01A-11D-A20C-08.1.bam	59.1	NA	0.08	58cfa82ee4b0c9d6adf6aa58	G32530.TCGA-EM-A3AQ-01A-11D-A20C-08.1.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3AQ-01A	E8F56D0F-EEE4-4DEF-A43A-DEC91F4382A1	Primary Tumor	Illumina HiSeq	c13857f7-bb38-4650-9294-ad8287c6c137	Thyroid	85	E13C3F11-913D-4371-9A7D-5E4DF15FB42A	DBACC1AD-C88A-4BCF-A45F-E9C83C762164	TCGA-EM-A3AQ-01A-11D-A20C-08	HG19_Broad_variant	TCGA-EM-A3AQ	TCGA-THCA	NA	s12215	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T1b	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A20C-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa12	58cfa82ee4b0c9d6adf6aa12	G26396.TCGA-41-5651-01A-01D-1696-08.1.filtered.	WGS	G26396.TCGA-41-5651-01A-01D-1696-08.1	G26396.TCGA-41-5651-01A-01D-1696-08.1.bam	350.03	1.9	0.05	58cfa82ee4b0c9d6adf6aa12	G26396.TCGA-41-5651-01A-01D-1696-08.1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-41-5651-01A	C184C3CA-7AD3-4202-B108-CB9FD5F5D947	Primary Tumor	Illumina HiSeq	cdec514c-a32f-496a-81c5-cde0ec0a3b5c	Brain	59	90F74516-FB74-4D3F-9D73-5D2BEE2ED381	5FD77BA9-5015-4D8B-86A0-582E5C76BDD6	TCGA-41-5651-01A-01D-1696-08	HG19_Broad_variant	TCGA-41-5651	TCGA-GBM	NA	s14304	Broad Institute of MIT and Harvard	Christiana Healthcare	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1696-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa18	58cfa82ee4b0c9d6adf6aa18	G26362.TCGA-06-0157-01A-01D-1491-08.1.filtered.	WGS	G26362.TCGA-06-0157-01A-01D-1491-08.1	G26362.TCGA-06-0157-01A-01D-1491-08.1.bam	331.7	1.89	0.05	58cfa82ee4b0c9d6adf6aa18	G26362.TCGA-06-0157-01A-01D-1491-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0157-01A	EA3B5DA2-6A12-400C-BF0F-E442F5EC1132	Primary Tumor	Illumina HiSeq	a1c991b7-fe00-4252-815c-ac64d737bcff	Brain	63	BD8A1623-5006-4E03-9EB7-0C5A6F9E73D0	B1E62D8E-24D2-4118-8CD0-3142ACEBDD5B	TCGA-06-0157-01A-01D-1491-08	HG19_Broad_variant	TCGA-06-0157	TCGA-GBM	97	s14345	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1491-08	FALSE
13722.58cfa82ee4b0c9d6adf6aab6	58cfa82ee4b0c9d6adf6aab6	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3.filtered.	WGS	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3.bam	30.45	NA	0.08	58cfa82ee4b0c9d6adf6aab6	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3N5-01A	A658BECF-3934-49F2-9E74-291DCA61D4BB	Primary Tumor	Illumina HiSeq	3519f8d9-0eab-45e8-b398-5ddc469243cd	Bladder	69	66559B5F-AB2F-406B-9EDB-0F5085EEC7C5	418A3DEC-96FF-4719-BECB-E1A8260CCE2F	TCGA-FD-A3N5-01A-11D-A21A-08	HG19_Broad_variant	TCGA-FD-A3N5	TCGA-BLCA	NA	s2677	Broad Institute of MIT and Harvard	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6aade	58cfa82ee4b0c9d6adf6aade	G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1.filtered.	WGS	G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1	G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1.bam	55.89	NA	0.07	58cfa82ee4b0c9d6adf6aade	G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A3PJ-01A	CB664EEF-BE6F-44EF-AA90-6F6DA0E6440A	Primary Tumor	Illumina HiSeq	d7aa3a92-c61a-478e-af73-14d0204cba5d	Bladder	76	29D79B83-FA80-490E-A8A1-C51C9AD061FE	B73523D7-F5A5-4140-8537-4DF4D1ECF465	TCGA-BT-A3PJ-01A-21D-A21Z-08	HG19_Broad_variant	TCGA-BT-A3PJ	TCGA-BLCA	NA	s3071	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3a	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A21Z-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa8c	58cfa82ee4b0c9d6adf6aa8c	G32527.TCGA-FE-A3PD-01A-11D-A21Z-08.1.filtered.	WGS	G32527.TCGA-FE-A3PD-01A-11D-A21Z-08.1	G32527.TCGA-FE-A3PD-01A-11D-A21Z-08.1.bam	59.24	NA	0.08	58cfa82ee4b0c9d6adf6aa8c	G32527.TCGA-FE-A3PD-01A-11D-A21Z-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A3PD-01A	39D90499-8549-4DA5-B391-C421F18FACF1	Primary Tumor	Illumina HiSeq	afcdae7e-5422-4f04-a64d-6bbdf39605aa	Thyroid	17	A6C23CA9-E6F4-4A2C-BB86-25EF76076381	5BDCA282-C671-48FF-B32B-2380996016C0	TCGA-FE-A3PD-01A-11D-A21Z-08	HG19_Broad_variant	TCGA-FE-A3PD	TCGA-THCA	NA	s12339	Broad Institute of MIT and Harvard	Ohio State University	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A21Z-08	TRUE
13722.58cfa82ee4b0c9d6adf6aae4	58cfa82ee4b0c9d6adf6aae4	G32464.TCGA-BT-A20P-01A-11D-A14W-08.1.filtered.	WGS	G32464.TCGA-BT-A20P-01A-11D-A14W-08.1	G32464.TCGA-BT-A20P-01A-11D-A14W-08.1.bam	75.72	2.03	0.08	58cfa82ee4b0c9d6adf6aae4	G32464.TCGA-BT-A20P-01A-11D-A14W-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20P-01A	F48937ED-E294-41F0-8872-7010391167A9	Primary Tumor	Illumina HiSeq	d714be1b-c30c-4f13-8a00-4bf93507bb1c	Bladder	81	6B43EEEC-4FEB-4062-827A-E63ED8CE3820	E6C78A98-F45B-482B-A551-4F11B8C1FF8B	TCGA-BT-A20P-01A-11D-A14W-08	HG19_Broad_variant	TCGA-BT-A20P	TCGA-BLCA	544	s3394	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A14W-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab28	58cfa82ee4b0c9d6adf6ab28	G26381.TCGA-14-1823-01A-01D-1494-08.1.filtered.	WGS	G26381.TCGA-14-1823-01A-01D-1494-08.1	G26381.TCGA-14-1823-01A-01D-1494-08.1.bam	365.37	1.91	0.05	58cfa82ee4b0c9d6adf6ab28	G26381.TCGA-14-1823-01A-01D-1494-08.1.bam	Dead	FEMALE	WHITE	Not available	Glioblastoma Multiforme	Aligned reads	TCGA-14-1823-01A	A515CF2D-E918-4958-9BF6-E611B425A97E	Primary Tumor	Illumina HiSeq	38fe2fc2-ccf1-494b-89f0-54ed8a5a213c	Brain	58	7EAD0574-478A-4FE1-AABE-34965101B05D	4A1AD661-F6AE-44E8-B50B-72FF658FF22B	TCGA-14-1823-01A-01D-1494-08	HG19_Broad_variant	TCGA-14-1823	TCGA-GBM	543	s13928	Broad Institute of MIT and Harvard	Emory University	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab42	58cfa82ee4b0c9d6adf6ab42	G32525.TCGA-DJ-A13W-01A-11D-A10S-08.3.filtered.	WGS	G32525.TCGA-DJ-A13W-01A-11D-A10S-08.3	G32525.TCGA-DJ-A13W-01A-11D-A10S-08.3.bam	50.62	1.95	0.08	58cfa82ee4b0c9d6adf6ab42	G32525.TCGA-DJ-A13W-01A-11D-A10S-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13W-01A	3B48CC5E-3396-4DD5-893D-54B75B98B016	Primary Tumor	Illumina HiSeq	2a8caa63-ca28-490f-8b5c-13db08afd1c8	Thyroid	45	4DCA97A5-B0E5-4383-8CC5-B6FF07741647	0C18A8B7-BAD1-4AA4-A6DF-472F89D9761C	TCGA-DJ-A13W-01A-11D-A10S-08	HG19_Broad_variant	TCGA-DJ-A13W	TCGA-THCA	NA	s12736	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A10S-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab62	58cfa82ee4b0c9d6adf6ab62	G26402.TCGA-06-2570-01A-01D-1495-08.1.filtered.	WGS	G26402.TCGA-06-2570-01A-01D-1495-08.1	G26402.TCGA-06-2570-01A-01D-1495-08.1.bam	502.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab62	G26402.TCGA-06-2570-01A-01D-1495-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-2570-01A	B37D944C-C65C-46D6-BB8B-3EB37CB85B68	Primary Tumor	Illumina HiSeq	c73a5a07-9d52-4d32-a3bc-1c70f3116562	Brain	21	42200DBC-8248-461D-BF90-5386360213A9	04339769-517C-448D-A7CA-951F83608C60	TCGA-06-2570-01A-01D-1495-08	HG19_Broad_variant	TCGA-06-2570	TCGA-GBM	NA	s13893	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1495-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab00	58cfa82ee4b0c9d6adf6ab00	G26405.TCGA-14-2554-01A-01D-1494-08.1.filtered.	WGS	G26405.TCGA-14-2554-01A-01D-1494-08.1	G26405.TCGA-14-2554-01A-01D-1494-08.1.bam	335.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab00	G26405.TCGA-14-2554-01A-01D-1494-08.1.bam	Dead	FEMALE	WHITE	Not available	Glioblastoma Multiforme	Aligned reads	TCGA-14-2554-01A	B1C4579C-72FA-4974-830C-B6A81ACE45F4	Primary Tumor	Illumina HiSeq	88f8661f-2c61-4518-94b2-eae9bec254e6	Brain	52	E8013962-7049-4596-AA49-E6403F608D98	53DEC97D-0464-4FFD-8E2E-95B2B9A03AF0	TCGA-14-2554-01A-01D-1494-08	HG19_Broad_variant	TCGA-14-2554	TCGA-GBM	532	s14371	Broad Institute of MIT and Harvard	Emory University	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6aba2	58cfa82ee4b0c9d6adf6aba2	G26376.TCGA-27-2523-01A-01D-1494-08.1.filtered.	WGS	G26376.TCGA-27-2523-01A-01D-1494-08.1	G26376.TCGA-27-2523-01A-01D-1494-08.1.bam	742.7	1.9	0.05	58cfa82ee4b0c9d6adf6aba2	G26376.TCGA-27-2523-01A-01D-1494-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-27-2523-01A	737B35E1-D668-4FCE-9B6E-76946C7952B6	Primary Tumor	Illumina HiSeq	6359c1e1-c29c-4c79-a8ae-237f7a11a242	Brain	63	96881D37-7A3E-4910-B897-19453118FE7C	D60F54F5-B154-42C4-99FB-CEA4E7A33DC7	TCGA-27-2523-01A-01D-1494-08	HG19_Broad_variant	TCGA-27-2523	TCGA-GBM	489	s13892	Broad Institute of MIT and Harvard	Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac76	58cfa82ee4b0c9d6adf6ac76	G41960.TCGA-50-5932-01A-11D-1753-08.2.filtered.	WGS	G41960.TCGA-50-5932-01A-11D-1753-08.2	G41960.TCGA-50-5932-01A-11D-1753-08.2.bam	289.4	1.9	0.05	58cfa82ee4b0c9d6adf6ac76	G41960.TCGA-50-5932-01A-11D-1753-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5932-01A	EBCBA7F2-CE13-4BAE-97CD-91A6B1DCD465	Primary Tumor	Illumina HiSeq	3c2b6b67-de08-43ef-a735-28548120fa66	Lung	75	7ECB9621-7A1F-4876-9DFB-9B77CC4CB7B4	6726C157-F688-491D-8B56-35628645DF89	TCGA-50-5932-01A-11D-1753-08	HG19_Broad_variant	TCGA-50-5932	TCGA-LUAD	1235	s11324	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1753-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac34	58cfa82ee4b0c9d6adf6ac34	G39020.TCGA-BR-4280-01A-01D-A290-08.1.filtered.	WGS	G39020.TCGA-BR-4280-01A-01D-A290-08.1	G39020.TCGA-BR-4280-01A-01D-A290-08.1.bam	252.9	1.9	0.07	58cfa82ee4b0c9d6adf6ac34	G39020.TCGA-BR-4280-01A-01D-A290-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4280-01A	E0916597-E489-45EF-A8F7-653A3C6591EF	Primary Tumor	Illumina HiSeq	82a3e711-b833-4607-8007-dd29e00eea85	Stomach	78	797D2D3A-F01C-4985-B27C-4E4C2838D34D	388A8875-C3F5-494E-8456-28BE8D3626E1	TCGA-BR-4280-01A-01D-A290-08	HG19_Broad_variant	TCGA-BR-4280	TCGA-STAD	NA	s14679	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T2b	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	A290-08	TRUE
13722.58cfa82ee4b0c9d6adf6ace9	58cfa82ee4b0c9d6adf6ace9	G39020.TCGA-CG-4443-01A-01D-A290-08.2.filtered.	WGS	G39020.TCGA-CG-4443-01A-01D-A290-08.2	G39020.TCGA-CG-4443-01A-01D-A290-08.2.bam	261.2	1.9	0.08	58cfa82ee4b0c9d6adf6ace9	G39020.TCGA-CG-4443-01A-01D-A290-08.2.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4443-01A	8CB0144B-BE6B-40A1-86A2-708F96D9B615	Primary Tumor	Illumina HiSeq	67df24ad-ea00-45a4-b4b5-b494b97f34df	Stomach	68	F4FB736A-42C9-4367-A327-D0D1C4CBA359	D8D5585D-32CD-4AC4-B410-A4122A17A558	TCGA-CG-4443-01A-01D-A290-08	HG19_Broad_variant	TCGA-CG-4443	TCGA-STAD	NA	s14391	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T1	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IA	A290-08	TRUE
13722.58cfa82ee4b0c9d6adf6aee0	58cfa82ee4b0c9d6adf6aee0	G39020.TCGA-HF-7136-01A-11D-2053-08.2.filtered.	WGS	G39020.TCGA-HF-7136-01A-11D-2053-08.2	G39020.TCGA-HF-7136-01A-11D-2053-08.2.bam	210.7	NA	0.05	58cfa82ee4b0c9d6adf6aee0	G39020.TCGA-HF-7136-01A-11D-2053-08.2.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-HF-7136-01A	647DC54F-A51B-40EA-9D97-C93598C2AF71	Primary Tumor	Illumina HiSeq	09ada83c-8149-4ed4-8e85-b2c9be12c8d5	Stomach	NA	F6BB75B6-D0C9-49C5-99D0-E658B490C98D	622EAA04-B8F9-471B-98B0-7BEFD119F14C	TCGA-HF-7136-01A-11D-2053-08	HG19_Broad_variant	TCGA-HF-7136	TCGA-STAD	NA	s14603	Broad Institute of MIT and Harvard	Ontario Institute for Cancer Research (OICR)	Canada	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIIA	2053-08	FALSE
13722.58cfa82ee4b0c9d6adf6af48	58cfa82ee4b0c9d6adf6af48	G41960.TCGA-78-7158-01A-11D-2036-08.2.filtered.	WGS	G41960.TCGA-78-7158-01A-11D-2036-08.2	G41960.TCGA-78-7158-01A-11D-2036-08.2.bam	575.7	NA	0.05	58cfa82ee4b0c9d6adf6af48	G41960.TCGA-78-7158-01A-11D-2036-08.2.bam	Dead	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-78-7158-01A	501C987E-D1EB-48A9-89EB-72A5062C90B4	Primary Tumor	Illumina HiSeq	a905fe2c-571c-4769-9c35-b107679cad76	Lung	59	EE0D4640-5609-430E-8B80-3058A3F313A8	199BBB0F-996C-40C1-B06D-2066F04BE778	TCGA-78-7158-01A-11D-2036-08	HG19_Broad_variant	TCGA-78-7158	TCGA-LUAD	179	s11325	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T4	N2	Lung Adenocarcinoma Mixed Subtype	Stage IIIB	2036-08	TRUE
13722.58cfa82ee4b0c9d6adf6b056	58cfa82ee4b0c9d6adf6b056	G41960.TCGA-97-8171-01A-11D-2284-08.2.filtered.	WGS	G41960.TCGA-97-8171-01A-11D-2284-08.2	G41960.TCGA-97-8171-01A-11D-2284-08.2.bam	239.3	NA	0.05	58cfa82ee4b0c9d6adf6b056	G41960.TCGA-97-8171-01A-11D-2284-08.2.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-97-8171-01A	397D3F69-1453-4057-B177-8723EEC923D1	Primary Tumor	Illumina HiSeq	e34a02d6-fc08-42eb-af7c-d4b40644bcf3	Lung	81	84CB5264-6158-40EC-8B65-F96A4A7D6CE4	FA2C3620-7E82-4B12-B135-87986F0F2890	TCGA-97-8171-01A-11D-2284-08	HG19_Broad_variant	TCGA-97-8171	TCGA-LUAD	NA	s10766	Broad Institute of MIT and Harvard	Washington University - NYU	United States	NO	T2a	N2	Lung Papillary Adenocarcinoma	Stage IV	2284-08	FALSE
13722.58cfa82ee4b0c9d6adf6a8aa	58cfa82ee4b0c9d6adf6a8aa	G35154.TCGA-E1-5319-01A-01D-1893-08.4.filtered.	WGS	G35154.TCGA-E1-5319-01A-01D-1893-08.4	G35154.TCGA-E1-5319-01A-01D-1893-08.4.bam	56	1.9	0.05	58cfa82ee4b0c9d6adf6a8aa	G35154.TCGA-E1-5319-01A-01D-1893-08.4.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-E1-5319-01A	84569C1A-6BAA-4380-AE3C-707DF1BE4618	Primary Tumor	Illumina HiSeq	6b14040f-a3ce-4fe5-a5f9-f311cd1ec11a	Brain	48	1EE9478B-84A5-4FFD-8499-F2E02A3A21D7	D252A54E-0377-4B3E-8228-26108EA704FA	TCGA-E1-5319-01A-01D-1893-08	HG19_Broad_variant	TCGA-E1-5319	TCGA-LGG	2907	s8323	Broad Institute of MIT and Harvard	Duke	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1893-08	FALSE
13722.58cfa82ee4b0c9d6adf6a8f4	58cfa82ee4b0c9d6adf6a8f4	G32456.TCGA-CF-A3MF-01A-12D-A21A-08.2.filtered.	WGS	G32456.TCGA-CF-A3MF-01A-12D-A21A-08.2	G32456.TCGA-CF-A3MF-01A-12D-A21A-08.2.bam	55.07	NA	0.08	58cfa82ee4b0c9d6adf6a8f4	G32456.TCGA-CF-A3MF-01A-12D-A21A-08.2.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A3MF-01A	1E308B12-0590-4DAE-94D0-A539FCF25DF7	Primary Tumor	Illumina HiSeq	62e960fb-aaf6-4d7e-b15d-1b5136f6fa37	Bladder	34	E9889071-4C6E-4761-9D65-06C6B5989FB7	C66C92D5-DF65-46E6-861D-D8A98808E6A3	TCGA-CF-A3MF-01A-12D-A21A-08	HG19_Broad_variant	TCGA-CF-A3MF	TCGA-BLCA	NA	s2683	Broad Institute of MIT and Harvard	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6a91a	58cfa82ee4b0c9d6adf6a91a	G32524.TCGA-DJ-A1QL-01A-11D-A14W-08.2.filtered.	WGS	G32524.TCGA-DJ-A1QL-01A-11D-A14W-08.2	G32524.TCGA-DJ-A1QL-01A-11D-A14W-08.2.bam	77.76	1.96	0.09	58cfa82ee4b0c9d6adf6a91a	G32524.TCGA-DJ-A1QL-01A-11D-A14W-08.2.bam	Alive	MALE	Not available	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QL-01A	E4B08E66-0772-4956-8670-E5C6553EECBE	Primary Tumor	Illumina HiSeq	c90da8dc-3705-4381-a713-d4a404dd09ce	Thyroid	70	62B6D426-E1E4-48E8-BC8F-6B07C67CC0D0	79169C46-7049-4576-9885-63973DB76AB9	TCGA-DJ-A1QL-01A-11D-A14W-08	HG19_Broad_variant	TCGA-DJ-A1QL	TCGA-THCA	NA	s12217	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A14W-08	TRUE
13722.58cfa82ee4b0c9d6adf6a94c	58cfa82ee4b0c9d6adf6a94c	G35154.TCGA-CS-5395-01A-01D-1468-08.1.filtered.	WGS	G35154.TCGA-CS-5395-01A-01D-1468-08.1	G35154.TCGA-CS-5395-01A-01D-1468-08.1.bam	44	1.9	0.05	58cfa82ee4b0c9d6adf6a94c	G35154.TCGA-CS-5395-01A-01D-1468-08.1.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	Not available	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-5395-01A	F86FA219-34E9-4812-8EDF-2B66D7219779	Primary Tumor	Illumina HiSeq	409fc6a2-e9df-4391-988e-bcb0d9e990b8	Brain	43	CB40F8BB-879E-496D-AE52-5535B277A952	3D477AC1-3BDF-4410-9594-1A3A1412C6AE	TCGA-CS-5395-01A-01D-1468-08	HG19_Broad_variant	TCGA-CS-5395	TCGA-LGG	639	s8319	Broad Institute of MIT and Harvard	Thomas Jefferson University	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1468-08	FALSE
13722.58cfa82ee4b0c9d6adf6a95c	58cfa82ee4b0c9d6adf6a95c	G35154.TCGA-DU-7301-01A-11D-2086-08.3.filtered.	WGS	G35154.TCGA-DU-7301-01A-11D-2086-08.3	G35154.TCGA-DU-7301-01A-11D-2086-08.3.bam	33	NA	0.05	58cfa82ee4b0c9d6adf6a95c	G35154.TCGA-DU-7301-01A-11D-2086-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7301-01A	84AE73E4-3B39-4444-9BFB-3FC6057EAB32	Primary Tumor	Illumina HiSeq	a788486c-7bba-436f-a31c-a5d294155cc6	Brain	53	D6BFF803-8B4A-44A1-AF59-0F2BABA7895F	BA94C29B-B76E-4D67-BF5A-CE6BC45D85F8	TCGA-DU-7301-01A-11D-2086-08	HG19_Broad_variant	TCGA-DU-7301	TCGA-LGG	788	s8325	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2086-08	FALSE
13722.58cfa82ee4b0c9d6adf6a966	58cfa82ee4b0c9d6adf6a966	G35154.TCGA-HW-7487-01A-11D-2024-08.3.filtered.	WGS	G35154.TCGA-HW-7487-01A-11D-2024-08.3	G35154.TCGA-HW-7487-01A-11D-2024-08.3.bam	85	NA	0.05	58cfa82ee4b0c9d6adf6a966	G35154.TCGA-HW-7487-01A-11D-2024-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HW-7487-01A	42251E02-B687-4BF1-A1B6-E3DD978542E4	Primary Tumor	Illumina HiSeq	efb882b9-fe40-4205-a704-5757740ee898	Brain	39	3040F10C-04E1-4CF8-8EAD-D74C856425C8	C1ABB741-4FCD-4161-B057-C7EFD619CC99	TCGA-HW-7487-01A-11D-2024-08	HG19_Broad_variant	TCGA-HW-7487	TCGA-LGG	NA	s8550	Broad Institute of MIT and Harvard	MSKCC	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2024-08	FALSE
13722.58cfa82ee4b0c9d6adf6a974	58cfa82ee4b0c9d6adf6a974	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1.filtered.	WGS	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1.bam	35.04	2	0.07	58cfa82ee4b0c9d6adf6a974	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A7-01A	3ED614E7-F356-4D87-985B-D3BBBAE3BB40	Primary Tumor	Illumina HiSeq	7a0d461d-525e-4b3a-86d1-d6d3306fb405	Bladder	67	D68D16F7-6117-4D3D-8347-CF5CD3F23AE4	91F458E6-64B7-454D-A542-B0AA23638FD8	TCGA-DK-A1A7-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A7	TCGA-BLCA	NA	s3070	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6a986	58cfa82ee4b0c9d6adf6a986	G35154.TCGA-DU-6407-01A-13D-1705-08.1.filtered.	WGS	G35154.TCGA-DU-6407-01A-13D-1705-08.1	G35154.TCGA-DU-6407-01A-13D-1705-08.1.bam	19.3	1.9	0.05	58cfa82ee4b0c9d6adf6a986	G35154.TCGA-DU-6407-01A-13D-1705-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6407-01A	70939245-41E0-4845-A473-5FEF719B9828	Primary Tumor	Illumina HiSeq	52ae2dd2-f573-41c6-ad1a-18b19c9eea35	Brain	35	29D91F2B-C040-46BC-9B9E-3A41790DC664	F92A34FA-014E-4B41-A6D0-3B46B8C8A3EE	TCGA-DU-6407-01A-13D-1705-08	HG19_Broad_variant	TCGA-DU-6407	TCGA-LGG	2875	s8532	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1705-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa80	58cfa82ee4b0c9d6adf6aa80	G32533.TCGA-EM-A3FQ-01A-11D-A21A-08.3.filtered.	WGS	G32533.TCGA-EM-A3FQ-01A-11D-A21A-08.3	G32533.TCGA-EM-A3FQ-01A-11D-A21A-08.3.bam	10.98	NA	0.08	58cfa82ee4b0c9d6adf6aa80	G32533.TCGA-EM-A3FQ-01A-11D-A21A-08.3.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3FQ-01A	FEF9C64F-5959-4DA0-AAA2-66B56FC7B4C3	Primary Tumor	Illumina HiSeq	dbbab09c-382c-48f0-aeca-e5ec1cc0c948	Thyroid	19	4F88157A-572E-4236-B956-206A9E227DEB	79133E29-BA0B-4E2F-A6D9-BF294C5144F0	TCGA-EM-A3FQ-01A-11D-A21A-08	HG19_Broad_variant	TCGA-EM-A3FQ	TCGA-THCA	NA	s12731	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T3	N1b	Other  specify	Stage I	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa88	58cfa82ee4b0c9d6adf6aa88	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.2.filtered.	WGS	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.2	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.2.bam	70.38	1.89	0.08	58cfa82ee4b0c9d6adf6aa88	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AG-01A	F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5	Primary Tumor	Illumina HiSeq	9ef4c333-8532-4ab7-bd4b-ba1161f87a6d	Bladder	65	64668AA0-DDE5-4534-8CD0-378881E4A4E4	7D2A22EB-7344-4CBA-AD7D-94C3F9EF3D7C	TCGA-DK-A1AG-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1AG	TCGA-BLCA	NA	s2848	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6aaba	58cfa82ee4b0c9d6adf6aaba	G32470.TCGA-FT-A3EE-01A-11D-A202-08.2.filtered.	WGS	G32470.TCGA-FT-A3EE-01A-11D-A202-08.2	G32470.TCGA-FT-A3EE-01A-11D-A202-08.2.bam	35.79	NA	0.07	58cfa82ee4b0c9d6adf6aaba	G32470.TCGA-FT-A3EE-01A-11D-A202-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FT-A3EE-01A	CCE62116-3DCD-400D-ADA0-9839CA02466E	Primary Tumor	Illumina HiSeq	cff49411-c565-469a-83c7-9a253f6b129d	Bladder	80	2356F78C-0653-468F-83DB-6CF6107BD259	FFDD4FEB-ACA3-4104-B1E8-954D705A6450	TCGA-FT-A3EE-01A-11D-A202-08	HG19_Broad_variant	TCGA-FT-A3EE	TCGA-BLCA	99	s3067	Broad Institute of MIT and Harvard	BLN - University of Miami	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A202-08	TRUE
13722.58cfa82ee4b0c9d6adf6aac4	58cfa82ee4b0c9d6adf6aac4	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.1.filtered.	WGS	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.1	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.1.bam	30.45	NA	0.08	58cfa82ee4b0c9d6adf6aac4	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3N5-01A	A658BECF-3934-49F2-9E74-291DCA61D4BB	Primary Tumor	Illumina HiSeq	2650b346-1fc6-4664-bfd1-3765e04cf29a	Bladder	69	66559B5F-AB2F-406B-9EDB-0F5085EEC7C5	418A3DEC-96FF-4719-BECB-E1A8260CCE2F	TCGA-FD-A3N5-01A-11D-A21A-08	HG19_Broad_variant	TCGA-FD-A3N5	TCGA-BLCA	NA	s3248	Broad Institute of MIT and Harvard	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6aad4	58cfa82ee4b0c9d6adf6aad4	G32539.TCGA-EM-A3AL-01A-11D-A202-08.1.filtered.	WGS	G32539.TCGA-EM-A3AL-01A-11D-A202-08.1	G32539.TCGA-EM-A3AL-01A-11D-A202-08.1.bam	56.44	NA	0.08	58cfa82ee4b0c9d6adf6aad4	G32539.TCGA-EM-A3AL-01A-11D-A202-08.1.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3AL-01A	0C50A2C2-1D4C-45CA-9127-F96D4DB18DAF	Primary Tumor	Illumina HiSeq	6ad47953-e067-450e-9c68-69b531caba51	Thyroid	45	593736E0-1BED-4EAF-BAC9-E90620554F1D	248FD0ED-F14C-40B8-9F14-E9C7ADF16E22	TCGA-EM-A3AL-01A-11D-A202-08	HG19_Broad_variant	TCGA-EM-A3AL	TCGA-THCA	NA	s12613	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T1b	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A202-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab22	58cfa82ee4b0c9d6adf6ab22	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3.filtered.	WGS	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3.bam	85.12	1.95	0.08	58cfa82ee4b0c9d6adf6ab22	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3.bam	Alive	MALE	WHITE	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A6-01A	9C274536-3CA1-4F0E-93A8-1688074D862F	Primary Tumor	Illumina HiSeq	694693d8-dc04-4516-bc18-e8a9ccb24d28	Bladder	53	7AD1CD01-0EA2-4FA4-9B05-C280BD256546	DF8A913C-5160-4FC5-950D-7C890E24E820	TCGA-DK-A1A6-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A6	TCGA-BLCA	NA	s2847	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T2a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab2e	58cfa82ee4b0c9d6adf6ab2e	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.2.filtered.	WGS	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.2	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.2.bam	85.12	1.95	0.08	58cfa82ee4b0c9d6adf6ab2e	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.2.bam	Alive	MALE	WHITE	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A6-01A	9C274536-3CA1-4F0E-93A8-1688074D862F	Primary Tumor	Illumina HiSeq	99a71c72-13a7-4c05-ae15-ccfd0da321dd	Bladder	53	7AD1CD01-0EA2-4FA4-9B05-C280BD256546	DF8A913C-5160-4FC5-950D-7C890E24E820	TCGA-DK-A1A6-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A6	TCGA-BLCA	NA	s3073	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T2a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab6c	58cfa82ee4b0c9d6adf6ab6c	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2.filtered.	WGS	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2.bam	35.04	2	0.07	58cfa82ee4b0c9d6adf6ab6c	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A7-01A	3ED614E7-F356-4D87-985B-D3BBBAE3BB40	Primary Tumor	Illumina HiSeq	4eade8e4-0984-473e-99f5-523fdc631190	Bladder	67	D68D16F7-6117-4D3D-8347-CF5CD3F23AE4	91F458E6-64B7-454D-A542-B0AA23638FD8	TCGA-DK-A1A7-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A7	TCGA-BLCA	NA	s3074	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab86	58cfa82ee4b0c9d6adf6ab86	G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5.filtered.	WGS	G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5	G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5.bam	39.39	NA	0.07	58cfa82ee4b0c9d6adf6ab86	G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-A4IH-01A	BD75D8EE-916B-4ABC-BF33-BCE6A4217076	Primary Tumor	Illumina HiSeq	dc2ac994-c455-4e1f-9319-2865614853ba	Head and Neck	57	F87EFB5E-24F5-4D2B-B6B3-987BBDA30E03	B537BC07-9998-49F4-BBBE-5B617152BFD9	TCGA-BA-A4IH-01A-11D-A25T-08	HG19_Broad_variant	TCGA-BA-A4IH	TCGA-HNSC	NA	s15747	Broad Institute of MIT and Harvard	UNC	United States	NO	T2	N1	Head and Neck Squamous Cell Carcinoma Basaloid Type	Stage IVA	A25T-08	FALSE
13722.58cfa82ee4b0c9d6adf6aba3	58cfa82ee4b0c9d6adf6aba3	G32532.TCGA-EL-A3H1-01A-11D-A21A-08.3.filtered.	WGS	G32532.TCGA-EL-A3H1-01A-11D-A21A-08.3	G32532.TCGA-EL-A3H1-01A-11D-A21A-08.3.bam	31.88	NA	0.08	58cfa82ee4b0c9d6adf6aba3	G32532.TCGA-EL-A3H1-01A-11D-A21A-08.3.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3H1-01A	8D54A2ED-03F1-4A23-BDD2-F3395F5D3716	Primary Tumor	Illumina HiSeq	9cc1b2f2-01f5-4ed3-873b-152726b61e55	Thyroid	66	9ED0332E-C846-4091-BF6E-0C5BF55B9F1A	62FCEB56-8C6E-4D20-9D2F-5B7042854D23	TCGA-EL-A3H1-01A-11D-A21A-08	HG19_Broad_variant	TCGA-EL-A3H1	TCGA-THCA	1500	s12733	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6abaa	58cfa82ee4b0c9d6adf6abaa	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4.filtered.	WGS	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4.bam	59.04	1.91	0.08	58cfa82ee4b0c9d6adf6abaa	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A5-01A	904A8757-E0C5-41EF-B583-C8F170CAAAC1	Primary Tumor	Illumina HiSeq	f0ccddad-f1d5-4cd3-bad7-f9710dba4127	Bladder	79	A9EF3EC5-B1C1-481F-89CF-1729FAB50173	448FE471-3F4E-4DC8-A4E0-6F147DC93ABE	TCGA-DK-A1A5-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A5	TCGA-BLCA	65	s3066	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6abb8	58cfa82ee4b0c9d6adf6abb8	G32453.TCGA-DK-A3IL-01A-11D-A20D-08.3.filtered.	WGS	G32453.TCGA-DK-A3IL-01A-11D-A20D-08.3	G32453.TCGA-DK-A3IL-01A-11D-A20D-08.3.bam	32.38	NA	0.08	58cfa82ee4b0c9d6adf6abb8	G32453.TCGA-DK-A3IL-01A-11D-A20D-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IL-01A	178B28CD-99C3-48DC-8D09-1EF71B4CEE80	Primary Tumor	Illumina HiSeq	092f2192-b2d3-48e8-be2f-f56c1febe40b	Bladder	79	59D6683F-5EB7-493D-8E8E-78B88BE2CD70	4838B5A9-968C-4178-BFFB-3FAFE1F6DC09	TCGA-DK-A3IL-01A-11D-A20D-08	HG19_Broad_variant	TCGA-DK-A3IL	TCGA-BLCA	NA	s2844	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A20D-08	TRUE
13722.58cfa82ee4b0c9d6adf6abd6	58cfa82ee4b0c9d6adf6abd6	G32535.TCGA-FK-A3SE-01A-11D-A22D-08.1.filtered.	WGS	G32535.TCGA-FK-A3SE-01A-11D-A22D-08.1	G32535.TCGA-FK-A3SE-01A-11D-A22D-08.1.bam	31.42	NA	0.08	58cfa82ee4b0c9d6adf6abd6	G32535.TCGA-FK-A3SE-01A-11D-A22D-08.1.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FK-A3SE-01A	AFB00CD4-E5DA-4251-86FB-532C3F65324C	Primary Tumor	Illumina HiSeq	e2561be5-1c52-4774-a3d5-2a7800d87c6a	Thyroid	31	D3CC158D-413D-49E6-8D23-3ED89FDEA94A	90883300-D4B6-45D7-AF9A-4E4CE4104500	TCGA-FK-A3SE-01A-11D-A22D-08	HG19_Broad_variant	TCGA-FK-A3SE	TCGA-THCA	NA	s12216	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A22D-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac56	58cfa82ee4b0c9d6adf6ac56	G39020.TCGA-BR-6452-01A-12D-1800-08.1.filtered.	WGS	G39020.TCGA-BR-6452-01A-12D-1800-08.1	G39020.TCGA-BR-6452-01A-12D-1800-08.1.bam	409.4	1.9	0.05	58cfa82ee4b0c9d6adf6ac56	G39020.TCGA-BR-6452-01A-12D-1800-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6452-01A	27988B3E-CDE1-4F4B-82A1-6D8AD08DB8E9	Primary Tumor	Illumina HiSeq	e69add2b-1a4d-44e6-8186-3fb2163afa5f	Stomach	78	76144F2F-2498-430D-B33C-F000394C427E	C8E961B4-E324-40A2-89F6-736EC3845BC9	TCGA-BR-6452-01A-12D-1800-08	HG19_Broad_variant	TCGA-BR-6452	TCGA-STAD	NA	s14524	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIA	1800-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad73	58cfa82ee4b0c9d6adf6ad73	G32529.TCGA-ET-A3DV-01A-12D-A202-08.3.filtered.	WGS	G32529.TCGA-ET-A3DV-01A-12D-A202-08.3	G32529.TCGA-ET-A3DV-01A-12D-A202-08.3.bam	16.24	NA	0.08	58cfa82ee4b0c9d6adf6ad73	G32529.TCGA-ET-A3DV-01A-12D-A202-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A3DV-01A	B46D88E9-8477-4900-8DA9-5E7DBDED0653	Primary Tumor	Illumina HiSeq	6319fae0-343d-45e8-a507-cc9f7acf1b38	Thyroid	68	CE24FE0A-5C4D-4FBE-A02C-76345EAA2892	5DEEAA45-4C1B-4AB2-A487-93C548838F68	TCGA-ET-A3DV-01A-12D-A202-08	HG19_Broad_variant	TCGA-ET-A3DV	TCGA-THCA	NA	s12343	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A202-08	TRUE
13722.58cfa82ee4b0c9d6adf6adb2	58cfa82ee4b0c9d6adf6adb2	G39020.TCGA-CG-5730-01A-11D-1600-08.1.filtered.	WGS	G39020.TCGA-CG-5730-01A-11D-1600-08.1	G39020.TCGA-CG-5730-01A-11D-1600-08.1.bam	326.3	1.9	0.05	58cfa82ee4b0c9d6adf6adb2	G39020.TCGA-CG-5730-01A-11D-1600-08.1.bam	Alive	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5730-01A	09587F1C-5C99-4102-BC49-84D50FA8D0CE	Primary Tumor	Illumina HiSeq	e44c7152-648d-41d1-91c5-7e8d1c29b687	Stomach	80	2986F11F-3C18-4621-8406-D46614537ED4	26ED0DD6-FCF5-4B45-A3A9-6F813D5FBAF7	TCGA-CG-5730-01A-11D-1600-08	HG19_Broad_variant	TCGA-CG-5730	TCGA-STAD	NA	s14959	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1600-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8ac	58cfa82ee4b0c9d6adf6a8ac	G35154.TCGA-EZ-7264-01A-11D-2024-08.2.filtered.	WGS	G35154.TCGA-EZ-7264-01A-11D-2024-08.2	G35154.TCGA-EZ-7264-01A-11D-2024-08.2.bam	329	NA	0.05	58cfa82ee4b0c9d6adf6a8ac	G35154.TCGA-EZ-7264-01A-11D-2024-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-EZ-7264-01A	FC3B7596-F515-446F-81DB-FED0154CA2C5	Primary Tumor	Illumina HiSeq	e0ea4522-35f1-40c7-92d2-5d1e7ec0cb63	Brain	47	EECBA415-5517-4265-8944-07AACBC679FB	00493087-9D9D-40CA-86D5-936F1B951C93	TCGA-EZ-7264-01A-11D-2024-08	HG19_Broad_variant	TCGA-EZ-7264	TCGA-LGG	NA	s8329	Broad Institute of MIT and Harvard	UNC	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2024-08	FALSE
13722.58cfa82de4b0c9d6adf6a76e	58cfa82de4b0c9d6adf6a76e	G14581.TCGA-64-1680-01A-02D-1040-01.2.filtered.	WGS	G14581.TCGA-64-1680-01A-02D-1040-01.2	G14581.TCGA-64-1680-01A-02D-1040-01.2.bam	380.53	1.9	0.15	58cfa82de4b0c9d6adf6a76e	G14581.TCGA-64-1680-01A-02D-1040-01.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-64-1680-01A	1AB7AD70-0F80-41D8-8EFA-3BAEBC8223CC	Primary Tumor	Illumina HiSeq	6b9dbd25-b2c7-4ba6-8030-e98c1c8e9991	Lung	63	0BDBE623-CF95-465A-917D-87DFB6A8618E	DD09C7AA-744A-413D-839F-E75E1825F9F9	TCGA-64-1680-01A-02D-1040-01	HG19_Broad_variant	TCGA-64-1680	TCGA-LUAD	NA	s11313	Broad Institute of MIT and Harvard	Fox Chase	None	NO	T2a	N2	Lung Adenocarcinoma Mixed Subtype	Stage IV	1040-01	FALSE
13722.58cfa82ee4b0c9d6adf6a8d7	58cfa82ee4b0c9d6adf6a8d7	G32459.TCGA-BL-A13J-01A-11D-A10S-08.3.filtered.	WGS	G32459.TCGA-BL-A13J-01A-11D-A10S-08.3	G32459.TCGA-BL-A13J-01A-11D-A10S-08.3.bam	57.46	1.9	0.08	58cfa82ee4b0c9d6adf6a8d7	G32459.TCGA-BL-A13J-01A-11D-A10S-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A13J-01A	556FCBC8-172A-4AF1-8822-AE036E8D68E8	Primary Tumor	Illumina HiSeq	37852645-c37a-4adb-8701-9300e0dcdb65	Bladder	65	CF23846D-A7D2-40A9-8B51-49A27967D101	0C7ACA3F-E006-4DE3-AFC2-20B4F727D4FD	TCGA-BL-A13J-01A-11D-A10S-08	HG19_Broad_variant	TCGA-BL-A13J	TCGA-BLCA	81	s3075	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T4	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A10S-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8b0	58cfa82ee4b0c9d6adf6a8b0	G35154.TCGA-FG-5964-01A-11D-1705-08.4.filtered.	WGS	G35154.TCGA-FG-5964-01A-11D-1705-08.4	G35154.TCGA-FG-5964-01A-11D-1705-08.4.bam	102.3	1.9	0.05	58cfa82ee4b0c9d6adf6a8b0	G35154.TCGA-FG-5964-01A-11D-1705-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-5964-01A	648252DA-DD86-48D1-AE75-4257E3142B0B	Primary Tumor	Illumina HiSeq	7c465b99-b3c1-44c6-899f-74975fb3d594	Brain	62	7BBFBDD1-4CB9-479C-8152-924D79E112F2	C6888BE2-4517-41E4-A801-9C915F24E737	TCGA-FG-5964-01A-11D-1705-08	HG19_Broad_variant	TCGA-FG-5964	TCGA-LGG	NA	s8109	Broad Institute of MIT and Harvard	Case Western	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1705-08	FALSE
13722.58cfa82ee4b0c9d6adf6a8d2	58cfa82ee4b0c9d6adf6a8d2	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3.filtered.	WGS	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3.bam	70.38	1.89	0.08	58cfa82ee4b0c9d6adf6a8d2	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AG-01A	F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5	Primary Tumor	Illumina HiSeq	af228568-1064-4709-8bc8-435278c73ca0	Bladder	65	64668AA0-DDE5-4534-8CD0-378881E4A4E4	7D2A22EB-7344-4CBA-AD7D-94C3F9EF3D7C	TCGA-DK-A1AG-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1AG	TCGA-BLCA	NA	s2687	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8ec	58cfa82ee4b0c9d6adf6a8ec	G35154.TCGA-HT-7695-01A-11D-2253-08.1.filtered.	WGS	G35154.TCGA-HT-7695-01A-11D-2253-08.1	G35154.TCGA-HT-7695-01A-11D-2253-08.1.bam	86	NA	0.05	58cfa82ee4b0c9d6adf6a8ec	G35154.TCGA-HT-7695-01A-11D-2253-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7695-01A	5017C115-39B8-4C5C-8BE6-2CB298D7C641	Primary Tumor	Illumina HiSeq	0e08feb2-0a06-458b-a3ea-797020f9a68f	Brain	29	8B58DBF3-022C-4337-9FAD-5AE43B1B84F2	86386B36-2950-4479-B79F-4B347053C8BC	TCGA-HT-7695-01A-11D-2253-08	HG19_Broad_variant	TCGA-HT-7695	TCGA-LGG	NA	s8538	Broad Institute of MIT and Harvard	Case Western - St Joes	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2253-08	FALSE
13722.58cfa82ee4b0c9d6adf6a8e0	58cfa82ee4b0c9d6adf6a8e0	G35154.TCGA-DB-5278-01A-01D-1468-08.1.filtered.	WGS	G35154.TCGA-DB-5278-01A-01D-1468-08.1	G35154.TCGA-DB-5278-01A-01D-1468-08.1.bam	215.3	1.9	0.05	58cfa82ee4b0c9d6adf6a8e0	G35154.TCGA-DB-5278-01A-01D-1468-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DB-5278-01A	010AAC75-3BFE-4BF2-B866-AF0F2D92F125	Primary Tumor	Illumina HiSeq	6780f08b-966e-4836-9cd8-46b87be05578	Brain	17	11437143-41F5-4005-9124-4D6A4A2F0E2D	6847E993-1414-4E6F-A2AF-39EBE218DD7C	TCGA-DB-5278-01A-01D-1468-08	HG19_Broad_variant	TCGA-DB-5278	TCGA-LGG	NA	s8101	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1468-08	FALSE
13722.58cfa82ee4b0c9d6adf6a94d	58cfa82ee4b0c9d6adf6a94d	G35154.TCGA-DU-5874-01A-11D-1705-08.2.filtered.	WGS	G35154.TCGA-DU-5874-01A-11D-1705-08.2	G35154.TCGA-DU-5874-01A-11D-1705-08.2.bam	301.3	1.9	0.05	58cfa82ee4b0c9d6adf6a94d	G35154.TCGA-DU-5874-01A-11D-1705-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-5874-01A	1CC53ADE-73C0-492B-A7DC-328269FD0E66	Primary Tumor	Illumina HiSeq	b0268c63-93dc-4e0b-b29b-217fd6028c92	Brain	62	3C7CE3D5-F9E4-4FAE-B033-2058446ED7F3	85D915B8-0184-4EC7-93AD-E9FFA2F5743B	TCGA-DU-5874-01A-11D-1705-08	HG19_Broad_variant	TCGA-DU-5874	TCGA-LGG	NA	s8546	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1705-08	FALSE
13722.58cfa82ee4b0c9d6adf6a952	58cfa82ee4b0c9d6adf6a952	G26382.TCGA-06-2557-01A-01D-1494-08.1.filtered.	WGS	G26382.TCGA-06-2557-01A-01D-1494-08.1	G26382.TCGA-06-2557-01A-01D-1494-08.1.bam	633.7	1.9	0.05	58cfa82ee4b0c9d6adf6a952	G26382.TCGA-06-2557-01A-01D-1494-08.1.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-2557-01A	6C28F086-6A25-40B6-93EB-BBA0014ACDA6	Primary Tumor	Illumina HiSeq	582d62de-97f1-4c69-8559-dd865f368abd	Brain	76	19521291-90A2-4865-9D3F-25973130D22E	C27290E4-6835-448A-ABDC-DF8DDD5F4630	TCGA-06-2557-01A-01D-1494-08	HG19_Broad_variant	TCGA-06-2557	TCGA-GBM	33	s14370	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6a967	58cfa82ee4b0c9d6adf6a967	G32458.TCGA-BT-A20V-01A-11D-A14W-08.2.filtered.	WGS	G32458.TCGA-BT-A20V-01A-11D-A14W-08.2	G32458.TCGA-BT-A20V-01A-11D-A14W-08.2.bam	101.87	2.11	0.08	58cfa82ee4b0c9d6adf6a967	G32458.TCGA-BT-A20V-01A-11D-A14W-08.2.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20V-01A	24F21425-B001-4986-AEDF-5B4DD851C6AD	Primary Tumor	Illumina HiSeq	a193bc83-ec94-46bb-b7ee-60b8b75c8ad8	Bladder	59	967443E3-35C3-4F41-9BB5-DC899D290806	973D0577-8CA4-44A1-817F-1D3C1BADA151	TCGA-BT-A20V-01A-11D-A14W-08	HG19_Broad_variant	TCGA-BT-A20V	TCGA-BLCA	154	s3252	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A14W-08	TRUE
13722.58cfa82ee4b0c9d6adf6a980	58cfa82ee4b0c9d6adf6a980	G35154.TCGA-DU-7009-01A-11D-2024-08.2.filtered.	WGS	G35154.TCGA-DU-7009-01A-11D-2024-08.2	G35154.TCGA-DU-7009-01A-11D-2024-08.2.bam	130.3	NA	0.05	58cfa82ee4b0c9d6adf6a980	G35154.TCGA-DU-7009-01A-11D-2024-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7009-01A	01C4CA12-AC08-41DD-9E4F-BFB0971688A2	Primary Tumor	Illumina HiSeq	446ab57b-076e-4f55-b617-050e5f14bfa5	Brain	32	C7CA8FEE-BD73-435B-B351-216E5DC38726	4853FD17-7214-4F0C-984B-1BE0346CA4AB	TCGA-DU-7009-01A-11D-2024-08	HG19_Broad_variant	TCGA-DU-7009	TCGA-LGG	NA	s8105	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2024-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9a8	58cfa82ee4b0c9d6adf6a9a8	G32468.TCGA-GD-A2C5-01A-12D-A17V-08.1.filtered.	WGS	G32468.TCGA-GD-A2C5-01A-12D-A17V-08.1	G32468.TCGA-GD-A2C5-01A-12D-A17V-08.1.bam	40.79	NA	0.08	58cfa82ee4b0c9d6adf6a9a8	G32468.TCGA-GD-A2C5-01A-12D-A17V-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A2C5-01A	5D54C742-5A8E-4C40-8D62-95E75E210AB8	Primary Tumor	Illumina HiSeq	5f1b4c77-5775-4a38-b100-dc28cb8fb2b3	Bladder	53	2CD62676-762C-461D-B111-1F81E7CD5877	2B142863-B963-4CC9-8F8F-C72503C93390	TCGA-GD-A2C5-01A-12D-A17V-08	HG19_Broad_variant	TCGA-GD-A2C5	TCGA-BLCA	NA	s3260	Broad Institute of MIT and Harvard	ABS - IUPUI	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A17V-08	TRUE
13722.58cfa82ee4b0c9d6adf6a9aa	58cfa82ee4b0c9d6adf6a9aa	G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2.filtered.	WGS	G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2	G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2.bam	46.65	NA	0.08	58cfa82ee4b0c9d6adf6a9aa	G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3CX-01A	934A58AF-0FFC-487E-9E95-FA7643B7D5CB	Primary Tumor	Illumina HiSeq	7466949f-795d-4b2c-99e4-92d507c8772e	Thyroid	22	C65B5941-3E1D-41C6-9458-CDE70425E7C7	D0A33FD2-085C-488B-B843-2CA97C85A5CB	TCGA-EL-A3CX-01A-11D-A19J-08	HG19_Broad_variant	TCGA-EL-A3CX	TCGA-THCA	NA	s12337	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A19J-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa1c	58cfa82ee4b0c9d6adf6aa1c	G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1.filtered.	WGS	G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1	G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1.bam	56.34	2.11	0.08	58cfa82ee4b0c9d6adf6aa1c	G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20Q-01A	419DEAAC-EA45-4BDD-9FA0-B5CD8429B44F	Primary Tumor	Illumina HiSeq	1e07bbf1-7f3c-4472-b21e-f9eaa7b11659	Bladder	73	F3906CD4-31C7-48A8-935B-5B7FAFEC1AE7	8C619CBC-9E91-4716-9711-5236E55D8F46	TCGA-BT-A20Q-01A-11D-A14W-08	HG19_Broad_variant	TCGA-BT-A20Q	TCGA-BLCA	593	s3255	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A14W-08	TRUE
13722.58cfa82ee4b0c9d6adf6a9e5	58cfa82ee4b0c9d6adf6a9e5	G26360.TCGA-32-1970-01A-01D-1494-08.1.filtered.	WGS	G26360.TCGA-32-1970-01A-01D-1494-08.1	G26360.TCGA-32-1970-01A-01D-1494-08.1.bam	398.7	1.9	0.05	58cfa82ee4b0c9d6adf6a9e5	G26360.TCGA-32-1970-01A-01D-1494-08.1.bam	Dead	MALE	WHITE	Not available	Glioblastoma Multiforme	Aligned reads	TCGA-32-1970-01A	6C5154D2-AF36-492F-B520-D925528824E4	Primary Tumor	Illumina HiSeq	ce02c656-69b1-46a5-a120-f424ab059f55	Brain	59	115D06A0-7FFB-4E2F-BC09-59EA55D12894	65723119-BDFE-46F0-B629-C171023ABD71	TCGA-32-1970-01A-01D-1494-08	HG19_Broad_variant	TCGA-32-1970	TCGA-GBM	468	s13979	Broad Institute of MIT and Harvard	St. Joseph's Hospital (AZ)	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa35	58cfa82ee4b0c9d6adf6aa35	G26363.TCGA-19-2624-01A-01D-1495-08.2.filtered.	WGS	G26363.TCGA-19-2624-01A-01D-1495-08.2	G26363.TCGA-19-2624-01A-01D-1495-08.2.bam	164.1	1.9	0.05	58cfa82ee4b0c9d6adf6aa35	G26363.TCGA-19-2624-01A-01D-1495-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-19-2624-01A	2F4A127F-101A-4192-B3E8-F9BE2C8648BC	Primary Tumor	Illumina HiSeq	d4065322-376e-4196-afdd-8e8b7d51e85b	Brain	51	C9E1BE85-0699-48B4-8977-0DB46AF4EC94	A8F86B64-914C-4D89-897B-33BCDD1759F7	TCGA-19-2624-01A-01D-1495-08	HG19_Broad_variant	TCGA-19-2624	TCGA-GBM	5	s14343	Broad Institute of MIT and Harvard	Case Western	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1495-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa38	58cfa82ee4b0c9d6adf6aa38	G23883.TCGA-A3-3324-01A-01D-2229-08.1.filtered.	WGS	G23883.TCGA-A3-3324-01A-01D-2229-08.1	G23883.TCGA-A3-3324-01A-01D-2229-08.1.bam	602.9	1.9	0.05	58cfa82ee4b0c9d6adf6aa38	G23883.TCGA-A3-3324-01A-01D-2229-08.1.bam	Alive	MALE	WHITE	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3324-01A	4FCA10BD-988A-47F9-8ED5-037C0D59D70C	Primary Tumor	Illumina HiSeq	4fa1626a-b369-4e9c-b908-528e1d550be7	Kidney	51	08CE626E-0734-4D54-BA3F-EA5702B886F3	BADA0A2B-88CC-4F38-9BE5-F4B698AE4DB1	TCGA-A3-3324-01A-01D-2229-08	HG19_Broad_variant	TCGA-A3-3324	TCGA-KIRC	NA	s9154	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2229-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa9e	58cfa82ee4b0c9d6adf6aa9e	G32455.TCGA-BT-A2LA-01A-11D-A18F-08.2.filtered.	WGS	G32455.TCGA-BT-A2LA-01A-11D-A18F-08.2	G32455.TCGA-BT-A2LA-01A-11D-A18F-08.2.bam	80.43	NA	0.07	58cfa82ee4b0c9d6adf6aa9e	G32455.TCGA-BT-A2LA-01A-11D-A18F-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A2LA-01A	797A71EE-372D-41E5-AEEE-5AB3C4661110	Primary Tumor	Illumina HiSeq	baad6267-e92d-4dc7-a751-271da7ad3f53	Bladder	54	6ED52558-8039-4658-A245-78A29968CE2F	45A7949D-E63F-4956-866C-DF51257032DE	TCGA-BT-A2LA-01A-11D-A18F-08	HG19_Broad_variant	TCGA-BT-A2LA	TCGA-BLCA	NA	s2851	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A18F-08	FALSE
13722.58cfa82ee4b0c9d6adf6aae6	58cfa82ee4b0c9d6adf6aae6	G32531.TCGA-FK-A3S3-01A-11D-A22D-08.1.filtered.	WGS	G32531.TCGA-FK-A3S3-01A-11D-A22D-08.1	G32531.TCGA-FK-A3S3-01A-11D-A22D-08.1.bam	22.44	NA	0.09	58cfa82ee4b0c9d6adf6aae6	G32531.TCGA-FK-A3S3-01A-11D-A22D-08.1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FK-A3S3-01A	785803BB-42A8-4AFB-B7B4-58C114894408	Primary Tumor	Illumina HiSeq	5c7965a4-3e29-4c83-87e5-2e23f356287c	Thyroid	43	F5EBEFBE-50FA-465A-A355-2C099941039D	15ABB2A3-10A2-4E04-8EB9-6EADBD976AF0	TCGA-FK-A3S3-01A-11D-A22D-08	HG19_Broad_variant	TCGA-FK-A3S3	TCGA-THCA	NA	s12344	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A22D-08	TRUE
13722.58cfa82ee4b0c9d6adf6aaac	58cfa82ee4b0c9d6adf6aaac	G26375.TCGA-27-2528-01A-01D-1494-08.1.filtered.	WGS	G26375.TCGA-27-2528-01A-01D-1494-08.1	G26375.TCGA-27-2528-01A-01D-1494-08.1.bam	202.7	1.9	0.05	58cfa82ee4b0c9d6adf6aaac	G26375.TCGA-27-2528-01A-01D-1494-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-27-2528-01A	BE3A7EF3-34ED-40E1-9D9C-187940596B26	Primary Tumor	Illumina HiSeq	29b9c185-f979-47f1-91dc-9b8ca4759c35	Brain	62	3190BD1A-A83A-45F6-959A-863BBAE58FFE	374CBD87-428E-4509-85C1-B7D3302C30A0	TCGA-27-2528-01A-01D-1494-08	HG19_Broad_variant	TCGA-27-2528	TCGA-GBM	480	s14221	Broad Institute of MIT and Harvard	Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6aaee	58cfa82ee4b0c9d6adf6aaee	G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2.filtered.	WGS	G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2	G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2.bam	54.46	NA	0.07	58cfa82ee4b0c9d6adf6aaee	G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-H4-A2HQ-01A	CEDE5274-279D-4021-8ACA-5ECC4BF94D66	Primary Tumor	Illumina HiSeq	211fa39b-cffd-430e-b28a-b6624e81fb93	Bladder	64	CBEDC0DB-39FD-4661-9531-CC24D422FAC4	94108975-B7A0-40BA-AD39-E44CC62E8CC0	TCGA-H4-A2HQ-01A-11D-A17V-08	HG19_Broad_variant	TCGA-H4-A2HQ	TCGA-BLCA	NA	s3250	Broad Institute of MIT and Harvard	Medical College of Georgia	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A17V-08	TRUE
13722.58cfa82ee4b0c9d6adf6aaa4	58cfa82ee4b0c9d6adf6aaa4	G26386.TCGA-06-0745-01A-01D-1492-08.1.filtered.	WGS	G26386.TCGA-06-0745-01A-01D-1492-08.1	G26386.TCGA-06-0745-01A-01D-1492-08.1.bam	339.57	1.91	0.05	58cfa82ee4b0c9d6adf6aaa4	G26386.TCGA-06-0745-01A-01D-1492-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0745-01A	386B629E-FAB1-4033-B088-45D6EEB4A13E	Primary Tumor	Illumina HiSeq	02ccb42a-947e-4baf-90b2-dbd453844f63	Brain	59	6EB5B7FF-1797-4C31-AB5B-6DB2B2641C5B	41D50A3C-49FC-4D8A-9C25-BBBCD3A5DA6F	TCGA-06-0745-01A-01D-1492-08	HG19_Broad_variant	TCGA-06-0745	TCGA-GBM	239	s14305	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1492-08	FALSE
13722.58cfa82ee4b0c9d6adf6aae8	58cfa82ee4b0c9d6adf6aae8	G32454.TCGA-CF-A27C-01A-11D-A16O-08.4.filtered.	WGS	G32454.TCGA-CF-A27C-01A-11D-A16O-08.4	G32454.TCGA-CF-A27C-01A-11D-A16O-08.4.bam	67.64	2.28	0.09	58cfa82ee4b0c9d6adf6aae8	G32454.TCGA-CF-A27C-01A-11D-A16O-08.4.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A27C-01A	7FEE9D6F-C0EA-43C2-89C2-66D965A077A8	Primary Tumor	Illumina HiSeq	456bc333-4951-4b6e-845e-2af77b0a86d7	Bladder	52	EAD6792B-4E52-4C28-891C-6D8696873A13	ACC629CB-AD03-4CEC-9B21-922E4932EF3E	TCGA-CF-A27C-01A-11D-A16O-08	HG19_Broad_variant	TCGA-CF-A27C	TCGA-BLCA	NA	s2678	Broad Institute of MIT and Harvard	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A16O-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab34	58cfa82ee4b0c9d6adf6ab34	G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2.filtered.	WGS	G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2	G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2.bam	56.18	NA	0.08	58cfa82ee4b0c9d6adf6ab34	G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A3PH-01A	932BCDD4-5145-49E8-9A95-8A546396F572	Primary Tumor	Illumina HiSeq	6a3d1aec-7ab7-4703-b3f0-5ba3f396d70d	Bladder	76	33A83E54-3BE5-4A68-8AB0-D31D0BCD3B67	CDA1A403-16B6-487C-A82A-C377D1D0F89D	TCGA-BT-A3PH-01A-11D-A21Z-08	HG19_Broad_variant	TCGA-BT-A3PH	TCGA-BLCA	142	s3254	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A21Z-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab40	58cfa82ee4b0c9d6adf6ab40	G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2.filtered.	WGS	G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2	G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2.bam	52.36	NA	0.08	58cfa82ee4b0c9d6adf6ab40	G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A2NF-01A	D32A4219-4CCA-470F-B6B3-11447D9F5E0B	Primary Tumor	Illumina HiSeq	a17559f3-505c-4dc1-855c-178b1740e1ac	Skin	53	52EDD1DB-F1C3-4B87-B959-B5B095E52463	0884FDF3-7A20-43BC-BF57-E71F36E11AB9	TCGA-ER-A2NF-01A-11D-A19A-08	HG19_Broad_variant	TCGA-ER-A2NF	TCGA-SKCM	NA	s7989	Broad Institute of MIT and Harvard	University of Pittsburgh	None	NO	T4b	N3	Not available	Stage IIIC	A19A-08	TRUE
13722.58cfa82ee4b0c9d6adf6abae	58cfa82ee4b0c9d6adf6abae	G32528.TCGA-DJ-A2Q8-01A-11D-A18F-08.5.filtered.	WGS	G32528.TCGA-DJ-A2Q8-01A-11D-A18F-08.5	G32528.TCGA-DJ-A2Q8-01A-11D-A18F-08.5.bam	37.93	NA	0.08	58cfa82ee4b0c9d6adf6abae	G32528.TCGA-DJ-A2Q8-01A-11D-A18F-08.5.bam	Alive	FEMALE	Not available	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A2Q8-01A	F9CF605F-F287-4EBA-8E8F-8BA47E14ECC4	Primary Tumor	Illumina HiSeq	304598e8-69da-48fa-a60c-8f025223e258	Thyroid	47	9AF5F9F1-36A3-48EA-A5E1-9B642E609E97	FA837B4D-55A7-4DCF-9FDF-CF9C13644DF7	TCGA-DJ-A2Q8-01A-11D-A18F-08	HG19_Broad_variant	TCGA-DJ-A2Q8	TCGA-THCA	NA	s12213	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T1a	N0	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage I	A18F-08	FALSE
13722.58cfa82ee4b0c9d6adf6abeb	58cfa82ee4b0c9d6adf6abeb	G35154.TCGA-HT-7689-01A-11D-2253-08.2.filtered.	WGS	G35154.TCGA-HT-7689-01A-11D-2253-08.2	G35154.TCGA-HT-7689-01A-11D-2253-08.2.bam	66	NA	0.05	58cfa82ee4b0c9d6adf6abeb	G35154.TCGA-HT-7689-01A-11D-2253-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7689-01A	D58B535A-6C95-43BB-AD88-0600E6447537	Primary Tumor	Illumina HiSeq	55583ba3-88d1-4c7c-8bf7-bfe2699d74da	Brain	58	80122820-0D29-4F56-BF14-AC5EEB6F2760	B95CD446-0FED-4DA2-892F-24B39D073AB4	TCGA-HT-7689-01A-11D-2253-08	HG19_Broad_variant	TCGA-HT-7689	TCGA-LGG	NA	s8336	Broad Institute of MIT and Harvard	Case Western - St Joes	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2253-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac86	58cfa82ee4b0c9d6adf6ac86	G41960.TCGA-75-7030-01A-11D-1945-08.2.filtered.	WGS	G41960.TCGA-75-7030-01A-11D-1945-08.2	G41960.TCGA-75-7030-01A-11D-1945-08.2.bam	124.7	NA	0.05	58cfa82ee4b0c9d6adf6ac86	G41960.TCGA-75-7030-01A-11D-1945-08.2.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-75-7030-01A	DF576520-A6B6-4C9B-8D06-3F59CC5342FD	Primary Tumor	Illumina HiSeq	804a0fba-a82e-4501-9b0b-87c34318562d	Lung	NA	56C937B3-B48F-4662-B992-3265DBB6BC7D	0CE6F3ED-BDBC-4B70-9DB4-2E48F4BF644D	TCGA-75-7030-01A-11D-1945-08	HG19_Broad_variant	TCGA-75-7030	TCGA-LUAD	NA	s10636	Broad Institute of MIT and Harvard	Ontario Institute for Cancer Research (OICR)	Canada	NO	T3	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6acc0	58cfa82ee4b0c9d6adf6acc0	G41960.TCGA-55-6984-01A-11D-1945-08.2.filtered.	WGS	G41960.TCGA-55-6984-01A-11D-1945-08.2	G41960.TCGA-55-6984-01A-11D-1945-08.2.bam	138.7	NA	0.05	58cfa82ee4b0c9d6adf6acc0	G41960.TCGA-55-6984-01A-11D-1945-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-6984-01A	F063DDBB-1668-40DF-9EC2-B0A23CA2C389	Primary Tumor	Illumina HiSeq	244af712-e56d-4419-bc80-cdbfc0262b92	Lung	71	76C0ADAE-EEF5-459E-A4C9-397D94EBFDCC	309F5324-5608-4F62-B744-5AB268B70927	TCGA-55-6984-01A-11D-1945-08	HG19_Broad_variant	TCGA-55-6984	TCGA-LUAD	760	s11321	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad83	58cfa82ee4b0c9d6adf6ad83	G39020.TCGA-BR-7722-01A-31D-2201-08.2.filtered.	WGS	G39020.TCGA-BR-7722-01A-31D-2201-08.2	G39020.TCGA-BR-7722-01A-31D-2201-08.2.bam	454.7	NA	0.05	58cfa82ee4b0c9d6adf6ad83	G39020.TCGA-BR-7722-01A-31D-2201-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-7722-01A	8D3E3D09-BC61-4D5E-B8D6-5AEE6CB488AE	Primary Tumor	Illumina HiSeq	2ca0a03f-9d9d-49da-98e7-b0ade46e5b18	Stomach	62	58038C32-1359-49EB-AAFE-2F44EC697F52	0FA9CFBA-0F49-47D0-AB54-9DD2144E0A73	TCGA-BR-7722-01A-31D-2201-08	HG19_Broad_variant	TCGA-BR-7722	TCGA-STAD	NA	s14806	Broad Institute of MIT and Harvard	Asterand	Ukraine	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIB	2201-08	FALSE
13722.58cfa82ee4b0c9d6adf6af24	58cfa82ee4b0c9d6adf6af24	G39020.TCGA-F1-6177-01A-11D-1800-08.2.filtered.	WGS	G39020.TCGA-F1-6177-01A-11D-1800-08.2	G39020.TCGA-F1-6177-01A-11D-1800-08.2.bam	466.4	1.8	0.05	58cfa82ee4b0c9d6adf6af24	G39020.TCGA-F1-6177-01A-11D-1800-08.2.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-F1-6177-01A	C3CBA26E-38C2-4569-AFD6-6B045E604808	Primary Tumor	Illumina HiSeq	347b5bd7-20b6-4635-ae86-d43256011296	Stomach	90	0538EFDE-935D-4571-A200-B181AB622447	1D0617E8-2725-4411-B50F-E46EA1D43242	TCGA-F1-6177-01A-11D-1800-08	HG19_Broad_variant	TCGA-F1-6177	TCGA-STAD	NA	s14962	Broad Institute of MIT and Harvard	UNC	United States	NO	T1b	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	1800-08	TRUE
13722.58cfa82ee4b0c9d6adf6adf6	58cfa82ee4b0c9d6adf6adf6	G39020.TCGA-CG-4442-01A-01D-A290-08.2.filtered.	WGS	G39020.TCGA-CG-4442-01A-01D-A290-08.2	G39020.TCGA-CG-4442-01A-01D-A290-08.2.bam	165.2	1.9	0.07	58cfa82ee4b0c9d6adf6adf6	G39020.TCGA-CG-4442-01A-01D-A290-08.2.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4442-01A	8FCCFF71-3710-4CB9-B8AF-61707AEBE5D8	Primary Tumor	Illumina HiSeq	05a46a94-fa5c-4e76-b887-07ec0fa0af0f	Stomach	85	51927F82-2585-465B-92ED-36EF46D44FAB	7E305F31-FBB0-4BCE-894B-1DD85E303421	TCGA-CG-4442-01A-01D-A290-08	HG19_Broad_variant	TCGA-CG-4442	TCGA-STAD	NA	s15042	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	A290-08	TRUE
13722.58cfa82de4b0c9d6adf6a70e	58cfa82de4b0c9d6adf6a70e	G12518.TCGA-34-2596-01A-01D-0963-08.1.filtered.	WGS	G12518.TCGA-34-2596-01A-01D-0963-08.1	G12518.TCGA-34-2596-01A-01D-0963-08.1.bam	77.3	1.9	0.14	58cfa82de4b0c9d6adf6a70e	G12518.TCGA-34-2596-01A-01D-0963-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-34-2596-01A	7D3E77CC-9603-4722-8E39-1912B678871B	Primary Tumor	Illumina HiSeq	1fb42274-b17f-4050-9559-5d39557227d6	Lung	70	C07C8C94-150B-40A2-8830-5BE34DD99554	692DFA4F-45E5-4183-B5DA-6650A1FBCABD	TCGA-34-2596-01A-01D-0963-08	HG19_Broad_variant	TCGA-34-2596	TCGA-LUSC	80	s10356	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIB	0963-08	FALSE
13722.58cfa82de4b0c9d6adf6a75c	58cfa82de4b0c9d6adf6a75c	G14083.TCGA-21-1082-01A-01D-1521-08.3.filtered.	WGS	G14083.TCGA-21-1082-01A-01D-1521-08.3	G14083.TCGA-21-1082-01A-01D-1521-08.3.bam	233.7	1.9	0.05	58cfa82de4b0c9d6adf6a75c	G14083.TCGA-21-1082-01A-01D-1521-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-21-1082-01A	0E2EE54A-51C9-4868-842D-A2A1C1CFB016	Primary Tumor	Illumina HiSeq	94c61492-d5ca-462e-84cf-6d6d690fe431	Lung	61	F091C76E-5D01-4F4B-8F6F-463C9F302930	1C3DF485-8E75-4378-87F6-C6463A520624	TCGA-21-1082-01A-01D-1521-08	HG19_Broad_variant	TCGA-21-1082	TCGA-LUSC	NA	s10247	Broad Institute of MIT and Harvard	Fox Chase Cancer Center	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1521-08	TRUE
13722.58cfa82de4b0c9d6adf6a750	58cfa82de4b0c9d6adf6a750	G14082.TCGA-21-1076-01A-02D-1521-08.2.filtered.	WGS	G14082.TCGA-21-1076-01A-02D-1521-08.2	G14082.TCGA-21-1076-01A-02D-1521-08.2.bam	423.7	1.9	0.05	58cfa82de4b0c9d6adf6a750	G14082.TCGA-21-1076-01A-02D-1521-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-21-1076-01A	220BE009-8F1E-4A77-AB04-3220B5F87EA6	Primary Tumor	Illumina HiSeq	f960f40f-32d5-4ab1-a88c-0e199b9d1969	Lung	54	22BE9844-4D9E-4372-A46A-B5C64480E5AA	504D4CB0-D2DD-420D-82E6-9EC14434A0FC	TCGA-21-1076-01A-02D-1521-08	HG19_Broad_variant	TCGA-21-1076	TCGA-LUSC	NA	s10358	Broad Institute of MIT and Harvard	Fox Chase Cancer Center	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1521-08	TRUE
13722.58cfa82ee4b0c9d6adf6a7e8	58cfa82ee4b0c9d6adf6a7e8	G25773.TCGA-75-5147-01A-01D-1625-08.2.filtered.	WGS	G25773.TCGA-75-5147-01A-01D-1625-08.2	G25773.TCGA-75-5147-01A-01D-1625-08.2.bam	817.7	1.9	0.05	58cfa82ee4b0c9d6adf6a7e8	G25773.TCGA-75-5147-01A-01D-1625-08.2.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-75-5147-01A	D2824E6D-3784-45C2-9B0F-52B17356B5DA	Primary Tumor	Illumina HiSeq	6ec725e2-6d00-4866-8473-fd1b02309066	Lung	NA	F9F9C1DD-8462-4560-82B8-AEA4309854C9	52910A60-BB15-4BA5-9D09-50D8EE6A445B	TCGA-75-5147-01A-01D-1625-08	HG19_Broad_variant	TCGA-75-5147	TCGA-LUAD	NA	s10974	Broad Institute of MIT and Harvard	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1625-08	FALSE
13722.58cfa82ee4b0c9d6adf6a82c	58cfa82ee4b0c9d6adf6a82c	G35154.TCGA-FG-7643-01A-11D-A461-08.2.filtered.	WGS	G35154.TCGA-FG-7643-01A-11D-A461-08.2	G35154.TCGA-FG-7643-01A-11D-A461-08.2.bam	9.7	NA	0.09	58cfa82ee4b0c9d6adf6a82c	G35154.TCGA-FG-7643-01A-11D-A461-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-7643-01A	B6F13250-31B3-46AD-B514-5A684F1094A9	Primary Tumor	Illumina HiSeq	ad52b277-d592-4ece-a72f-4d48f9394453	Brain	49	71F68BC7-2612-4D84-8948-5A06D30AF488	025B53E6-9687-4085-B5CC-3585CE87625D	TCGA-FG-7643-01A-11D-A461-08	HG19_Broad_variant	TCGA-FG-7643	TCGA-LGG	NA	s8327	Broad Institute of MIT and Harvard	Case Western	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a826	58cfa82ee4b0c9d6adf6a826	G35154.TCGA-DU-5872-01A-11D-A465-08.1.filtered.	WGS	G35154.TCGA-DU-5872-01A-11D-A465-08.1	G35154.TCGA-DU-5872-01A-11D-A465-08.1.bam	31.7	1.8	0.09	58cfa82ee4b0c9d6adf6a826	G35154.TCGA-DU-5872-01A-11D-A465-08.1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-5872-01A	48607130-C09A-491D-882F-7D2591D13182	Primary Tumor	Illumina HiSeq	359efa91-062f-491e-805a-0130efb943eb	Brain	43	048550EE-189D-483D-B07F-B77F10278420	0BCE913F-C4A0-4CC6-9A8B-A223F00CBA11	TCGA-DU-5872-01A-11D-A465-08	HG19_Broad_variant	TCGA-DU-5872	TCGA-LGG	NA	s8528	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	A465-08	FALSE
13722.58cfa82de4b0c9d6adf6a762	58cfa82de4b0c9d6adf6a762	G14856.TCGA-05-4432-01A-01D-1931-08.2.filtered.	WGS	G14856.TCGA-05-4432-01A-01D-1931-08.2	G14856.TCGA-05-4432-01A-01D-1931-08.2.bam	306.53	1.9	0.14	58cfa82de4b0c9d6adf6a762	G14856.TCGA-05-4432-01A-01D-1931-08.2.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4432-01A	E737F650-B72D-44E7-B750-558A56716803	Primary Tumor	Illumina HiSeq	612f40cd-a773-4962-b831-73dc8d9fb669	Lung	66	2A675528-1ABC-4220-A61A-25109850CE0D	3FBF4DA2-16C9-49AF-A5B3-3DC6C928E75C	TCGA-05-4432-01A-01D-1931-08	HG19_Broad_variant	TCGA-05-4432	TCGA-LUAD	NA	s11425	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N1	Lung Adenocarcinoma Mixed Subtype	Stage IIB	1931-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8b3	58cfa82ee4b0c9d6adf6a8b3	G35154.TCGA-FG-A4MT-01A-11D-A461-08.3.filtered.	WGS	G35154.TCGA-FG-A4MT-01A-11D-A461-08.3	G35154.TCGA-FG-A4MT-01A-11D-A461-08.3.bam	24.05	NA	0.08	58cfa82ee4b0c9d6adf6a8b3	G35154.TCGA-FG-A4MT-01A-11D-A461-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-A4MT-01A	E30F1994-3622-43D0-BEC2-6D7E2D9881D2	Primary Tumor	Illumina HiSeq	19c19563-8424-46b9-b88c-72e6dcc4ec23	Brain	27	18C49A42-5EB4-4A3F-9233-C2557EA684BF	1120B01A-0819-4C90-A1B4-C2B85108E786	TCGA-FG-A4MT-01A-11D-A461-08	HG19_Broad_variant	TCGA-FG-A4MT	TCGA-LGG	NA	s8740	Broad Institute of MIT and Harvard	Case Western	United States	NO	Not available	Not available	Oligodendroglioma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8ca	58cfa82ee4b0c9d6adf6a8ca	G35154.TCGA-DH-A669-01A-12D-A31L-08.3.filtered.	WGS	G35154.TCGA-DH-A669-01A-12D-A31L-08.3	G35154.TCGA-DH-A669-01A-12D-A31L-08.3.bam	53.17	NA	0.07	58cfa82ee4b0c9d6adf6a8ca	G35154.TCGA-DH-A669-01A-12D-A31L-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DH-A669-01A	76E54EF6-1799-4FD9-BEC3-0EA960E8461E	Primary Tumor	Illumina HiSeq	5ce3eb80-b2f7-4ebe-bcda-690bfbf4a5ba	Brain	70	78A57936-140F-4593-9BF4-30B850247FAB	425BF16E-AEB2-453A-932B-B3F59016B041	TCGA-DH-A669-01A-12D-A31L-08	HG19_Broad_variant	TCGA-DH-A669	TCGA-LGG	919	s8099	Broad Institute of MIT and Harvard	University of Florida	United States	NO	Not available	Not available	Oligodendroglioma	Not available	A31L-08	FALSE
13722.58cfa82ee4b0c9d6adf6a8d6	58cfa82ee4b0c9d6adf6a8d6	G23072.TCGA_BB_4225_01A_01D_2268_08.1.filtered.	WGS	G23072.TCGA_BB_4225_01A_01D_2268_08.1	G23072.TCGA_BB_4225_01A_01D_2268_08.1.bam	56.7	1.9	0.15	58cfa82ee4b0c9d6adf6a8d6	G23072.TCGA_BB_4225_01A_01D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BB-4225-01A	C1F50A22-38DF-41CC-A1F4-F7985504A7AC	Primary Tumor	Illumina HiSeq	e43130ec-f2f3-4984-8ba9-8f0e641acce9	Head and Neck	73	AC42070B-F4D6-47BE-96AA-A713D66A0072	81598359-24D5-4A8B-A6E6-7A6F94289119	TCGA-BB-4225-01A-01D-2268-08	HG19_Broad_variant	TCGA-BB-4225	TCGA-HNSC	NA	s16163	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8a4	58cfa82ee4b0c9d6adf6a8a4	G35154.TCGA-CS-6669-01A-11D-1893-08.5.filtered.	WGS	G35154.TCGA-CS-6669-01A-11D-1893-08.5	G35154.TCGA-CS-6669-01A-11D-1893-08.5.bam	11.7	1.9	0.05	58cfa82ee4b0c9d6adf6a8a4	G35154.TCGA-CS-6669-01A-11D-1893-08.5.bam	Alive	FEMALE	WHITE	Not available	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-6669-01A	DC5BDD21-B23F-400E-BBE2-4C98A517FC9E	Primary Tumor	Illumina HiSeq	7069c071-1fef-4c6f-b741-c67ee56619bb	Brain	26	57FAE3BD-B822-4855-A4A1-AFDCC20F6071	218A9531-9264-43BC-8535-858D4CB0919E	TCGA-CS-6669-01A-11D-1893-08	HG19_Broad_variant	TCGA-CS-6669	TCGA-LGG	NA	s8523	Broad Institute of MIT and Harvard	Thomas Jefferson University	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1893-08	FALSE
13722.58cfa82ee4b0c9d6adf6a906	58cfa82ee4b0c9d6adf6a906	G35154.TCGA-CS-6665-01A-11D-1893-08.2.filtered.	WGS	G35154.TCGA-CS-6665-01A-11D-1893-08.2	G35154.TCGA-CS-6665-01A-11D-1893-08.2.bam	98.7	1.9	0.05	58cfa82ee4b0c9d6adf6a906	G35154.TCGA-CS-6665-01A-11D-1893-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-6665-01A	C16D9F69-26F9-4EC7-B2D5-FF9F7DACFE0F	Primary Tumor	Illumina HiSeq	9d827820-042a-412f-ae10-1f97190c446d	Brain	51	ABDDB338-559A-4386-872B-D1A57C460113	682D5B5E-3569-403C-B31C-887BD0AA26A5	TCGA-CS-6665-01A-11D-1893-08	HG19_Broad_variant	TCGA-CS-6665	TCGA-LGG	NA	s8317	Broad Institute of MIT and Harvard	Thomas Jefferson University	United States	NO	Not available	Not available	Astrocytoma	Not available	1893-08	FALSE
13722.58cfa82ee4b0c9d6adf6a85a	58cfa82ee4b0c9d6adf6a85a	G35154.TCGA-HT-7602-01A-21D-2086-08.4.filtered.	WGS	G35154.TCGA-HT-7602-01A-21D-2086-08.4	G35154.TCGA-HT-7602-01A-21D-2086-08.4.bam	15.13	NA	0.05	58cfa82ee4b0c9d6adf6a85a	G35154.TCGA-HT-7602-01A-21D-2086-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7602-01A	799E9106-E62E-4681-8861-137F474EE8B8	Primary Tumor	Illumina HiSeq	fdc7bab5-c807-4791-be95-6a588e86a4b8	Brain	21	0997BB1A-F0A4-4CB8-9714-5BAF9C391CE8	88395C0E-4AFE-434D-8B20-5A3EEF8B7F00	TCGA-HT-7602-01A-21D-2086-08	HG19_Broad_variant	TCGA-HT-7602	TCGA-LGG	NA	s8531	Broad Institute of MIT and Harvard	Case Western - St Joes	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2086-08	FALSE
13722.58cfa82ee4b0c9d6adf6a956	58cfa82ee4b0c9d6adf6a956	G35154.TCGA-DU-6401-01A-11D-1705-08.2.filtered.	WGS	G35154.TCGA-DU-6401-01A-11D-1705-08.2	G35154.TCGA-DU-6401-01A-11D-1705-08.2.bam	124.3	1.9	0.05	58cfa82ee4b0c9d6adf6a956	G35154.TCGA-DU-6401-01A-11D-1705-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6401-01A	97CB8701-7D63-4142-B404-006FBB3ECB0B	Primary Tumor	Illumina HiSeq	f0537710-8458-4890-8a52-3f4457eb308f	Brain	31	680DBC4E-5CEC-4E76-848F-72BC0A2407C6	3A81F733-B3A3-4578-B925-A663612BC92C	TCGA-DU-6401-01A-11D-1705-08	HG19_Broad_variant	TCGA-DU-6401	TCGA-LGG	2660	s8536	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1705-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9a0	58cfa82ee4b0c9d6adf6a9a0	G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4.filtered.	WGS	G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4	G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4.bam	11.46	NA	0.08	58cfa82ee4b0c9d6adf6a9a0	G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-TM-A7CF-01A	033C1F48-9225-4159-B23B-7042272877DA	Primary Tumor	Illumina HiSeq	41c3ad23-569a-452e-8577-85a783c2a020	Brain	41	ABE68BC0-FE69-409E-851E-3CCF10C8AC94	979F7FD8-AB07-40A0-869A-D08FB8E598FF	TCGA-TM-A7CF-01A-11D-A32B-08	HG19_Broad_variant	TCGA-TM-A7CF	TCGA-LGG	NA	s8116	Broad Institute of MIT and Harvard	The University of New South Wales	Australia	NO	Not available	Not available	Astrocytoma	Not available	A32B-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9ea	58cfa82ee4b0c9d6adf6a9ea	G25772.TCGA-38-4630-01A-01D-2364-08.3.filtered.	WGS	G25772.TCGA-38-4630-01A-01D-2364-08.3	G25772.TCGA-38-4630-01A-01D-2364-08.3.bam	339.9	1.9	0.05	58cfa82ee4b0c9d6adf6a9ea	G25772.TCGA-38-4630-01A-01D-2364-08.3.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-38-4630-01A	F1985735-A188-4567-A88A-530F9B80291B	Primary Tumor	Illumina HiSeq	1ece9db5-148a-413e-9dc4-bf65d88ecc5f	Lung	75	83D01FF9-D0A9-4606-80ED-9A417A980EF7	2282CF06-9C70-47F0-958C-C9E5697AC2C8	TCGA-38-4630-01A-01D-2364-08	HG19_Broad_variant	TCGA-38-4630	TCGA-LUAD	1073	s10975	Broad Institute of MIT and Harvard	UNC	United States	NO	T2	N0	Lung Papillary Adenocarcinoma	Stage IB	2364-08	FALSE
13722.58cfa82ee4b0c9d6adf6a99c	58cfa82ee4b0c9d6adf6a99c	G35154.TCGA-IK-7675-01A-11D-2086-08.6.filtered.	WGS	G35154.TCGA-IK-7675-01A-11D-2086-08.6	G35154.TCGA-IK-7675-01A-11D-2086-08.6.bam	224	NA	0.05	58cfa82ee4b0c9d6adf6a99c	G35154.TCGA-IK-7675-01A-11D-2086-08.6.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-IK-7675-01A	A5F851C5-6130-4EA1-9F86-BE59331A92F7	Primary Tumor	Illumina HiSeq	19191a31-9d4e-43a8-a88e-aff919fd0f95	Brain	43	661F567E-3E63-4692-8EF8-B80A83E6C8DE	A78544D7-65C6-4778-AF62-CEEC24C14056	TCGA-IK-7675-01A-11D-2086-08	HG19_Broad_variant	TCGA-IK-7675	TCGA-LGG	578	s8552	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2086-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab0e	58cfa82ee4b0c9d6adf6ab0e	G35154.TCGA-HW-7486-01A-11D-2024-08.6.filtered.	WGS	G35154.TCGA-HW-7486-01A-11D-2024-08.6	G35154.TCGA-HW-7486-01A-11D-2024-08.6.bam	21	NA	0.05	58cfa82ee4b0c9d6adf6ab0e	G35154.TCGA-HW-7486-01A-11D-2024-08.6.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HW-7486-01A	55A67639-ED05-4143-AF96-A377BC5489EE	Primary Tumor	Illumina HiSeq	77a6b9b7-4a25-4784-95e5-98346720dcef	Brain	37	F0C5DF7C-53AA-4D90-8189-44A2BB55A696	67F88CD9-AB77-4227-A8D7-5512246F9772	TCGA-HW-7486-01A-11D-2024-08	HG19_Broad_variant	TCGA-HW-7486	TCGA-LGG	NA	s8551	Broad Institute of MIT and Harvard	MSKCC	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2024-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab5f	58cfa82ee4b0c9d6adf6ab5f	G37566.TCGA-CH-5771-01A-21D-1576-08.1.filtered.	WGS	G37566.TCGA-CH-5771-01A-21D-1576-08.1	G37566.TCGA-CH-5771-01A-21D-1576-08.1.bam	30.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab5f	G37566.TCGA-CH-5771-01A-21D-1576-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5771-01A	3ACD8328-76F7-4F43-9660-394B95748C3D	Primary Tumor	Illumina HiSeq	e5382b76-d2ee-4eab-b245-b0d58fda770e	Prostate	63	19C87DE2-7936-4277-8AA8-3942D36E7579	87E1FFEE-A8CD-4D75-937E-ED415CF43546	TCGA-CH-5771-01A-21D-1576-08	HG19_Broad_variant	TCGA-CH-5771	TCGA-PRAD	NA	s3759	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1576-08	TRUE
13722.58cfa82ee4b0c9d6adf6a9fd	58cfa82ee4b0c9d6adf6a9fd	G32534.TCGA-DJ-A3US-01A-11D-A22D-08.3.filtered.	WGS	G32534.TCGA-DJ-A3US-01A-11D-A22D-08.3	G32534.TCGA-DJ-A3US-01A-11D-A22D-08.3.bam	47.65	NA	0.08	58cfa82ee4b0c9d6adf6a9fd	G32534.TCGA-DJ-A3US-01A-11D-A22D-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A3US-01A	6EE95DC8-2BAC-4691-AFA2-8222E07506AD	Primary Tumor	Illumina HiSeq	dbbfcd8f-5283-4bf9-98f1-9211808bfed9	Thyroid	37	9F63C13D-6008-416E-9E6B-D4ED4210E569	AD874249-9964-4E48-AA3F-7E828EA28F3F	TCGA-DJ-A3US-01A-11D-A22D-08	HG19_Broad_variant	TCGA-DJ-A3US	TCGA-THCA	NA	s12730	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A22D-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab54	58cfa82ee4b0c9d6adf6ab54	G37566.TCGA-CH-5788-01A-11D-1576-08.4.filtered.	WGS	G37566.TCGA-CH-5788-01A-11D-1576-08.4	G37566.TCGA-CH-5788-01A-11D-1576-08.4.bam	257.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab54	G37566.TCGA-CH-5788-01A-11D-1576-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5788-01A	C039014F-821C-43D6-9D3C-914F9C8D98FA	Primary Tumor	Illumina HiSeq	fc337685-dcbd-4e7f-9b5b-369121193a7a	Prostate	69	144E0265-C04E-4538-A721-94DEF2570486	9E272BEA-9193-4C10-A802-F7E18B2937A3	TCGA-CH-5788-01A-11D-1576-08	HG19_Broad_variant	TCGA-CH-5788	TCGA-PRAD	NA	s3579	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type	Not available	1576-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab7c	58cfa82ee4b0c9d6adf6ab7c	G37566.TCGA-G9-6336-01A-11D-1786-08.1.filtered.	WGS	G37566.TCGA-G9-6336-01A-11D-1786-08.1	G37566.TCGA-G9-6336-01A-11D-1786-08.1.bam	81.4	1.9	0.05	58cfa82ee4b0c9d6adf6ab7c	G37566.TCGA-G9-6336-01A-11D-1786-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6336-01A	59207BCD-F127-481F-B576-8716DA7D7D97	Primary Tumor	Illumina HiSeq	69760af4-102b-4920-92f4-1424ac8db32a	Prostate	57	34C8B195-ECAB-492B-AED2-43ACFEDEF708	AB318624-DB9D-41D8-B7B8-34712434F28F	TCGA-G9-6336-01A-11D-1786-08	HG19_Broad_variant	TCGA-G9-6336	TCGA-PRAD	NA	s3410	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	Not available	N0	Prostate Adenocarcinoma Acinar Type	Not available	1786-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab66	58cfa82ee4b0c9d6adf6ab66	G25779.TCGA-49-4512-01A-21D-1855-08.4.filtered.	WGS	G25779.TCGA-49-4512-01A-21D-1855-08.4	G25779.TCGA-49-4512-01A-21D-1855-08.4.bam	180.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab66	G25779.TCGA-49-4512-01A-21D-1855-08.4.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4512-01A	A1E65587-24C1-4B41-92A7-4E1F15FFFD78	Primary Tumor	Illumina HiSeq	5f8b200d-759a-4368-b604-2b51822122d3	Lung	69	D809A778-D1AC-4406-AB09-67CC70F1F0C2	FA6A60F5-8949-4E01-9435-D3117601627F	TCGA-49-4512-01A-21D-1855-08	HG19_Broad_variant	TCGA-49-4512	TCGA-LUAD	905	s10893	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1855-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab6e	58cfa82ee4b0c9d6adf6ab6e	G37566.TCGA-EJ-7791-01A-11D-2114-08.2.filtered.	WGS	G37566.TCGA-EJ-7791-01A-11D-2114-08.2	G37566.TCGA-EJ-7791-01A-11D-2114-08.2.bam	97.3	NA	0.05	58cfa82ee4b0c9d6adf6ab6e	G37566.TCGA-EJ-7791-01A-11D-2114-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7791-01A	4FE004E5-49F9-4336-A690-6EBAD512C813	Primary Tumor	Illumina HiSeq	60424977-6a58-4b53-9607-4cf61abb2c55	Prostate	67	57ED8A64-46F9-4E1F-8550-CEF121A6BBC6	D32F41FB-0744-4A62-81F6-0260C4920049	TCGA-EJ-7791-01A-11D-2114-08	HG19_Broad_variant	TCGA-EJ-7791	TCGA-PRAD	NA	s3927	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2114-08	FALSE
13722.58cfa82ee4b0c9d6adf6aba8	58cfa82ee4b0c9d6adf6aba8	G35154.TCGA-TQ-A7RK-01A-11D-A33T-08.3.filtered.	WGS	G35154.TCGA-TQ-A7RK-01A-11D-A33T-08.3	G35154.TCGA-TQ-A7RK-01A-11D-A33T-08.3.bam	15.56	NA	0.08	58cfa82ee4b0c9d6adf6aba8	G35154.TCGA-TQ-A7RK-01A-11D-A33T-08.3.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-TQ-A7RK-01A	2F8C789E-BBD8-4753-A48B-6894C21162F8	Primary Tumor	Illumina HiSeq	4b48a880-f86b-4e8b-9d21-65c14ba90284	Brain	29	5793003F-E131-4259-91CB-BE9B65B0E523	EE20C616-5CA0-4B81-81A0-FE1551E6F760	TCGA-TQ-A7RK-01A-11D-A33T-08	HG19_Broad_variant	TCGA-TQ-A7RK	TCGA-LGG	NA	s8745	Broad Institute of MIT and Harvard	University of Sao Paulo	Brazil	NO	Not available	Not available	Oligoastrocytoma	Not available	A33T-08	FALSE
13722.58cfa82ee4b0c9d6adf6aba0	58cfa82ee4b0c9d6adf6aba0	G37566.TCGA-EJ-5503-01A-01D-1576-08.2.filtered.	WGS	G37566.TCGA-EJ-5503-01A-01D-1576-08.2	G37566.TCGA-EJ-5503-01A-01D-1576-08.2.bam	172.7	1.9	0.05	58cfa82ee4b0c9d6adf6aba0	G37566.TCGA-EJ-5503-01A-01D-1576-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5503-01A	AA252F78-EBF3-42F9-86AF-BB6E57345706	Primary Tumor	Illumina HiSeq	b6f47487-689c-45fe-9716-1aa948f2b2c4	Prostate	50	627B9FF8-2557-4470-824A-B76A8BCD1E9F	25C002F7-E972-421A-B32D-7DD675D81931	TCGA-EJ-5503-01A-01D-1576-08	HG19_Broad_variant	TCGA-EJ-5503	TCGA-PRAD	NA	s3581	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1576-08	TRUE
13722.58cfa82ee4b0c9d6adf6abd0	58cfa82ee4b0c9d6adf6abd0	G35154.TCGA-TQ-A7RV-01A-21D-A34A-08.3.filtered.	WGS	G35154.TCGA-TQ-A7RV-01A-21D-A34A-08.3	G35154.TCGA-TQ-A7RV-01A-21D-A34A-08.3.bam	8.31	NA	0.08	58cfa82ee4b0c9d6adf6abd0	G35154.TCGA-TQ-A7RV-01A-21D-A34A-08.3.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-TQ-A7RV-01A	5A3EDEB6-133E-4116-9F80-2485BD70754D	Primary Tumor	Illumina HiSeq	90057127-5744-4f65-853a-66561166dcbc	Brain	27	06D89076-34D4-496D-A412-F8C3B46A3A4B	33B54500-B50B-4368-8406-71015C43B929	TCGA-TQ-A7RV-01A-21D-A34A-08	HG19_Broad_variant	TCGA-TQ-A7RV	TCGA-LGG	NA	s8124	Broad Institute of MIT and Harvard	University of Sao Paulo	Brazil	NO	Not available	Not available	Astrocytoma	Not available	A34A-08	FALSE
13722.58cfa82ee4b0c9d6adf6abf6	58cfa82ee4b0c9d6adf6abf6	G35154.TCGA-FG-8182-01A-11D-2253-08.3.filtered.	WGS	G35154.TCGA-FG-8182-01A-11D-2253-08.3	G35154.TCGA-FG-8182-01A-11D-2253-08.3.bam	58.6	NA	0.05	58cfa82ee4b0c9d6adf6abf6	G35154.TCGA-FG-8182-01A-11D-2253-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-8182-01A	6A0BCF0C-FA4C-4119-99D2-F722B781D20F	Primary Tumor	Illumina HiSeq	de01f2de-931f-4b79-9abc-966eaee7ca0a	Brain	35	0CF6BE14-2F25-4361-ADE5-7E5B6CA1063E	2AEAAB9F-4459-4BE8-91E7-E0746CBD671C	TCGA-FG-8182-01A-11D-2253-08	HG19_Broad_variant	TCGA-FG-8182	TCGA-LGG	NA	s8112	Broad Institute of MIT and Harvard	Case Western	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2253-08	FALSE
13722.58cfa82ee4b0c9d6adf6abd2	58cfa82ee4b0c9d6adf6abd2	G37566.TCGA-CH-5763-01A-11D-1576-08.1.filtered.	WGS	G37566.TCGA-CH-5763-01A-11D-1576-08.1	G37566.TCGA-CH-5763-01A-11D-1576-08.1.bam	172.7	1.9	0.05	58cfa82ee4b0c9d6adf6abd2	G37566.TCGA-CH-5763-01A-11D-1576-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5763-01A	18E79A01-07A2-4CD5-B700-71D41724E041	Primary Tumor	Illumina HiSeq	ba68ecb8-6421-467d-b680-850c82a0b95d	Prostate	66	F4192448-E5B3-4A9F-8354-9FE28503017A	581BE6CF-9778-49C3-9C77-1316EAA78929	TCGA-CH-5763-01A-11D-1576-08	HG19_Broad_variant	TCGA-CH-5763	TCGA-PRAD	NA	s3405	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1576-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac26	58cfa82ee4b0c9d6adf6ac26	G37566.TCGA-G9-6365-01A-11D-1786-08.1.filtered.	WGS	G37566.TCGA-G9-6365-01A-11D-1786-08.1	G37566.TCGA-G9-6365-01A-11D-1786-08.1.bam	59.4	1.9	0.05	58cfa82ee4b0c9d6adf6ac26	G37566.TCGA-G9-6365-01A-11D-1786-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6365-01A	6845076E-E940-4437-8618-81DB4A447544	Primary Tumor	Illumina HiSeq	9cc69179-2c77-45b6-b3b1-0b1042756f81	Prostate	71	95D6E1D3-91C1-40E5-986D-1C5ABB33A03F	769E2AC9-A121-4B2A-A0FD-5F755B579811	TCGA-G9-6365-01A-11D-1786-08	HG19_Broad_variant	TCGA-G9-6365	TCGA-PRAD	NA	s3412	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T4	N0	Prostate Adenocarcinoma Acinar Type	Not available	1786-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac30	58cfa82ee4b0c9d6adf6ac30	G37566.TCGA-HC-7233-01A-11D-2114-08.2.filtered.	WGS	G37566.TCGA-HC-7233-01A-11D-2114-08.2	G37566.TCGA-HC-7233-01A-11D-2114-08.2.bam	207.3	NA	0.05	58cfa82ee4b0c9d6adf6ac30	G37566.TCGA-HC-7233-01A-11D-2114-08.2.bam	Alive	MALE	WHITE	Not available	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7233-01A	E2B33861-2247-413F-B2E5-9BE3B604666C	Primary Tumor	Illumina HiSeq	4e0a9ee2-a019-4269-90e4-b6c02d5b0091	Prostate	73	848C2C7B-918E-4A09-BAD9-3B3D59BBC101	0C9A5DBC-F7F3-43E7-83D1-77B9FB4B8B54	TCGA-HC-7233-01A-11D-2114-08	HG19_Broad_variant	TCGA-HC-7233	TCGA-PRAD	NA	s3765	Broad Institute of MIT and Harvard	International Genomics Consortium	Yemen	NO	T2a	N0	Prostate Adenocarcinoma Acinar Type	Not available	2114-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac40	58cfa82ee4b0c9d6adf6ac40	G39020.TCGA-BR-4255-01A-01D-A290-08.4.filtered.	WGS	G39020.TCGA-BR-4255-01A-01D-A290-08.4	G39020.TCGA-BR-4255-01A-01D-A290-08.4.bam	0	1.9	0.07	58cfa82ee4b0c9d6adf6ac40	G39020.TCGA-BR-4255-01A-01D-A290-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4255-01A	956017BA-5E4B-42C7-B93D-42316874BA93	Primary Tumor	Illumina HiSeq	5085f26e-d490-4a13-a172-4cac0f68a682	Stomach	76	A64A7CB8-BA30-45A3-B1DC-2A62D6B1919F	0CD60B96-EB2D-4687-9709-D1455EC45DE7	TCGA-BR-4255-01A-01D-A290-08	HG19_Broad_variant	TCGA-BR-4255	TCGA-STAD	NA	s15172	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIIA	A290-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac22	58cfa82ee4b0c9d6adf6ac22	G37566.TCGA-HC-7075-01A-11D-1961-08.2.filtered.	WGS	G37566.TCGA-HC-7075-01A-11D-1961-08.2	G37566.TCGA-HC-7075-01A-11D-1961-08.2.bam	242.7	NA	0.05	58cfa82ee4b0c9d6adf6ac22	G37566.TCGA-HC-7075-01A-11D-1961-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7075-01A	5DD69C3E-9A3D-450C-9F10-10B4D6DAEEBA	Primary Tumor	Illumina HiSeq	8f4cf0ab-38b1-49e1-8c15-82f9d02b5f9f	Prostate	63	1FA3E5C2-E415-42FA-AEA3-F6C84959522A	DDC422E4-87E2-4FC0-B56B-DDC2D6A92F58	TCGA-HC-7075-01A-11D-1961-08	HG19_Broad_variant	TCGA-HC-7075	TCGA-PRAD	NA	s3406	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2a	Not available	Prostate Adenocarcinoma Acinar Type	Not available	1961-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac91	58cfa82ee4b0c9d6adf6ac91	G47088.TCGA-22-5477-01A-01D-1632-08.1.filtered.	WGS	G47088.TCGA-22-5477-01A-01D-1632-08.1	G47088.TCGA-22-5477-01A-01D-1632-08.1.bam	859.7	1.9	0.05	58cfa82ee4b0c9d6adf6ac91	G47088.TCGA-22-5477-01A-01D-1632-08.1.bam	Dead	MALE	WHITE	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-22-5477-01A	BD15F523-45C4-4D7C-A3CC-4FB56ABB0E54	Primary Tumor	Illumina HiSeq	198a167a-3034-46af-a58f-46712ddf3eb0	Lung	65	F9D568B1-6951-4EAF-8867-4C86BDAEAA04	E7EBC6FB-0926-4C8A-A67B-0C6B9C1FFABA	TCGA-22-5477-01A-01D-1632-08	HG19_Broad_variant	TCGA-22-5477	TCGA-LUSC	1346	s10500	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	United States	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	1632-08	FALSE
13722.58cfa82ee4b0c9d6adf6acae	58cfa82ee4b0c9d6adf6acae	G37568.TCGA-DK-A1AA-01A-11D-A13W-08.3.filtered.	WGS	G37568.TCGA-DK-A1AA-01A-11D-A13W-08.3	G37568.TCGA-DK-A1AA-01A-11D-A13W-08.3.bam	72.54	1.95	0.08	58cfa82ee4b0c9d6adf6acae	G37568.TCGA-DK-A1AA-01A-11D-A13W-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AA-01A	56D8A1B8-1268-4362-A7F1-77B76FBF1B59	Primary Tumor	Illumina HiSeq	0ff07006-7458-42f5-b1fd-d84db4c2f25d	Bladder	57	577700D1-C366-41EF-8A0D-E50DEEFB5E3C	804FFA2E-158B-447D-945C-707684134C87	TCGA-DK-A1AA-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1AA	TCGA-BLCA	NA	s3079	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6acbe	58cfa82ee4b0c9d6adf6acbe	G37566.TCGA-HI-7169-01A-11D-2114-08.2.filtered.	WGS	G37566.TCGA-HI-7169-01A-11D-2114-08.2	G37566.TCGA-HI-7169-01A-11D-2114-08.2.bam	54.6	NA	0.05	58cfa82ee4b0c9d6adf6acbe	G37566.TCGA-HI-7169-01A-11D-2114-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HI-7169-01A	11FB5853-8EEB-4AD8-825D-3EAAF3FA08D6	Primary Tumor	Illumina HiSeq	4ec05d23-3f9f-473a-b292-63ddb0e7d37f	Prostate	55	AEEF0836-305C-465C-A9CA-6C1825353AE7	E1FC4226-40CE-43B7-B92E-AA7CECD0CF4D	TCGA-HI-7169-01A-11D-2114-08	HG19_Broad_variant	TCGA-HI-7169	TCGA-PRAD	NA	s3586	Broad Institute of MIT and Harvard	Fox Chase	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	2114-08	FALSE
13722.58cfa82ee4b0c9d6adf6acb4	58cfa82ee4b0c9d6adf6acb4	G47088.TCGA-77-6843-01A-11D-1945-08.1.filtered.	WGS	G47088.TCGA-77-6843-01A-11D-1945-08.1	G47088.TCGA-77-6843-01A-11D-1945-08.1.bam	285.7	1.9	0.05	58cfa82ee4b0c9d6adf6acb4	G47088.TCGA-77-6843-01A-11D-1945-08.1.bam	Dead	MALE	WHITE	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-77-6843-01A	C2598334-F866-4CC3-93EC-2D2E8B85D319	Primary Tumor	Illumina HiSeq	8cc492fe-df3d-4eb2-a46e-ef531153cf54	Lung	74	8712518A-FE08-43FD-B497-620ECC0AA0AC	FAB3D6F4-DE1C-4D6C-BDEA-AC39A7884657	TCGA-77-6843-01A-11D-1945-08	HG19_Broad_variant	TCGA-77-6843	TCGA-LUSC	2224	s10363	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T1	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIA	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6acc2	58cfa82ee4b0c9d6adf6acc2	G48125.TCGA-23-1124-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-23-1124-01A-01D-A312-08.2	G48125.TCGA-23-1124-01A-01D-A312-08.2.bam	307.67	1.9	0.08	58cfa82ee4b0c9d6adf6acc2	G48125.TCGA-23-1124-01A-01D-A312-08.2.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-23-1124-01A	8A6D2CE3-CC57-451B-9B07-8263782AA23F	Primary Tumor	Illumina HiSeq	65f9302b-3490-40e3-926a-d77a313fe760	Ovary	62	D8246FDA-3072-4470-8A7C-DE05BAC409C2	9A5BB831-8CB8-4DE0-B94B-088CB38DEF1A	TCGA-23-1124-01A-01D-A312-08	HG19_Broad_variant	TCGA-23-1124	TCGA-OV	1768	s17409	Broad Institute of MIT and Harvard	Cedars Sinai	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6acee	58cfa82ee4b0c9d6adf6acee	G39020.TCGA-CG-4474-01A-02D-A290-08.2.filtered.	WGS	G39020.TCGA-CG-4474-01A-02D-A290-08.2	G39020.TCGA-CG-4474-01A-02D-A290-08.2.bam	112.2	1.9	0.07	58cfa82ee4b0c9d6adf6acee	G39020.TCGA-CG-4474-01A-02D-A290-08.2.bam	Alive	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4474-01A	39DD61A8-CD17-4DF3-AE17-61E239EB00BD	Primary Tumor	Illumina HiSeq	fce67618-325e-4007-bf20-bd524f4bd049	Stomach	67	68D21E75-16AC-48D0-B7CA-ABFDE13DED29	5C4B369C-51A3-4CA7-8B9D-2A8E49C0DDE7	TCGA-CG-4474-01A-02D-A290-08	HG19_Broad_variant	TCGA-CG-4474	TCGA-STAD	NA	s14525	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T4a	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage IV	A290-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad30	58cfa82ee4b0c9d6adf6ad30	G49837.TCGA-43-5670-01A-21D-A320-08.1.filtered.	WGS	G49837.TCGA-43-5670-01A-21D-A320-08.1	G49837.TCGA-43-5670-01A-21D-A320-08.1.bam	559	NA	0.07	58cfa82ee4b0c9d6adf6ad30	G49837.TCGA-43-5670-01A-21D-A320-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-43-5670-01A	7D905F8F-3967-4EA8-96C8-17B1B03FBEC3	Primary Tumor	Illumina HiSeq	118f7a8c-af7e-4f0d-a235-99c5487eee74	Lung	70	6B829F48-BA74-40D7-B92F-41A2A2B7D136	369C06F2-8904-49CB-99D1-DD297ED0CD0C	TCGA-43-5670-01A-21D-A320-08	HG19_Broad_variant	TCGA-43-5670	TCGA-LUSC	NA	s10369	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T2b	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIA	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad57	58cfa82ee4b0c9d6adf6ad57	G8893.TCGA-66-2766-01A-01D-1180-08.4.filtered.	WGS	G8893.TCGA-66-2766-01A-01D-1180-08.4	G8893.TCGA-66-2766-01A-01D-1180-08.4.bam	564.3	1.9	0.14	58cfa82ee4b0c9d6adf6ad57	G8893.TCGA-66-2766-01A-01D-1180-08.4.bam	Alive	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2766-01A	B913D254-8307-4B8A-8313-D978E32BB38F	Primary Tumor	Illumina HiSeq	cba17a86-671f-4744-a52b-a93f56b8ee16	Lung	54	09215E83-EDAC-472D-B849-9225C532358C	45E16B70-C3EC-493E-86D1-505FFDF5056C	TCGA-66-2766-01A-01D-1180-08	HG19_Broad_variant	TCGA-66-2766	TCGA-LUSC	NA	s10262	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1180-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad61	58cfa82ee4b0c9d6adf6ad61	G8892.TCGA-66-2757-01A-01D-1180-08.1.filtered.	WGS	G8892.TCGA-66-2757-01A-01D-1180-08.1	G8892.TCGA-66-2757-01A-01D-1180-08.1.bam	161.3	1.9	0.15	58cfa82ee4b0c9d6adf6ad61	G8892.TCGA-66-2757-01A-01D-1180-08.1.bam	Alive	FEMALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2757-01A	A02932F3-5606-42A5-AEE4-E5B9F5AA1AAA	Primary Tumor	Illumina HiSeq	994d5f87-3d5a-4efb-badb-127ee3dd9480	Lung	65	7C727433-A8A8-44EB-AC11-DCB5EBD9250C	0E2DD8AA-7B45-4E26-BA3C-1A202FCB6BE3	TCGA-66-2757-01A-01D-1180-08	HG19_Broad_variant	TCGA-66-2757	TCGA-LUSC	NA	s10087	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	1180-08	FALSE
13722.58cfa82ee4b0c9d6adf6adb4	58cfa82ee4b0c9d6adf6adb4	G47088.TCGA-92-8064-01A-11D-2244-08.2.filtered.	WGS	G47088.TCGA-92-8064-01A-11D-2244-08.2	G47088.TCGA-92-8064-01A-11D-2244-08.2.bam	406.33	NA	0.05	58cfa82ee4b0c9d6adf6adb4	G47088.TCGA-92-8064-01A-11D-2244-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-92-8064-01A	DC6CEECE-EFAA-4B9D-9E12-D35863D7A902	Primary Tumor	Illumina HiSeq	8a33c586-703c-4354-9bde-caab929fcc59	Lung	58	014AD75E-86D2-423F-B9D3-84657D459A28	0E6654C9-CD5E-4F94-A6D4-54F2BB16DE1F	TCGA-92-8064-01A-11D-2244-08	HG19_Broad_variant	TCGA-92-8064	TCGA-LUSC	NA	s10077	Broad Institute of MIT and Harvard	Washington University - St. Louis	United States	NO	T2b	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	2244-08	FALSE
13722.58cfa82ee4b0c9d6adf6ace0	58cfa82ee4b0c9d6adf6ace0	G39020.TCGA-CG-5723-01A-11D-1600-08.1.filtered.	WGS	G39020.TCGA-CG-5723-01A-11D-1600-08.1	G39020.TCGA-CG-5723-01A-11D-1600-08.1.bam	224	1.9	0.05	58cfa82ee4b0c9d6adf6ace0	G39020.TCGA-CG-5723-01A-11D-1600-08.1.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5723-01A	0F00AD32-E4BE-49D4-A02A-D233BFC913C5	Primary Tumor	Illumina HiSeq	2a8e56af-ea0b-4304-805e-db8a07ae73dc	Stomach	83	4CCD9CCB-BF50-44EB-AA55-133D8824C433	FFB4F42B-58E9-40C3-8963-11804F041375	TCGA-CG-5723-01A-11D-1600-08	HG19_Broad_variant	TCGA-CG-5723	TCGA-STAD	NA	s14810	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1600-08	TRUE
13722.58cfa82ee4b0c9d6adf6add4	58cfa82ee4b0c9d6adf6add4	G39020.TCGA-CG-5724-01A-11D-1600-08.3.filtered.	WGS	G39020.TCGA-CG-5724-01A-11D-1600-08.3	G39020.TCGA-CG-5724-01A-11D-1600-08.3.bam	362	1.9	0.05	58cfa82ee4b0c9d6adf6add4	G39020.TCGA-CG-5724-01A-11D-1600-08.3.bam	Dead	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5724-01A	0B4E8D73-459D-4930-9D1A-ABB8D53E1844	Primary Tumor	Illumina HiSeq	f2f2a0e8-364c-4603-8030-6f0f803fe21c	Stomach	59	4D624B21-5AEE-42B8-B192-8AFECB51434D	6DAC8CA0-F776-4EA2-85C4-AEFBA4966BE7	TCGA-CG-5724-01A-11D-1600-08	HG19_Broad_variant	TCGA-CG-5724	TCGA-STAD	366	s15174	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T3	N3	Stomach  Adenocarcinoma  Diffuse Type	Stage IV	1600-08	TRUE
13722.58cfa82ee4b0c9d6adf6adca	58cfa82ee4b0c9d6adf6adca	G39020.TCGA-BR-A4J4-01A-12D-A25D-08.3.filtered.	WGS	G39020.TCGA-BR-A4J4-01A-12D-A25D-08.3	G39020.TCGA-BR-A4J4-01A-12D-A25D-08.3.bam	25.07	NA	0.08	58cfa82ee4b0c9d6adf6adca	G39020.TCGA-BR-A4J4-01A-12D-A25D-08.3.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-A4J4-01A	8A24F1A3-4BAB-4591-9676-7BEE01D096C1	Primary Tumor	Illumina HiSeq	2cdabae0-c924-481e-ad7e-bbe3f72f5c79	Stomach	39	5A5C4538-D75D-4DA5-8E8C-DD92766FEE50	2C316B7E-6A82-4BA1-9F34-D8BFCF82D41E	TCGA-BR-A4J4-01A-12D-A25D-08	HG19_Broad_variant	TCGA-BR-A4J4	TCGA-STAD	NA	s14459	Broad Institute of MIT and Harvard	Asterand	Vietnam	NO	T4a	N2	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIIB	A25D-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae36	58cfa82ee4b0c9d6adf6ae36	G49837.TCGA-90-7767-01A-11D-A320-08.3.filtered.	WGS	G49837.TCGA-90-7767-01A-11D-A320-08.3	G49837.TCGA-90-7767-01A-11D-A320-08.3.bam	263	NA	0.08	58cfa82ee4b0c9d6adf6ae36	G49837.TCGA-90-7767-01A-11D-A320-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-90-7767-01A	9DFF11CD-0784-4A60-9C77-43F8957D3DFA	Primary Tumor	Illumina HiSeq	667b4d6b-e888-4912-a5fd-74910e9b2f8e	Lung	56	609D3070-4B64-42EE-B071-42BE33DF7600	48F68F73-3AC0-44AC-BA12-B8889FCB7F38	TCGA-90-7767-01A-11D-A320-08	HG19_Broad_variant	TCGA-90-7767	TCGA-LUSC	NA	s9981	Broad Institute of MIT and Harvard	ABS - IUPUI	United States	NO	T2b	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ae5d	58cfa82ee4b0c9d6adf6ae5d	G49837.TCGA-37-4135-01A-01D-A320-08.2.filtered.	WGS	G49837.TCGA-37-4135-01A-01D-A320-08.2	G49837.TCGA-37-4135-01A-01D-A320-08.2.bam	968.93	1.9	0.07	58cfa82ee4b0c9d6adf6ae5d	G49837.TCGA-37-4135-01A-01D-A320-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-37-4135-01A	1F6B2ACA-7357-40D1-BA7A-99227D9900A2	Primary Tumor	Illumina HiSeq	00a52da3-1aca-4f65-b9ab-15fe28578557	Lung	68	5294476F-A200-453E-9D11-9C50F3C3FA5D	C48D7F4A-E98A-4077-A749-EB9F56F05B84	TCGA-37-4135-01A-01D-A320-08	HG19_Broad_variant	TCGA-37-4135	TCGA-LUSC	NA	s10504	Broad Institute of MIT and Harvard	Cureline	Russia	NO	T2a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6aecd	58cfa82ee4b0c9d6adf6aecd	G37566.TCGA-HC-7744-01A-11D-2114-08.1.filtered.	WGS	G37566.TCGA-HC-7744-01A-11D-2114-08.1	G37566.TCGA-HC-7744-01A-11D-2114-08.1.bam	170.3	NA	0.05	58cfa82ee4b0c9d6adf6aecd	G37566.TCGA-HC-7744-01A-11D-2114-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7744-01A	F6381367-142C-45D0-92B3-C1727D1813CE	Primary Tumor	Illumina HiSeq	8589d977-d1ca-42ea-975f-c3e664d57eba	Prostate	46	41E0D8F7-E104-43C4-B3BB-FD0B5CB3C7B2	0192D529-7340-45D8-A5F0-249CBB11CA19	TCGA-HC-7744-01A-11D-2114-08	HG19_Broad_variant	TCGA-HC-7744	TCGA-PRAD	NA	s3925	Broad Institute of MIT and Harvard	International Genomics Consortium	None	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	2114-08	FALSE
13722.58cfa82ee4b0c9d6adf6af06	58cfa82ee4b0c9d6adf6af06	G39020.TCGA-HU-A4G6-01A-11D-A24D-08.3.filtered.	WGS	G39020.TCGA-HU-A4G6-01A-11D-A24D-08.3	G39020.TCGA-HU-A4G6-01A-11D-A24D-08.3.bam	18.13	NA	0.08	58cfa82ee4b0c9d6adf6af06	G39020.TCGA-HU-A4G6-01A-11D-A24D-08.3.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4G6-01A	30A82E9F-2A2D-4A66-BDB1-26B881C21D01	Primary Tumor	Illumina HiSeq	01564622-cd3b-4f99-885f-ac2d8ca424c3	Stomach	74	41D015E0-E20E-45B7-98F1-3A010F78A8B4	C79CE3D3-4758-4F52-9DA1-38F994C99F4E	TCGA-HU-A4G6-01A-11D-A24D-08	HG19_Broad_variant	TCGA-HU-A4G6	TCGA-STAD	NA	s14393	Broad Institute of MIT and Harvard	National Cancer Center Korea	Korea South	NO	T1b	N0	Stomach Intestinal Adenocarcinoma Papillary Type	Stage IA	A24D-08	FALSE
13722.58cfa82de4b0c9d6adf6a73e	58cfa82de4b0c9d6adf6a73e	G14851.TCGA-05-4422-01A-01D-1931-08.2.filtered.	WGS	G14851.TCGA-05-4422-01A-01D-1931-08.2	G14851.TCGA-05-4422-01A-01D-1931-08.2.bam	631.63	1.9	0.15	58cfa82de4b0c9d6adf6a73e	G14851.TCGA-05-4422-01A-01D-1931-08.2.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4422-01A	44DEC838-B653-42A7-A58B-A1FD232CD68C	Primary Tumor	Illumina HiSeq	b70e3630-efee-4b99-b77b-c3000baf9819	Lung	68	DACBC55D-25C6-4E86-BD1B-38345B4DF7A7	6D2B0633-5BE4-4026-920C-427D3AA7C763	TCGA-05-4422-01A-01D-1931-08	HG19_Broad_variant	TCGA-05-4422	TCGA-LUAD	NA	s11104	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a746	58cfa82de4b0c9d6adf6a746	G14848.TCGA-05-4398-01A-01D-1931-08.3.filtered.	WGS	G14848.TCGA-05-4398-01A-01D-1931-08.3	G14848.TCGA-05-4398-01A-01D-1931-08.3.bam	403.53	1.9	0.15	58cfa82de4b0c9d6adf6a746	G14848.TCGA-05-4398-01A-01D-1931-08.3.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4398-01A	31C96E35-5E2F-429C-B12A-7BC5A497A300	Primary Tumor	Illumina HiSeq	fc9ee166-a6ea-4c5a-9978-b63277aec83e	Lung	47	DA010683-C537-478F-8F95-E606B05DBC5C	23D77176-DFED-4BEE-AC96-9934377D8D81	TCGA-05-4398-01A-01D-1931-08	HG19_Broad_variant	TCGA-05-4398	TCGA-LUAD	NA	s10625	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T4	N3	Lung Adenocarcinoma Mixed Subtype	Stage IIIB	1931-08	TRUE
13722.58cfa82ee4b0c9d6adf6af08	58cfa82ee4b0c9d6adf6af08	G39020.TCGA-D7-A4YX-01A-11D-A25D-08.2.filtered.	WGS	G39020.TCGA-D7-A4YX-01A-11D-A25D-08.2	G39020.TCGA-D7-A4YX-01A-11D-A25D-08.2.bam	42.47	NA	0.08	58cfa82ee4b0c9d6adf6af08	G39020.TCGA-D7-A4YX-01A-11D-A25D-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-A4YX-01A	2B4F014F-74E9-4DDA-A1AD-ABCBD124FC44	Primary Tumor	Illumina HiSeq	004a24e0-0e6d-4811-aac1-344ce1d54320	Stomach	63	DCFF683D-629E-4E67-9E9F-CE5752A2B276	A4C838DF-6AC4-455A-8096-8EC680064374	TCGA-D7-A4YX-01A-11D-A25D-08	HG19_Broad_variant	TCGA-D7-A4YX	TCGA-STAD	NA	s14462	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIB	A25D-08	FALSE
13722.58cfa82ee4b0c9d6adf6af34	58cfa82ee4b0c9d6adf6af34	G37566.TCGA-G9-6370-01A-11D-1786-08.2.filtered.	WGS	G37566.TCGA-G9-6370-01A-11D-1786-08.2	G37566.TCGA-G9-6370-01A-11D-1786-08.2.bam	59.4	2	0.05	58cfa82ee4b0c9d6adf6af34	G37566.TCGA-G9-6370-01A-11D-1786-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6370-01A	F947B0BC-BDAC-44E8-B5B9-FFAE4147740A	Primary Tumor	Illumina HiSeq	48541dbc-810e-4dad-a90a-5d33e6df1766	Prostate	52	644E1E7D-DFD1-4F83-82DC-AE0C7E010F6F	9689CB33-8AC9-4EE5-800D-3900769988AF	TCGA-G9-6370-01A-11D-1786-08	HG19_Broad_variant	TCGA-G9-6370	TCGA-PRAD	NA	s3582	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	1786-08	FALSE
13722.58cfa82ee4b0c9d6adf6af46	58cfa82ee4b0c9d6adf6af46	G48125.TCGA-10-0934-01A-02D-A312-08.3.filtered.	WGS	G48125.TCGA-10-0934-01A-02D-A312-08.3	G48125.TCGA-10-0934-01A-02D-A312-08.3.bam	91.67	1.8	0.07	58cfa82ee4b0c9d6adf6af46	G48125.TCGA-10-0934-01A-02D-A312-08.3.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-10-0934-01A	65DDCCD2-70A7-48B3-88E1-9D6FD1DCD11B	Primary Tumor	Illumina HiSeq	91697160-9785-41b6-a697-589c82cd7017	Ovary	50	27A33C2D-6704-4164-AA5B-894665DEA55F	0664753B-7566-41E0-8006-7009C6735406	TCGA-10-0934-01A-02D-A312-08	HG19_Broad_variant	TCGA-10-0934	TCGA-OV	204	s17165	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6af5b	58cfa82ee4b0c9d6adf6af5b	G48125.TCGA-09-2050-01A-01D-A312-08.1.filtered.	WGS	G48125.TCGA-09-2050-01A-01D-A312-08.1	G48125.TCGA-09-2050-01A-01D-A312-08.1.bam	724.97	1.9	0.08	58cfa82ee4b0c9d6adf6af5b	G48125.TCGA-09-2050-01A-01D-A312-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-09-2050-01A	3C037ACF-F453-4513-A6DD-129163DDDE2A	Primary Tumor	Illumina HiSeq	221bef91-5df9-4516-81ee-79e1ffc01030	Ovary	65	239E7813-BA65-4F3C-B7DE-77E166707C75	7A921087-8E62-4A93-A757-FD8CDBE1EB8F	TCGA-09-2050-01A-01D-A312-08	HG19_Broad_variant	TCGA-09-2050	TCGA-OV	NA	s17351	Broad Institute of MIT and Harvard	UCSF	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6af82	58cfa82ee4b0c9d6adf6af82	G39020.TCGA-D7-6822-01A-11D-1882-08.3.filtered.	WGS	G39020.TCGA-D7-6822-01A-11D-1882-08.3	G39020.TCGA-D7-6822-01A-11D-1882-08.3.bam	442.7	1.9	0.05	58cfa82ee4b0c9d6adf6af82	G39020.TCGA-D7-6822-01A-11D-1882-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6822-01A	E2AAABD9-F4BA-4763-A28A-C14D46A4BC5D	Primary Tumor	Illumina HiSeq	6bbb2709-a3ca-451a-82c8-996e619878b9	Stomach	77	C30AFDA8-FC63-4228-A9A9-42BCDB562ACE	1021B60D-F7B2-43B0-B2CC-F282D619D533	TCGA-D7-6822-01A-11D-1882-08	HG19_Broad_variant	TCGA-D7-6822	TCGA-STAD	NA	s15097	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IB	1882-08	FALSE
13722.58cfa82ee4b0c9d6adf6af86	58cfa82ee4b0c9d6adf6af86	G41960.TCGA-55-8299-01A-11D-2284-08.1.filtered.	WGS	G41960.TCGA-55-8299-01A-11D-2284-08.1	G41960.TCGA-55-8299-01A-11D-2284-08.1.bam	255.7	NA	0.05	58cfa82ee4b0c9d6adf6af86	G41960.TCGA-55-8299-01A-11D-2284-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-8299-01A	2CD8EA73-CB3F-4B17-9B97-FA12EB03B85B	Primary Tumor	Illumina HiSeq	0900edf4-dd21-4cc0-a6cb-6de863318729	Lung	61	5D0ED8D1-6E84-4F6C-8E0E-0317AA8B0E3F	15E097E3-E468-466C-8E57-B59FBA90BBF2	TCGA-55-8299-01A-11D-2284-08	HG19_Broad_variant	TCGA-55-8299	TCGA-LUAD	NA	s10765	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T1b	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	2284-08	FALSE
13722.58cfa82ee4b0c9d6adf6afd8	58cfa82ee4b0c9d6adf6afd8	G48125.TCGA-10-0938-01A-02D-A312-08.2.filtered.	WGS	G48125.TCGA-10-0938-01A-02D-A312-08.2	G48125.TCGA-10-0938-01A-02D-A312-08.2.bam	115.67	1.9	0.07	58cfa82ee4b0c9d6adf6afd8	G48125.TCGA-10-0938-01A-02D-A312-08.2.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-10-0938-01A	7CA97692-0BF5-4BBD-81CE-10A051D04BD5	Primary Tumor	Illumina HiSeq	6df8b7aa-5a5e-4a7c-bd82-de0c3fff4dda	Ovary	80	C11664E8-8883-4A0F-87C3-6FDC903860D5	8093649A-74D6-4832-9154-8CC0182FA381	TCGA-10-0938-01A-02D-A312-08	HG19_Broad_variant	TCGA-10-0938	TCGA-OV	636	s17481	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6b070	58cfa82ee4b0c9d6adf6b070	G8890.TCGA-60-2722-01A-01D-1180-08.2.filtered.	WGS	G8890.TCGA-60-2722-01A-01D-1180-08.2	G8890.TCGA-60-2722-01A-01D-1180-08.2.bam	179	1.9	0.15	58cfa82ee4b0c9d6adf6b070	G8890.TCGA-60-2722-01A-01D-1180-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2722-01A	6FD72426-F6C8-47CA-A500-D5D3600B9B15	Primary Tumor	Illumina HiSeq	417178a5-e706-47ee-92d7-de1eb647b4fc	Lung	66	060717AD-F034-46FA-8E9B-94A9422E4666	96DC785C-8417-4813-8D15-C32B22D78B74	TCGA-60-2722-01A-01D-1180-08	HG19_Broad_variant	TCGA-60-2722	TCGA-LUSC	NA	s9982	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIB	1180-08	FALSE
13722.58cfa82de4b0c9d6adf6a73c	58cfa82de4b0c9d6adf6a73c	G13228.TCGA-43-3920-01A-01D-1553-08.4.filtered.	WGS	G13228.TCGA-43-3920-01A-01D-1553-08.4	G13228.TCGA-43-3920-01A-01D-1553-08.4.bam	835.37	1.9	0.05	58cfa82de4b0c9d6adf6a73c	G13228.TCGA-43-3920-01A-01D-1553-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-43-3920-01A	9293E197-E38A-4E19-A7D0-1B45D1AD48BD	Primary Tumor	Illumina HiSeq	3281e662-29ac-4441-86e2-07a71d47196c	Lung	71	BBC07C89-5540-4217-AA56-3608539983C2	A762DD44-A8AC-4269-8163-BBF6D0F8D4B3	TCGA-43-3920-01A-01D-1553-08	HG19_Broad_variant	TCGA-43-3920	TCGA-LUSC	NA	s10157	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1553-08	FALSE
13722.58cfa82de4b0c9d6adf6a738	58cfa82de4b0c9d6adf6a738	G14681.TCGA-60-2719-01A-01D-1522-08.1.filtered.	WGS	G14681.TCGA-60-2719-01A-01D-1522-08.1	G14681.TCGA-60-2719-01A-01D-1522-08.1.bam	604.3	1.9	0.05	58cfa82de4b0c9d6adf6a738	G14681.TCGA-60-2719-01A-01D-1522-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2719-01A	585E6487-B0A3-4828-8A06-46BEE01DFF74	Primary Tumor	Illumina HiSeq	f600dac8-9a96-4214-a398-c9e40ed580ec	Lung	83	DD32EF9A-246B-47C9-A0E3-60A110E9047C	EE6CC68E-8D2A-41EE-82C6-0FECDF7E6259	TCGA-60-2719-01A-01D-1522-08	HG19_Broad_variant	TCGA-60-2719	TCGA-LUSC	NA	s10495	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1522-08	TRUE
13722.58cfa82de4b0c9d6adf6a74c	58cfa82de4b0c9d6adf6a74c	G14084.TCGA-22-1016-01A-01D-1521-08.3.filtered.	WGS	G14084.TCGA-22-1016-01A-01D-1521-08.3	G14084.TCGA-22-1016-01A-01D-1521-08.3.bam	313	1.9	0.05	58cfa82de4b0c9d6adf6a74c	G14084.TCGA-22-1016-01A-01D-1521-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-22-1016-01A	037C57D1-B4A5-45DC-BDA4-0550461D321B	Primary Tumor	Illumina HiSeq	ec4da199-1467-4435-944a-7558f9ffd8ea	Lung	65	DDB395E5-4B12-4610-9755-01E444B35C2E	935B113E-F5ED-4A07-8E1D-1603DABA7F40	TCGA-22-1016-01A-01D-1521-08	HG19_Broad_variant	TCGA-22-1016	TCGA-LUSC	822	s9974	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1521-08	TRUE
13722.58cfa82de4b0c9d6adf6a763	58cfa82de4b0c9d6adf6a763	G13231.TCGA-60-2724-01A-01D-1522-08.3.filtered.	WGS	G13231.TCGA-60-2724-01A-01D-1522-08.3	G13231.TCGA-60-2724-01A-01D-1522-08.3.bam	508.3	1.9	0.05	58cfa82de4b0c9d6adf6a763	G13231.TCGA-60-2724-01A-01D-1522-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2724-01A	A3E1AC67-A1F2-44FB-8343-A7E8239FC24A	Primary Tumor	Illumina HiSeq	fe7af73f-7704-440b-85f1-35dc1b30dea2	Lung	47	048E7EB0-57A4-4EED-A999-4E46D9FEF885	387C6519-6529-4074-A5AB-00F8052A5732	TCGA-60-2724-01A-01D-1522-08	HG19_Broad_variant	TCGA-60-2724	TCGA-LUSC	NA	s10155	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T3	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1522-08	TRUE
13722.58cfa82de4b0c9d6adf6a794	58cfa82de4b0c9d6adf6a794	G14088.TCGA-60-2698-01A-01D-1522-08.1.filtered.	WGS	G14088.TCGA-60-2698-01A-01D-1522-08.1	G14088.TCGA-60-2698-01A-01D-1522-08.1.bam	258.3	1.9	0.05	58cfa82de4b0c9d6adf6a794	G14088.TCGA-60-2698-01A-01D-1522-08.1.bam	Dead	MALE	WHITE	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2698-01A	FD9EE494-65FE-4DE4-ADFF-7952A059B17F	Primary Tumor	Illumina HiSeq	31535197-5bd8-4176-8b52-4bd012f6cb0b	Lung	62	A908CE38-12E6-4EC6-BAAB-9D79221AB6EB	2045C788-9EA8-4EA5-A5E3-65FC16A62ADB	TCGA-60-2698-01A-01D-1522-08	HG19_Broad_variant	TCGA-60-2698	TCGA-LUSC	311	s10494	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIB	1522-08	TRUE
13722.58cfa82ee4b0c9d6adf6a918	58cfa82ee4b0c9d6adf6a918	G25776.TCGA-75-6203-01A-11D-1753-08.1.filtered.	WGS	G25776.TCGA-75-6203-01A-11D-1753-08.1	G25776.TCGA-75-6203-01A-11D-1753-08.1.bam	49.4	1.9	0.05	58cfa82ee4b0c9d6adf6a918	G25776.TCGA-75-6203-01A-11D-1753-08.1.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-75-6203-01A	A8D6694C-A213-4544-AC0B-63BCE16D8F4E	Primary Tumor	Illumina HiSeq	976f4757-1570-44bb-9a05-7680fc9d30b6	Lung	NA	336EB991-5705-4BC0-A167-6D7F82F81697	D9CD7F95-07D3-4B87-BE83-87340B08D249	TCGA-75-6203-01A-11D-1753-08	HG19_Broad_variant	TCGA-75-6203	TCGA-LUAD	NA	s10892	Broad Institute of MIT and Harvard	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1753-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8f6	58cfa82ee4b0c9d6adf6a8f6	G35154.TCGA-FG-5965-01B-11D-1893-08.2.filtered.	WGS	G35154.TCGA-FG-5965-01B-11D-1893-08.2	G35154.TCGA-FG-5965-01B-11D-1893-08.2.bam	86.7	1.9	0.05	58cfa82ee4b0c9d6adf6a8f6	G35154.TCGA-FG-5965-01B-11D-1893-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-5965-01B	2CFC07F3-A31C-41A2-A9E3-B708D2421A78	Primary Tumor	Illumina HiSeq	8e6db5b3-96e4-4a80-9604-99a9433a1bb5	Brain	39	93FBE6D3-2091-4151-9075-0ED2DD4B886F	0730868D-1FE9-4964-A0CC-A12A74D161E6	TCGA-FG-5965-01B-11D-1893-08	HG19_Broad_variant	TCGA-FG-5965	TCGA-LGG	NA	s8106	Broad Institute of MIT and Harvard	Case Western	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	1893-08	FALSE
13722.58cfa82ee4b0c9d6adf6a7fa	58cfa82ee4b0c9d6adf6a7fa	G25780.TCGA-49-6742-01A-11D-1855-08.4.filtered.	WGS	G25780.TCGA-49-6742-01A-11D-1855-08.4	G25780.TCGA-49-6742-01A-11D-1855-08.4.bam	39.7	2	0.05	58cfa82ee4b0c9d6adf6a7fa	G25780.TCGA-49-6742-01A-11D-1855-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-6742-01A	21FB46F9-4BBB-441C-AF19-A687E9138344	Primary Tumor	Illumina HiSeq	2fdfd442-4aa3-49d0-82e8-7b21b059e7e3	Lung	70	F0A4AE58-D5BC-4AB0-B1CF-0D951EA91FC7	49DEC0C2-8E75-4F44-A253-82B2EA605890	TCGA-49-6742-01A-11D-1855-08	HG19_Broad_variant	TCGA-49-6742	TCGA-LUAD	NA	s10895	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T2a	N1	Mucinous (Colloid) Carcinoma	Stage IIA	1855-08	FALSE
13722.58cfa82ee4b0c9d6adf6a97e	58cfa82ee4b0c9d6adf6a97e	G35154.TCGA-DU-7013-01A-11D-A461-08.1.filtered.	WGS	G35154.TCGA-DU-7013-01A-11D-A461-08.1	G35154.TCGA-DU-7013-01A-11D-A461-08.1.bam	277.7	NA	0.08	58cfa82ee4b0c9d6adf6a97e	G35154.TCGA-DU-7013-01A-11D-A461-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7013-01A	D61B5D20-4D6D-4FDC-AFE8-4B100B686EDA	Primary Tumor	Illumina HiSeq	06158eca-e4b3-400e-806c-5342049e40aa	Brain	59	0F43B42C-EE65-4DF3-BDFF-2101E15B7C9B	344F8786-3383-446B-8662-DEA1FA3B6FF5	TCGA-DU-7013-01A-11D-A461-08	HG19_Broad_variant	TCGA-DU-7013	TCGA-LGG	269	s8533	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Astrocytoma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a9de	58cfa82ee4b0c9d6adf6a9de	G25782.TCGA-55-6982-01A-11D-1945-08.2.filtered.	WGS	G25782.TCGA-55-6982-01A-11D-1945-08.2	G25782.TCGA-55-6982-01A-11D-1945-08.2.bam	86.7	NA	0.05	58cfa82ee4b0c9d6adf6a9de	G25782.TCGA-55-6982-01A-11D-1945-08.2.bam	Dead	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-55-6982-01A	35CB7841-9B09-465A-90C5-E3B8A9FAAD49	Primary Tumor	Illumina HiSeq	c6027d22-f05d-42e4-a467-de21b4606751	Lung	79	3B284FC6-7DC4-46C2-8EC9-1121EF0B4308	B7F11036-7AC4-41BC-A9A4-64162725FDFC	TCGA-55-6982-01A-11D-1945-08	HG19_Broad_variant	TCGA-55-6982	TCGA-LUAD	995	s11109	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa82	58cfa82ee4b0c9d6adf6aa82	G25781.TCGA-50-6597-01A-11D-1855-08.4.filtered.	WGS	G25781.TCGA-50-6597-01A-11D-1855-08.4	G25781.TCGA-50-6597-01A-11D-1855-08.4.bam	12.7	1.9	0.05	58cfa82ee4b0c9d6adf6aa82	G25781.TCGA-50-6597-01A-11D-1855-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-6597-01A	0D66BF6C-EED0-4726-BD5B-3BF6D610B4E0	Primary Tumor	Illumina HiSeq	0e48684b-e0b4-4625-9f32-7e0331dfcefe	Lung	79	C5363830-3DB9-4C0C-AA47-B32FDC888C60	CD0AEED5-93A1-4287-8A88-FE6B7B5E3983	TCGA-50-6597-01A-11D-1855-08	HG19_Broad_variant	TCGA-50-6597	TCGA-LUAD	NA	s11110	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1855-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa01	58cfa82ee4b0c9d6adf6aa01	G23078.TCGA_CR_6487_01A_11D_2268_08.2.filtered.	WGS	G23078.TCGA_CR_6487_01A_11D_2268_08.2	G23078.TCGA_CR_6487_01A_11D_2268_08.2.bam	287.7	1.9	0.14	58cfa82ee4b0c9d6adf6aa01	G23078.TCGA_CR_6487_01A_11D_2268_08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6487-01A	9AE5101B-6031-4AB1-BFCA-198C41AF3184	Primary Tumor	Illumina HiSeq	5efcbe11-0d48-4b66-abce-d78199fe8fd8	Head and Neck	50	027DEDD3-BD53-420E-B7F2-EB5B8C26BCDC	1DB83E80-BDF7-4D8D-8008-BD8406D641FC	TCGA-CR-6487-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-6487	TCGA-HNSC	NA	s15606	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa8a	58cfa82ee4b0c9d6adf6aa8a	G32523.TCGA-DJ-A2Q2-01A-11D-A19J-08.4.filtered.	WGS	G32523.TCGA-DJ-A2Q2-01A-11D-A19J-08.4	G32523.TCGA-DJ-A2Q2-01A-11D-A19J-08.4.bam	41.27	NA	0.08	58cfa82ee4b0c9d6adf6aa8a	G32523.TCGA-DJ-A2Q2-01A-11D-A19J-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A2Q2-01A	A00DA907-E527-45F9-9AFB-2FAD2C7B0940	Primary Tumor	Illumina HiSeq	a59111e2-1f5e-429d-bb7f-4e413ed0baeb	Thyroid	57	A2E3CA88-9FF0-44AD-8C5A-CA4C7B404DE6	565E656C-D5E3-4FE4-A10C-2E9CA1E498B5	TCGA-DJ-A2Q2-01A-11D-A19J-08	HG19_Broad_variant	TCGA-DJ-A2Q2	TCGA-THCA	NA	s11972	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A19J-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab92	58cfa82ee4b0c9d6adf6ab92	G25790.TCGA-50-5066-01A-01D-1625-08.2.filtered.	WGS	G25790.TCGA-50-5066-01A-01D-1625-08.2	G25790.TCGA-50-5066-01A-01D-1625-08.2.bam	1182.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab92	G25790.TCGA-50-5066-01A-01D-1625-08.2.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5066-01A	3199CFE5-3BE3-43CD-A36B-5CF2C7A9929F	Primary Tumor	Illumina HiSeq	a9a4ae39-4e53-45e6-b9c0-2df2afca64ee	Lung	72	478CC306-6AEE-4597-8834-1E5CF8B05A59	F5A97315-1906-4774-980E-0879C6AD368E	TCGA-50-5066-01A-01D-1625-08	HG19_Broad_variant	TCGA-50-5066	TCGA-LUAD	NA	s10894	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1625-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab5e	58cfa82ee4b0c9d6adf6ab5e	G25785.TCGA-78-7143-01A-11D-2036-08.1.filtered.	WGS	G25785.TCGA-78-7143-01A-11D-2036-08.1	G25785.TCGA-78-7143-01A-11D-2036-08.1.bam	405.7	NA	0.05	58cfa82ee4b0c9d6adf6ab5e	G25785.TCGA-78-7143-01A-11D-2036-08.1.bam	Dead	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-78-7143-01A	54254F5A-50E8-4150-A9B7-56A0470D2A56	Primary Tumor	Illumina HiSeq	d0505bbf-c663-484b-93b6-a129883be59b	Lung	62	EE72F78D-E5DB-4C99-9034-0B5BBF6DF849	B710996C-8D35-4A2C-BC51-389B3E35B0F3	TCGA-78-7143-01A-11D-2036-08	HG19_Broad_variant	TCGA-78-7143	TCGA-LUAD	4961	s11107	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T2	N0	Lung Bronchioloalveolar Carcinoma Nonmucinous	Stage IB	2036-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab20	58cfa82ee4b0c9d6adf6ab20	G32543.TCGA-GN-A26C-01A-11D-A19A-08.5.filtered.	WGS	G32543.TCGA-GN-A26C-01A-11D-A19A-08.5	G32543.TCGA-GN-A26C-01A-11D-A19A-08.5.bam	55.8	NA	0.08	58cfa82ee4b0c9d6adf6ab20	G32543.TCGA-GN-A26C-01A-11D-A19A-08.5.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-GN-A26C-01A	FA099993-EF30-4EFF-A8FB-AA41B5EA671A	Primary Tumor	Illumina HiSeq	da9e3264-de3a-4fca-bfda-59022f9417d2	Skin	77	8288B632-9E64-401C-8F45-F268367F40E4	E2774050-1257-4C29-B201-D79CE70FE17E	TCGA-GN-A26C-01A-11D-A19A-08	HG19_Broad_variant	TCGA-GN-A26C	TCGA-SKCM	821	s7477	Broad Institute of MIT and Harvard	Roswell	United States	NO	T4b	N2b	Not available	Stage IIIC	A19A-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac51	58cfa82ee4b0c9d6adf6ac51	G39020.TCGA-BR-6456-01A-11D-1800-08.3.filtered.	WGS	G39020.TCGA-BR-6456-01A-11D-1800-08.3	G39020.TCGA-BR-6456-01A-11D-1800-08.3.bam	282.7	1.9	0.05	58cfa82ee4b0c9d6adf6ac51	G39020.TCGA-BR-6456-01A-11D-1800-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6456-01A	1CA3C5E0-32B0-4467-8EC0-CA212E35D2B3	Primary Tumor	Illumina HiSeq	9830e4a0-d8b1-4166-8375-49851288cf1f	Stomach	74	53369A25-3BC4-48CB-9004-DA3507C4D478	C612570A-881D-421F-98B9-0E4563133744	TCGA-BR-6456-01A-11D-1800-08	HG19_Broad_variant	TCGA-BR-6456	TCGA-STAD	NA	s14876	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIB	1800-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac75	58cfa82ee4b0c9d6adf6ac75	G47088.TCGA-21-5782-01A-01D-1632-08.1.filtered.	WGS	G47088.TCGA-21-5782-01A-01D-1632-08.1	G47088.TCGA-21-5782-01A-01D-1632-08.1.bam	384.7	1.9	0.05	58cfa82ee4b0c9d6adf6ac75	G47088.TCGA-21-5782-01A-01D-1632-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-21-5782-01A	E21964B8-47C7-4A5F-BFA7-7206222883D2	Primary Tumor	Illumina HiSeq	80a5fd2e-393b-43b1-9bbd-0e02bd6053a2	Lung	68	9ABF3A20-B34D-429B-9C13-0468DFC20700	4C2AD4A0-5D57-4E27-9F35-058B2F205F50	TCGA-21-5782-01A-01D-1632-08	HG19_Broad_variant	TCGA-21-5782	TCGA-LUSC	962	s10362	Broad Institute of MIT and Harvard	Fox Chase Cancer Center	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1632-08	FALSE
13722.58cfa82ee4b0c9d6adf6abc6	58cfa82ee4b0c9d6adf6abc6	G32540.TCGA-EL-A3CV-01A-11D-A19J-08.2.filtered.	WGS	G32540.TCGA-EL-A3CV-01A-11D-A19J-08.2	G32540.TCGA-EL-A3CV-01A-11D-A19J-08.2.bam	15.76	NA	0.08	58cfa82ee4b0c9d6adf6abc6	G32540.TCGA-EL-A3CV-01A-11D-A19J-08.2.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3CV-01A	FB83F7D7-2182-4FB7-8E3E-8AD7F1FEAC72	Primary Tumor	Illumina HiSeq	bd9e1da9-58f5-49d6-b838-2acffb8ee860	Thyroid	40	7BC433ED-7908-4297-AA5A-E033924BCED1	B1753E9C-29D0-4955-89D2-949CDABD1211	TCGA-EL-A3CV-01A-11D-A19J-08	HG19_Broad_variant	TCGA-EL-A3CV	TCGA-THCA	NA	s12727	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A19J-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac8b	58cfa82ee4b0c9d6adf6ac8b	G47088.TCGA-98-8022-01A-11D-2244-08.2.filtered.	WGS	G47088.TCGA-98-8022-01A-11D-2244-08.2	G47088.TCGA-98-8022-01A-11D-2244-08.2.bam	276.03	NA	0.05	58cfa82ee4b0c9d6adf6ac8b	G47088.TCGA-98-8022-01A-11D-2244-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-98-8022-01A	ADC853B1-B8BF-488C-A1E2-E95603459B55	Primary Tumor	Illumina HiSeq	490e3546-83cd-4a44-a792-f1c2e1530f4a	Lung	61	95933B01-06CA-4F3E-8995-EB2AB01A2C4C	6962BC97-FBB8-4220-A600-E3C251E245CB	TCGA-98-8022-01A-11D-2244-08	HG19_Broad_variant	TCGA-98-8022	TCGA-LUSC	NA	s10499	Broad Institute of MIT and Harvard	Washington University - Alabama	United States	NO	T1a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	2244-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac8f	58cfa82ee4b0c9d6adf6ac8f	G48125.TCGA-13-1477-01A-01D-A312-08.3.filtered.	WGS	G48125.TCGA-13-1477-01A-01D-A312-08.3	G48125.TCGA-13-1477-01A-01D-A312-08.3.bam	173.97	1.9	0.08	58cfa82ee4b0c9d6adf6ac8f	G48125.TCGA-13-1477-01A-01D-A312-08.3.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-1477-01A	13F5814C-1F99-4FFA-84A4-3BBD8979FAAE	Primary Tumor	Illumina HiSeq	20a1de59-1aa6-4045-a699-63a91e441931	Ovary	49	79908395-D442-44A3-8E91-97C3AE97DDD5	0AE2193F-0D68-485A-B8C2-7568CBCCE33E	TCGA-13-1477-01A-01D-A312-08	HG19_Broad_variant	TCGA-13-1477	TCGA-OV	1662	s18023	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac73	58cfa82ee4b0c9d6adf6ac73	G47088.TCGA-85-8277-01A-11D-2293-08.1.filtered.	WGS	G47088.TCGA-85-8277-01A-11D-2293-08.1	G47088.TCGA-85-8277-01A-11D-2293-08.1.bam	270.3	NA	0.05	58cfa82ee4b0c9d6adf6ac73	G47088.TCGA-85-8277-01A-11D-2293-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-85-8277-01A	8E6020A1-68DF-4D57-AD4E-33ACC0861FB3	Primary Tumor	Illumina HiSeq	b6b09fc0-6713-4047-8081-3b8224052fec	Lung	70	5600CB1A-D0F4-468E-B8D2-E431B77496BF	649F2C20-5B50-40A8-A6FD-9A51F3D5B9DF	TCGA-85-8277-01A-11D-2293-08	HG19_Broad_variant	TCGA-85-8277	TCGA-LUSC	NA	s10075	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T3	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIA	2293-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac9e	58cfa82ee4b0c9d6adf6ac9e	G48125.TCGA-04-1542-01A-01D-A312-08.1.filtered.	WGS	G48125.TCGA-04-1542-01A-01D-A312-08.1	G48125.TCGA-04-1542-01A-01D-A312-08.1.bam	136.34	1.9	0.08	58cfa82ee4b0c9d6adf6ac9e	G48125.TCGA-04-1542-01A-01D-A312-08.1.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-04-1542-01A	0C1A2E7D-E7E4-481E-A012-EF214C444497	Primary Tumor	Illumina HiSeq	b959ed10-2767-48bb-8031-f7a331c04f91	Ovary	52	D33FD264-13DB-4642-AFCA-37125751CC28	A0BBB3B1-E774-4C75-9301-BA43FB803F20	TCGA-04-1542-01A-01D-A312-08	HG19_Broad_variant	TCGA-04-1542	TCGA-OV	2561	s18019	Broad Institute of MIT and Harvard	Gynecologic Oncology Group	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac97	58cfa82ee4b0c9d6adf6ac97	G48125.TCGA-13-1487-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-13-1487-01A-01D-A312-08.2	G48125.TCGA-13-1487-01A-01D-A312-08.2.bam	298.97	1.9	0.07	58cfa82ee4b0c9d6adf6ac97	G48125.TCGA-13-1487-01A-01D-A312-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-1487-01A	C9E28934-8379-4511-817C-D787F2C4CA3A	Primary Tumor	Illumina HiSeq	3ce95963-7650-4fe7-9cbc-554ee9d56aa7	Ovary	74	BFF12F06-DABC-4424-AC53-65CA01D0A406	44EEBC04-C027-45AE-BECA-C4012B494F29	TCGA-13-1487-01A-01D-A312-08	HG19_Broad_variant	TCGA-13-1487	TCGA-OV	681	s17280	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6aca8	58cfa82ee4b0c9d6adf6aca8	G39020.TCGA-HU-A4H0-01A-11D-A25D-08.1.filtered.	WGS	G39020.TCGA-HU-A4H0-01A-11D-A25D-08.1	G39020.TCGA-HU-A4H0-01A-11D-A25D-08.1.bam	42.83	NA	0.08	58cfa82ee4b0c9d6adf6aca8	G39020.TCGA-HU-A4H0-01A-11D-A25D-08.1.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4H0-01A	FE45EAEE-FF0C-4D52-B18C-04DC2D64D3B4	Primary Tumor	Illumina HiSeq	787fd694-c915-406f-a8a1-0ca998d01d93	Stomach	72	568CBF5F-86DA-4420-9C70-324D11B8E481	7116CC90-F465-4E7E-AA27-48A83ED258E9	TCGA-HU-A4H0-01A-11D-A25D-08	HG19_Broad_variant	TCGA-HU-A4H0	TCGA-STAD	NA	s14394	Broad Institute of MIT and Harvard	National Cancer Center Korea	Korea South	NO	T4a	N3b	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIC	A25D-08	FALSE
13722.58cfa82ee4b0c9d6adf6acbc	58cfa82ee4b0c9d6adf6acbc	G37566.TCGA-HC-8258-01A-11D-2260-08.3.filtered.	WGS	G37566.TCGA-HC-8258-01A-11D-2260-08.3	G37566.TCGA-HC-8258-01A-11D-2260-08.3.bam	103.3	NA	0.05	58cfa82ee4b0c9d6adf6acbc	G37566.TCGA-HC-8258-01A-11D-2260-08.3.bam	Alive	MALE	Not available	Not available	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-8258-01A	DA5B0169-E4F4-4674-B348-220AF03FF4B5	Primary Tumor	Illumina HiSeq	696d5596-7630-4286-a1c4-8a3ea96ddf16	Prostate	56	B8881603-9353-4F63-93D7-E14EFED64AA6	597E4011-EA99-4356-B1D9-8CFE35DB7C3B	TCGA-HC-8258-01A-11D-2260-08	HG19_Broad_variant	TCGA-HC-8258	TCGA-PRAD	NA	s3583	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2260-08	FALSE
13722.58cfa82ee4b0c9d6adf6acaa	58cfa82ee4b0c9d6adf6acaa	G47088.TCGA-68-8250-01A-11D-2293-08.1.filtered.	WGS	G47088.TCGA-68-8250-01A-11D-2293-08.1	G47088.TCGA-68-8250-01A-11D-2293-08.1.bam	242.3	NA	0.05	58cfa82ee4b0c9d6adf6acaa	G47088.TCGA-68-8250-01A-11D-2293-08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-68-8250-01A	7B982D5E-3A7D-40AC-BD25-6044C62879B6	Primary Tumor	Illumina HiSeq	c923eeaa-1b36-49b3-97b7-f64875389d5f	Lung	66	A6A1A05E-9126-45CD-B7BE-C1C342FAF5AF	71A2B4A2-88DD-4911-A67E-70B3309C4A12	TCGA-68-8250-01A-11D-2293-08	HG19_Broad_variant	TCGA-68-8250	TCGA-LUSC	NA	s10252	Broad Institute of MIT and Harvard	Washington University - Cleveland Clinic	United States	NO	T1a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	2293-08	FALSE
13722.58cfa82ee4b0c9d6adf6acb6	58cfa82ee4b0c9d6adf6acb6	G48125.TCGA-23-1118-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-23-1118-01A-01D-A312-08.2	G48125.TCGA-23-1118-01A-01D-A312-08.2.bam	362.67	1.9	0.08	58cfa82ee4b0c9d6adf6acb6	G48125.TCGA-23-1118-01A-01D-A312-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-23-1118-01A	700E91BB-D675-41B2-BBBD-935767C7B447	Primary Tumor	Illumina HiSeq	be8b86e7-e6da-45ca-a286-471e3ef37950	Ovary	45	E1BE8AD9-1A52-4677-8436-3DA22AD12E9A	33EA81F2-DB2C-4567-BD7B-4CB9AADFEF88	TCGA-23-1118-01A-01D-A312-08	HG19_Broad_variant	TCGA-23-1118	TCGA-OV	NA	s18021	Broad Institute of MIT and Harvard	Cedars Sinai	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6accf	58cfa82ee4b0c9d6adf6accf	G48125.TCGA-24-1557-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-24-1557-01A-01D-A312-08.2	G48125.TCGA-24-1557-01A-01D-A312-08.2.bam	115.97	1.9	0.08	58cfa82ee4b0c9d6adf6accf	G48125.TCGA-24-1557-01A-01D-A312-08.2.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1557-01A	7DCC809B-E33A-4453-B92A-C00786F48CB0	Primary Tumor	Illumina HiSeq	07bba28c-8d1a-4228-bd9e-1b27066ba518	Ovary	49	FA79B363-380E-48AE-BB82-DB395085353C	BFF518FB-6DA7-4DFC-AE4C-BD3F641028E2	TCGA-24-1557-01A-01D-A312-08	HG19_Broad_variant	TCGA-24-1557	TCGA-OV	1213	s17862	Broad Institute of MIT and Harvard	Washington University	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6acc8	58cfa82ee4b0c9d6adf6acc8	G39020.TCGA-D7-8570-01A-11D-2340-08.2.filtered.	WGS	G39020.TCGA-D7-8570-01A-11D-2340-08.2	G39020.TCGA-D7-8570-01A-11D-2340-08.2.bam	318.7	NA	0.05	58cfa82ee4b0c9d6adf6acc8	G39020.TCGA-D7-8570-01A-11D-2340-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-8570-01A	1E1CDF72-820F-48A4-8FB6-89575D07CDE9	Primary Tumor	Illumina HiSeq	4b984072-ec9c-4924-a922-f7c4f5c2eacc	Stomach	44	E23E2A9C-5080-4276-8982-9CF078027A48	429AAD6F-816D-4739-BAA3-B0EBF2FCD501	TCGA-D7-8570-01A-11D-2340-08	HG19_Broad_variant	TCGA-D7-8570	TCGA-STAD	NA	s14877	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T3	N3a	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IIIB	2340-08	FALSE
13722.58cfa82ee4b0c9d6adf6aaec	58cfa82ee4b0c9d6adf6aaec	G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4.filtered.	WGS	G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4	G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4.bam	25.01	NA	0.08	58cfa82ee4b0c9d6adf6aaec	G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3T0-01A	861F94CE-45FF-4588-ADDB-E1EA48878C2E	Primary Tumor	Illumina HiSeq	5c6477ae-68e1-4407-8f81-53f64006df76	Thyroid	45	913D384C-657A-4AE0-9E8E-E9BDB77D140E	54426B1A-E0D3-4D8E-9E81-2D8E6B153B22	TCGA-EL-A3T0-01A-22D-A22D-08	HG19_Broad_variant	TCGA-EL-A3T0	TCGA-THCA	NA	s11975	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T3	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A22D-08	TRUE
13722.58cfa82ee4b0c9d6adf6ace6	58cfa82ee4b0c9d6adf6ace6	G39020.TCGA-CD-5802-01A-11D-1600-08.1.filtered.	WGS	G39020.TCGA-CD-5802-01A-11D-1600-08.1	G39020.TCGA-CD-5802-01A-11D-1600-08.1.bam	199	2	0.05	58cfa82ee4b0c9d6adf6ace6	G39020.TCGA-CD-5802-01A-11D-1600-08.1.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-5802-01A	0AECAC64-5982-4D76-8F31-958F6A00951D	Primary Tumor	Illumina HiSeq	314d6a95-e101-4389-b923-7b28a44e27c9	Stomach	58	93C38FFB-27AC-4C91-939D-7102EE72F404	C1B44966-0F72-4C4F-8783-AB3FFE7F17B2	TCGA-CD-5802-01A-11D-1600-08	HG19_Broad_variant	TCGA-CD-5802	TCGA-STAD	NA	s15171	Broad Institute of MIT and Harvard	ILSbio	Vietnam	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1600-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad1a	58cfa82ee4b0c9d6adf6ad1a	G48125.TCGA-24-1466-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-24-1466-01A-01D-A312-08.2	G48125.TCGA-24-1466-01A-01D-A312-08.2.bam	110.27	1.9	0.08	58cfa82ee4b0c9d6adf6ad1a	G48125.TCGA-24-1466-01A-01D-A312-08.2.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1466-01A	098ACB76-0BF5-44E5-BCAE-F919CF5FA5E5	Primary Tumor	Illumina HiSeq	13f5418c-eee9-41bd-bcaa-1ecf0416e01f	Ovary	74	3BF6EC5D-E075-41A7-BF32-470EC1F09E98	84CA6AB0-9EDC-4636-9D27-55CDBA334D7D	TCGA-24-1466-01A-01D-A312-08	HG19_Broad_variant	TCGA-24-1466	TCGA-OV	1373	s17889	Broad Institute of MIT and Harvard	Washington University	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad04	58cfa82ee4b0c9d6adf6ad04	G49537.TCGA-EL-A3MY-01A-11D-A21A-08.1.filtered.	WGS	G49537.TCGA-EL-A3MY-01A-11D-A21A-08.1	G49537.TCGA-EL-A3MY-01A-11D-A21A-08.1.bam	37.42	NA	0.08	58cfa82ee4b0c9d6adf6ad04	G49537.TCGA-EL-A3MY-01A-11D-A21A-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3MY-01A	7746BE87-7AD0-48A7-84FB-08A81B220BDB	Primary Tumor	Illumina HiSeq	961c7c05-824f-48c1-aed0-956b03c74c9f	Thyroid	81	E1C4D037-D70F-4AB1-BB34-554538C934CD	A9C29EDD-2EF1-46EF-93C6-796CF0332A2B	TCGA-EL-A3MY-01A-11D-A21A-08	HG19_Broad_variant	TCGA-EL-A3MY	TCGA-THCA	533	s12621	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T4	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage IVC	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad22	58cfa82ee4b0c9d6adf6ad22	G49537.TCGA-BJ-A28T-01A-11D-A33C-08.2.filtered.	WGS	G49537.TCGA-BJ-A28T-01A-11D-A33C-08.2	G49537.TCGA-BJ-A28T-01A-11D-A33C-08.2.bam	61.44	2	0.08	58cfa82ee4b0c9d6adf6ad22	G49537.TCGA-BJ-A28T-01A-11D-A33C-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A28T-01A	A9D8F797-8A53-4BE5-B957-0F1F6D080390	Primary Tumor	Illumina HiSeq	e27094ec-2670-4ef1-a358-d36554e52da1	Thyroid	34	4CA4149A-E952-4A25-9163-8D4C15B09A62	1D97BA51-D981-4986-9F71-C2B6CB9961C3	TCGA-BJ-A28T-01A-11D-A33C-08	HG19_Broad_variant	TCGA-BJ-A28T	TCGA-THCA	NA	s12218	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T1	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A33C-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad24	58cfa82ee4b0c9d6adf6ad24	G49837.TCGA-18-3408-01A-01D-A320-08.4.filtered.	WGS	G49837.TCGA-18-3408-01A-01D-A320-08.4	G49837.TCGA-18-3408-01A-01D-A320-08.4.bam	385.94	1.9	0.08	58cfa82ee4b0c9d6adf6ad24	G49837.TCGA-18-3408-01A-01D-A320-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-18-3408-01A	D4BC755A-2585-4529-AE36-7E1D88BDECFE	Primary Tumor	Illumina HiSeq	cea31b4d-7d33-4497-ae63-50688d12b045	Lung	77	EEFFADF9-2CCB-4937-AE1E-1D50ABA41C4D	24BADF07-8615-48A3-8D6E-45C3D783F18D	TCGA-18-3408-01A-01D-A320-08	HG19_Broad_variant	TCGA-18-3408	TCGA-LUSC	NA	s10257	Broad Institute of MIT and Harvard	Princess Margaret Hospital (Canada)	Canada	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad2e	58cfa82ee4b0c9d6adf6ad2e	G49837.TCGA-56-7582-01A-11D-A320-08.4.filtered.	WGS	G49837.TCGA-56-7582-01A-11D-A320-08.4	G49837.TCGA-56-7582-01A-11D-A320-08.4.bam	60	NA	0.08	58cfa82ee4b0c9d6adf6ad2e	G49837.TCGA-56-7582-01A-11D-A320-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-56-7582-01A	B5E2CBDA-BBFA-4EF8-A9C4-CB978BEF9B23	Primary Tumor	Illumina HiSeq	0a8f41dd-07fb-47be-b963-8d807c40760c	Lung	83	1220E8B3-E16E-454E-BC49-60F49F9FE090	89C48E53-C8A9-4518-B3B8-509CDCAFF52B	TCGA-56-7582-01A-11D-A320-08	HG19_Broad_variant	TCGA-56-7582	TCGA-LUSC	NA	s10163	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad1b	58cfa82ee4b0c9d6adf6ad1b	G49538.TCGA-06-0221-01A-01D-A32W-08.1.filtered.	WGS	G49538.TCGA-06-0221-01A-01D-A32W-08.1	G49538.TCGA-06-0221-01A-01D-A32W-08.1.bam	381.7	1.89	0.08	58cfa82ee4b0c9d6adf6ad1b	G49538.TCGA-06-0221-01A-01D-A32W-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0221-01A	054F472F-98CB-4559-B2E2-B5F800FC8EEF	Primary Tumor	Illumina HiSeq	684acac7-d7c1-4383-b72f-66e303b0d0e7	Brain	31	6E8D83F2-70BF-44F0-BD64-64D9DFE26F02	96CBA715-CEF0-4E39-92D5-4DEC27E83F1A	TCGA-06-0221-01A-01D-A32W-08	HG19_Broad_variant	TCGA-06-0221	TCGA-GBM	603	s14092	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	A32W-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad33	58cfa82ee4b0c9d6adf6ad33	G49837.TCGA-66-2759-01A-01D-A320-08.2.filtered.	WGS	G49837.TCGA-66-2759-01A-01D-A320-08.2	G49837.TCGA-66-2759-01A-01D-A320-08.2.bam	604.93	1.9	0.08	58cfa82ee4b0c9d6adf6ad33	G49837.TCGA-66-2759-01A-01D-A320-08.2.bam	Alive	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2759-01A	E6B72C24-1607-43B9-8B8A-7BF83EEA5895	Primary Tumor	Illumina HiSeq	38482025-33d2-4b12-a2f0-2654d26fe714	Lung	66	33918A59-C2B0-435E-BA63-8A39DA191712	7AC0B303-D685-4FA5-BFEC-34D2BA1DBC8E	TCGA-66-2759-01A-01D-A320-08	HG19_Broad_variant	TCGA-66-2759	TCGA-LUSC	NA	s10165	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIA	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad38	58cfa82ee4b0c9d6adf6ad38	G49537.TCGA-BJ-A28V-01A-11D-A19J-08.1.filtered.	WGS	G49537.TCGA-BJ-A28V-01A-11D-A19J-08.1	G49537.TCGA-BJ-A28V-01A-11D-A19J-08.1.bam	78.4	2	0.08	58cfa82ee4b0c9d6adf6ad38	G49537.TCGA-BJ-A28V-01A-11D-A19J-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A28V-01A	BED1FB3C-4459-460E-8190-29211857FA73	Primary Tumor	Illumina HiSeq	68b5668a-a719-42b2-99bb-d26c59c19b2f	Thyroid	80	4862B699-580D-4F2E-97A0-BD8918537067	19233FD1-5229-466E-ACF3-5882165758E0	TCGA-BJ-A28V-01A-11D-A19J-08	HG19_Broad_variant	TCGA-BJ-A28V	TCGA-THCA	NA	s12617	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A19J-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad41	58cfa82ee4b0c9d6adf6ad41	G49837.TCGA-52-7812-01A-11D-A320-08.3.filtered.	WGS	G49837.TCGA-52-7812-01A-11D-A320-08.3	G49837.TCGA-52-7812-01A-11D-A320-08.3.bam	402	NA	0.08	58cfa82ee4b0c9d6adf6ad41	G49837.TCGA-52-7812-01A-11D-A320-08.3.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-52-7812-01A	81B7CBC1-C037-426F-95B0-D729A30697DA	Primary Tumor	Illumina HiSeq	7beb10bf-82e5-4496-80a3-2e212fece28a	Lung	68	75384E41-370E-4972-870C-2845FB4DED2F	2FE2433B-9A55-431F-A869-2B5A63E8E8FC	TCGA-52-7812-01A-11D-A320-08	HG19_Broad_variant	TCGA-52-7812	TCGA-LUSC	835	s10258	Broad Institute of MIT and Harvard	University of Miami	United States	NO	T2	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIA	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad51	58cfa82ee4b0c9d6adf6ad51	G48125.TCGA-24-1614-01A-01D-A312-08.3.filtered.	WGS	G48125.TCGA-24-1614-01A-01D-A312-08.3	G48125.TCGA-24-1614-01A-01D-A312-08.3.bam	51.67	1.9	0.08	58cfa82ee4b0c9d6adf6ad51	G48125.TCGA-24-1614-01A-01D-A312-08.3.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1614-01A	D3164236-C14A-4230-B527-ECD1A3992F02	Primary Tumor	Illumina HiSeq	c60278e1-2516-4bfa-8d8e-236a0501a227	Ovary	57	C36E2D42-0759-46F2-8032-B92E555400C9	5CC7C966-499E-49E3-B509-4EEB00EE03D4	TCGA-24-1614-01A-01D-A312-08	HG19_Broad_variant	TCGA-24-1614	TCGA-OV	1470	s17350	Broad Institute of MIT and Harvard	Washington University	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad63	58cfa82ee4b0c9d6adf6ad63	G49537.TCGA-BJ-A0Z2-01A-11D-A10S-08.2.filtered.	WGS	G49537.TCGA-BJ-A0Z2-01A-11D-A10S-08.2	G49537.TCGA-BJ-A0Z2-01A-11D-A10S-08.2.bam	89.84	1.92	0.07	58cfa82ee4b0c9d6adf6ad63	G49537.TCGA-BJ-A0Z2-01A-11D-A10S-08.2.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0Z2-01A	F9CEFFC0-D544-418D-B4A9-BD3C84E37026	Primary Tumor	Illumina HiSeq	b84e6415-1014-4d91-a469-879b108fa3bb	Thyroid	57	B06B7493-F38A-493F-8B47-61E0FA4D111F	2DD5EEA1-42A1-4E8B-99AC-20399CC7E15C	TCGA-BJ-A0Z2-01A-11D-A10S-08	HG19_Broad_variant	TCGA-BJ-A0Z2	TCGA-THCA	NA	s12618	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage IVC	A10S-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad47	58cfa82ee4b0c9d6adf6ad47	G49837.TCGA-68-7755-01A-11D-A320-08.2.filtered.	WGS	G49837.TCGA-68-7755-01A-11D-A320-08.2	G49837.TCGA-68-7755-01A-11D-A320-08.2.bam	35	NA	0.08	58cfa82ee4b0c9d6adf6ad47	G49837.TCGA-68-7755-01A-11D-A320-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-68-7755-01A	3666BC65-8E40-409E-9A1F-41583DD6D978	Primary Tumor	Illumina HiSeq	2a201b20-3b01-4291-9e87-443bfb483c69	Lung	60	87D21E55-7F4A-4652-B7F7-1E64CB300FAE	84E601B7-DFA5-4CD5-9FEF-07F03967A0D4	TCGA-68-7755-01A-11D-A320-08	HG19_Broad_variant	TCGA-68-7755	TCGA-LUSC	NA	s10372	Broad Institute of MIT and Harvard	Washington University - Cleveland Clinic	United States	NO	T1b	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIA	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad3e	58cfa82ee4b0c9d6adf6ad3e	G39020.TCGA-D7-5579-01A-01D-1600-08.2.filtered.	WGS	G39020.TCGA-D7-5579-01A-01D-1600-08.2	G39020.TCGA-D7-5579-01A-01D-1600-08.2.bam	84.7	1.89	0.05	58cfa82ee4b0c9d6adf6ad3e	G39020.TCGA-D7-5579-01A-01D-1600-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-5579-01A	8B5746F9-DBEE-40BD-9141-1081960CF286	Primary Tumor	Illumina HiSeq	9296203d-9b4e-42bc-b596-e5d928afb7fc	Stomach	74	633DCE5B-7A88-46DC-AD06-8897A609675B	3DB3B7B1-DA1D-4B9C-A92A-C60FECF4328C	TCGA-D7-5579-01A-01D-1600-08	HG19_Broad_variant	TCGA-D7-5579	TCGA-STAD	NA	s15098	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T3	N2	Stomach Intestinal Adenocarcinoma Mucinous Type	Stage IIIA	1600-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad69	58cfa82ee4b0c9d6adf6ad69	G48125.TCGA-25-2400-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-25-2400-01A-01D-A312-08.2	G48125.TCGA-25-2400-01A-01D-A312-08.2.bam	26.97	1.9	0.08	58cfa82ee4b0c9d6adf6ad69	G48125.TCGA-25-2400-01A-01D-A312-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-2400-01A	5C127332-5CA0-45F1-A5AC-4876AD94E491	Primary Tumor	Illumina HiSeq	8cee9d85-d13a-49d0-a53e-c44c00ed4e36	Ovary	76	B5E8849B-9002-4B65-A2EA-6A46C04ABA4A	D67CAD13-E849-48B0-926C-10B6046BA0B9	TCGA-25-2400-01A-01D-A312-08	HG19_Broad_variant	TCGA-25-2400	TCGA-OV	1278	s17800	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad3a	58cfa82ee4b0c9d6adf6ad3a	G49537.TCGA-BJ-A0ZB-01A-11D-A10S-08.1.filtered.	WGS	G49537.TCGA-BJ-A0ZB-01A-11D-A10S-08.1	G49537.TCGA-BJ-A0ZB-01A-11D-A10S-08.1.bam	79.63	2	0.08	58cfa82ee4b0c9d6adf6ad3a	G49537.TCGA-BJ-A0ZB-01A-11D-A10S-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZB-01A	DC4D8468-6F34-40CB-A826-8D582CD86FDE	Primary Tumor	Illumina HiSeq	da7e540d-041b-4d8e-9158-52775a1aad5f	Thyroid	66	145A474E-D262-468A-8DB7-EE9F1B7CE0A7	ADD0B0F6-B4A8-4B73-B634-C3600DC567D5	TCGA-BJ-A0ZB-01A-11D-A10S-08	HG19_Broad_variant	TCGA-BJ-A0ZB	TCGA-THCA	NA	s12221	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IVA	A10S-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad8a	58cfa82ee4b0c9d6adf6ad8a	G39020.TCGA-BR-6564-01A-12D-1882-08.2.filtered.	WGS	G39020.TCGA-BR-6564-01A-12D-1882-08.2	G39020.TCGA-BR-6564-01A-12D-1882-08.2.bam	29.7	1.9	0.05	58cfa82ee4b0c9d6adf6ad8a	G39020.TCGA-BR-6564-01A-12D-1882-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6564-01A	AF1086CC-B330-4AD6-AE1C-3B5C7259949A	Primary Tumor	Illumina HiSeq	69520aa9-d9e7-49e5-a7a9-0b1e402a69c4	Stomach	46	B8355E52-D7A7-4711-BBA7-BC4D201741F2	2E66EB75-097C-4AD8-B2B3-9F5849DFD02F	TCGA-BR-6564-01A-12D-1882-08	HG19_Broad_variant	TCGA-BR-6564	TCGA-STAD	NA	s15037	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T3	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIA	1882-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad43	58cfa82ee4b0c9d6adf6ad43	G49837.TCGA-66-2744-01A-01D-A320-08.3.filtered.	WGS	G49837.TCGA-66-2744-01A-01D-A320-08.3	G49837.TCGA-66-2744-01A-01D-A320-08.3.bam	87.27	1.9	0.07	58cfa82ee4b0c9d6adf6ad43	G49837.TCGA-66-2744-01A-01D-A320-08.3.bam	Alive	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2744-01A	1EE543D5-B8C0-4F79-8373-6BB6319F2EE2	Primary Tumor	Illumina HiSeq	8188fa37-2482-4c3a-bc2d-c8ead7d2171c	Lung	71	75E00DD8-0AD9-4447-9407-0AB6AC0A7173	706868B5-4920-433A-BEA3-92E9BF83059B	TCGA-66-2744-01A-01D-A320-08	HG19_Broad_variant	TCGA-66-2744	TCGA-LUSC	NA	s10082	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad7a	58cfa82ee4b0c9d6adf6ad7a	G39020.TCGA-BR-8381-01A-11D-2394-08.2.filtered.	WGS	G39020.TCGA-BR-8381-01A-11D-2394-08.2	G39020.TCGA-BR-8381-01A-11D-2394-08.2.bam	329	NA	0.05	58cfa82ee4b0c9d6adf6ad7a	G39020.TCGA-BR-8381-01A-11D-2394-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8381-01A	AEF8D98F-7A1C-47F3-B5A7-A3CB299C70DE	Primary Tumor	Illumina HiSeq	8d5cdec5-779b-4ca8-a709-f2fbc527642b	Stomach	51	1DDC7F73-D793-4AE6-8A6A-851069892FAD	D6738C83-7B52-4224-846A-67BD085AAAB8	TCGA-BR-8381-01A-11D-2394-08	HG19_Broad_variant	TCGA-BR-8381	TCGA-STAD	NA	s15170	Broad Institute of MIT and Harvard	Asterand	Ukraine	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIB	2394-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad9a	58cfa82ee4b0c9d6adf6ad9a	G49837.TCGA-96-7545-01A-21D-A320-08.2.filtered.	WGS	G49837.TCGA-96-7545-01A-21D-A320-08.2	G49837.TCGA-96-7545-01A-21D-A320-08.2.bam	100	NA	0.08	58cfa82ee4b0c9d6adf6ad9a	G49837.TCGA-96-7545-01A-21D-A320-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-96-7545-01A	4CA13C92-84B4-4EDF-842A-B20B7E713415	Primary Tumor	Illumina HiSeq	dadefdff-15a7-4c69-8436-344e649bc017	Lung	73	59F2654E-7F41-480B-B59C-F0DB373B7160	B7A7D93B-38A7-4FC3-A433-3BB0A8CB7C42	TCGA-96-7545-01A-21D-A320-08	HG19_Broad_variant	TCGA-96-7545	TCGA-LUSC	NA	s10084	Broad Institute of MIT and Harvard	Washington University - NYU	United States	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ada0	58cfa82ee4b0c9d6adf6ada0	G39020.TCGA-CD-5799-01A-11D-1600-08.1.filtered.	WGS	G39020.TCGA-CD-5799-01A-11D-1600-08.1	G39020.TCGA-CD-5799-01A-11D-1600-08.1.bam	177.7	2	0.05	58cfa82ee4b0c9d6adf6ada0	G39020.TCGA-CD-5799-01A-11D-1600-08.1.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-5799-01A	C991697F-77F9-412A-9BD1-0E47F7387CB2	Primary Tumor	Illumina HiSeq	4086df7e-765b-48a9-bece-369629691ae0	Stomach	45	A3180E0E-EB99-49DD-8252-5FEA05A9885F	EB59B79F-BD36-4BF4-83E3-2AF73BD1D30A	TCGA-CD-5799-01A-11D-1600-08	HG19_Broad_variant	TCGA-CD-5799	TCGA-STAD	NA	s14602	Broad Institute of MIT and Harvard	ILSBIO	Vietnam	NO	T2	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1600-08	TRUE
13722.58cfa82ee4b0c9d6adf6adda	58cfa82ee4b0c9d6adf6adda	G49837.TCGA-18-3415-01A-01D-A320-08.2.filtered.	WGS	G49837.TCGA-18-3415-01A-01D-A320-08.2	G49837.TCGA-18-3415-01A-01D-A320-08.2.bam	369.94	1.9	0.08	58cfa82ee4b0c9d6adf6adda	G49837.TCGA-18-3415-01A-01D-A320-08.2.bam	Alive	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-18-3415-01A	9A874B64-D0D6-416E-97BC-E9071ED0B16B	Primary Tumor	Illumina HiSeq	c83a2887-3d9e-4a59-9e29-39e05ea6378b	Lung	77	23327C39-2E21-4604-9EBA-15884AE356FC	34881C6B-F59F-42C0-9F29-9C5C47262AE6	TCGA-18-3415-01A-01D-A320-08	HG19_Broad_variant	TCGA-18-3415	TCGA-LUSC	NA	s10080	Broad Institute of MIT and Harvard	Princess Margaret Hospital (Canada)	Canada	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6add8	58cfa82ee4b0c9d6adf6add8	G48125.TCGA-25-1634-01A-01D-A312-08.4.filtered.	WGS	G48125.TCGA-25-1634-01A-01D-A312-08.4	G48125.TCGA-25-1634-01A-01D-A312-08.4.bam	303.97	1.9	0.08	58cfa82ee4b0c9d6adf6add8	G48125.TCGA-25-1634-01A-01D-A312-08.4.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-1634-01A	15556B28-C6BD-455A-87B6-4B7B3E33D0E4	Primary Tumor	Illumina HiSeq	ed70494d-da6d-45b7-ad0f-59cd3afa7d46	Ovary	75	C0091BB4-1079-4254-AD42-42AC1DDD7F1E	3A5EAED6-FCFD-437A-B61C-FD3725C64717	TCGA-25-1634-01A-01D-A312-08	HG19_Broad_variant	TCGA-25-1634	TCGA-OV	1091	s17863	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6adfc	58cfa82ee4b0c9d6adf6adfc	G49538.TCGA-06-0211-01A-01D-1491-08.1.filtered.	WGS	G49538.TCGA-06-0211-01A-01D-1491-08.1	G49538.TCGA-06-0211-01A-01D-1491-08.1.bam	0	1.88	0.05	58cfa82ee4b0c9d6adf6adfc	G49538.TCGA-06-0211-01A-01D-1491-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0211-01A	5C984433-33CF-42FC-B3BA-511EFCDCAB19	Primary Tumor	Illumina HiSeq	c68adb10-306f-4541-92b1-c6b5baa25d00	Brain	47	83177103-6AE2-444E-8AE7-E1BF76B1351D	CAEF21A2-190E-456D-95C9-3927A0B250AC	TCGA-06-0211-01A-01D-1491-08	HG19_Broad_variant	TCGA-06-0211	TCGA-GBM	360	s13948	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1491-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae46	58cfa82ee4b0c9d6adf6ae46	G49837.TCGA-33-4586-01A-01D-A320-08.2.filtered.	WGS	G49837.TCGA-33-4586-01A-01D-A320-08.2	G49837.TCGA-33-4586-01A-01D-A320-08.2.bam	362	1.9	0.07	58cfa82ee4b0c9d6adf6ae46	G49837.TCGA-33-4586-01A-01D-A320-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-33-4586-01A	376DFD27-68E8-4A1A-9C4F-5064279B2A9E	Primary Tumor	Illumina HiSeq	e894d311-bbc3-468a-bed1-2c6328ae7bda	Lung	57	A41992A4-D0F9-4D5B-8D05-0E3025D9C8FF	B88F014E-BC0F-4775-8228-39E0B471C3B0	TCGA-33-4586-01A-01D-A320-08	HG19_Broad_variant	TCGA-33-4586	TCGA-LUSC	428	s10162	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T2	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIA	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ae1a	58cfa82ee4b0c9d6adf6ae1a	G49837.TCGA-66-2795-01A-02D-A320-08.4.filtered.	WGS	G49837.TCGA-66-2795-01A-02D-A320-08.4	G49837.TCGA-66-2795-01A-02D-A320-08.4.bam	612.94	1.9	0.08	58cfa82ee4b0c9d6adf6ae1a	G49837.TCGA-66-2795-01A-02D-A320-08.4.bam	Alive	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2795-01A	DA93A143-5799-4856-A5F4-3FF3B9284311	Primary Tumor	Illumina HiSeq	ad1129fe-92b3-4515-b91f-4b415f4e371f	Lung	68	9DC330BF-ACBD-4419-B533-35CF59ACEC71	D18C6E64-9598-488A-8AB3-3652072F9277	TCGA-66-2795-01A-02D-A320-08	HG19_Broad_variant	TCGA-66-2795	TCGA-LUSC	NA	s10256	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T4	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ae76	58cfa82ee4b0c9d6adf6ae76	G49537.TCGA-FE-A22Z-01A-11D-A35R-08.1.filtered.	WGS	G49537.TCGA-FE-A22Z-01A-11D-A35R-08.1	G49537.TCGA-FE-A22Z-01A-11D-A35R-08.1.bam	78.59	2.03	0.08	58cfa82ee4b0c9d6adf6ae76	G49537.TCGA-FE-A22Z-01A-11D-A35R-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A22Z-01A	78D14F86-896A-4F98-9274-B2E8E387ADD9	Primary Tumor	Illumina HiSeq	d881881c-7108-46ea-92a8-1b1d9c915d5b	Thyroid	61	D206D300-E0CE-4A40-AF1F-45A685346A6E	8845FCE6-E2B4-4929-942B-57096B0BBAFC	TCGA-FE-A22Z-01A-11D-A35R-08	HG19_Broad_variant	TCGA-FE-A22Z	TCGA-THCA	NA	s12737	Broad Institute of MIT and Harvard	Ohio State University	United States	NO	T4a	N1	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage IVA	A35R-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae3b	58cfa82ee4b0c9d6adf6ae3b	G49837.TCGA-77-7139-01A-11D-A320-08.3.filtered.	WGS	G49837.TCGA-77-7139-01A-11D-A320-08.3	G49837.TCGA-77-7139-01A-11D-A320-08.3.bam	403	NA	0.08	58cfa82ee4b0c9d6adf6ae3b	G49837.TCGA-77-7139-01A-11D-A320-08.3.bam	Alive	MALE	WHITE	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-77-7139-01A	EE850103-6314-41A3-9734-8B520DE95B40	Primary Tumor	Illumina HiSeq	af2dee93-083d-492d-87c8-73cb962d49a2	Lung	56	48F646FE-03C6-4E7B-ACF1-9869E379443E	AD41F1F3-E38E-4418-9C16-52BCA5719F39	TCGA-77-7139-01A-11D-A320-08	HG19_Broad_variant	TCGA-77-7139	TCGA-LUSC	NA	s10260	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ae79	58cfa82ee4b0c9d6adf6ae79	G49538.TCGA-14-1402-01A-01D-1493-08.3.filtered.	WGS	G49538.TCGA-14-1402-01A-01D-1493-08.3	G49538.TCGA-14-1402-01A-01D-1493-08.3.bam	484	1.9	0.05	58cfa82ee4b0c9d6adf6ae79	G49538.TCGA-14-1402-01A-01D-1493-08.3.bam	Dead	FEMALE	WHITE	Not available	Glioblastoma Multiforme	Aligned reads	TCGA-14-1402-01A	BF339349-062F-4EA9-A0B2-D87D3A21099E	Primary Tumor	Illumina HiSeq	16d26bf2-f6a6-472e-b26a-fcd17cf66832	Brain	58	90A6DB9D-669E-4507-A0B9-B1C5D8F5BF4D	6FEE80F8-11CB-4DE7-ADED-E586708D2368	TCGA-14-1402-01A-01D-1493-08	HG19_Broad_variant	TCGA-14-1402	TCGA-GBM	975	s14028	Broad Institute of MIT and Harvard	Emory University	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1493-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae86	58cfa82ee4b0c9d6adf6ae86	G49538.TCGA-14-1034-01A-01D-1492-08.3.filtered.	WGS	G49538.TCGA-14-1034-01A-01D-1492-08.3	G49538.TCGA-14-1034-01A-01D-1492-08.3.bam	15	1.9	0.05	58cfa82ee4b0c9d6adf6ae86	G49538.TCGA-14-1034-01A-01D-1492-08.3.bam	Dead	FEMALE	Not available	Not available	Glioblastoma Multiforme	Aligned reads	TCGA-14-1034-01A	0078B0C4-68A9-483B-9AAB-61156D263213	Primary Tumor	Illumina HiSeq	08541db8-2e7a-44e8-af91-65a951e09952	Brain	60	F2FFA9FF-86D6-41EF-92E7-7F87E981985B	86CD18AE-6390-4669-A707-4E0E334C690A	TCGA-14-1034-01A-01D-1492-08	HG19_Broad_variant	TCGA-14-1034	TCGA-GBM	485	s13984	Broad Institute of MIT and Harvard	Emory University	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1492-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae81	58cfa82ee4b0c9d6adf6ae81	G49538.TCGA-06-0210-01A-01D-1491-08.1.filtered.	WGS	G49538.TCGA-06-0210-01A-01D-1491-08.1	G49538.TCGA-06-0210-01A-01D-1491-08.1.bam	195.7	1.89	0.05	58cfa82ee4b0c9d6adf6ae81	G49538.TCGA-06-0210-01A-01D-1491-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0210-01A	DE7B7CAC-F094-4D59-8651-E991E34EA093	Primary Tumor	Illumina HiSeq	47e69676-3a06-4711-ab31-5c65c734e472	Brain	72	D56A1EB8-D47B-41C3-B5D0-F5632DF77B3F	E362F533-5394-4E4A-9E4A-375FFC5F427B	TCGA-06-0210-01A-01D-1491-08	HG19_Broad_variant	TCGA-06-0210	TCGA-GBM	225	s13986	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1491-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae8a	58cfa82ee4b0c9d6adf6ae8a	G49537.TCGA-L6-A4ET-01A-11D-A257-08.2.filtered.	WGS	G49537.TCGA-L6-A4ET-01A-11D-A257-08.2	G49537.TCGA-L6-A4ET-01A-11D-A257-08.2.bam	42.4	NA	0.08	58cfa82ee4b0c9d6adf6ae8a	G49537.TCGA-L6-A4ET-01A-11D-A257-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-L6-A4ET-01A	E1FF7694-64E1-47ED-B0D8-34ACFB4FFEF1	Primary Tumor	Illumina HiSeq	1e492402-4405-430b-a336-e8043ef159c8	Thyroid	49	D6183BCA-9A4D-41AC-940D-0EAA23DECF56	546B97B0-AB82-42A1-BBD2-241523278EC3	TCGA-L6-A4ET-01A-11D-A257-08	HG19_Broad_variant	TCGA-L6-A4ET	TCGA-THCA	NA	s12743	Broad Institute of MIT and Harvard	National Institutes of Health	United States	NO	T3	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage IVC	A257-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae91	58cfa82ee4b0c9d6adf6ae91	G49538.TCGA-06-0125-01A-01D-1490-08.2.filtered.	WGS	G49538.TCGA-06-0125-01A-01D-1490-08.2	G49538.TCGA-06-0125-01A-01D-1490-08.2.bam	43.8	1.87	0.05	58cfa82ee4b0c9d6adf6ae91	G49538.TCGA-06-0125-01A-01D-1490-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0125-01A	8DA3103E-3E6C-4176-A583-D5FE5E60601E	Primary Tumor	Illumina HiSeq	759af811-403e-4320-a598-d3291f429679	Brain	63	3A30326B-7523-4565-9A7E-0F7B5536B1CA	0D2A3D87-8ED4-4B27-82EB-FDE852EDE1D7	TCGA-06-0125-01A-01D-1490-08	HG19_Broad_variant	TCGA-06-0125	TCGA-GBM	1448	s14373	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1490-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae8b	58cfa82ee4b0c9d6adf6ae8b	G49537.TCGA-EM-A22O-01A-11D-A17V-08.1.filtered.	WGS	G49537.TCGA-EM-A22O-01A-11D-A17V-08.1	G49537.TCGA-EM-A22O-01A-11D-A17V-08.1.bam	89.61	1.91	0.09	58cfa82ee4b0c9d6adf6ae8b	G49537.TCGA-EM-A22O-01A-11D-A17V-08.1.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EM-A22O-01A	6ABC861A-376D-446B-ACEE-FB0F03A82C09	Primary Tumor	Illumina HiSeq	93872277-a7c8-4d30-999d-afa2db9d4986	Thyroid	75	AACF33BD-95CE-40FD-9828-1E78CBBB0E1B	13642CF8-9840-4A7D-A26A-95F65B2C70C3	TCGA-EM-A22O-01A-11D-A17V-08	HG19_Broad_variant	TCGA-EM-A22O	TCGA-THCA	NA	s12087	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T4a	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage IVA	A17V-08	TRUE
13722.58cfa82ee4b0c9d6adf6ae9a	58cfa82ee4b0c9d6adf6ae9a	G49537.TCGA-FK-A3SD-01A-11D-A22D-08.1.filtered.	WGS	G49537.TCGA-FK-A3SD-01A-11D-A22D-08.1	G49537.TCGA-FK-A3SD-01A-11D-A22D-08.1.bam	32.19	NA	0.07	58cfa82ee4b0c9d6adf6ae9a	G49537.TCGA-FK-A3SD-01A-11D-A22D-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FK-A3SD-01A	63B01B43-A68A-4046-89B0-736BA4D08504	Primary Tumor	Illumina HiSeq	f713e001-9c18-4a72-a093-90bd147d414f	Thyroid	61	B48D226E-610A-40DC-B62A-6DB863A7366C	29578759-9CCB-4A24-B5B8-C45EBD4339D9	TCGA-FK-A3SD-01A-11D-A22D-08	HG19_Broad_variant	TCGA-FK-A3SD	TCGA-THCA	NA	s12739	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A22D-08	TRUE
13722.58cfa82ee4b0c9d6adf6aebe	58cfa82ee4b0c9d6adf6aebe	G49538.TCGA-06-0190-01A-01D-1491-08.1.filtered.	WGS	G49538.TCGA-06-0190-01A-01D-1491-08.1	G49538.TCGA-06-0190-01A-01D-1491-08.1.bam	73.7	1.9	0.05	58cfa82ee4b0c9d6adf6aebe	G49538.TCGA-06-0190-01A-01D-1491-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0190-01A	74139255-A635-4C87-814D-3DD04ED630A8	Primary Tumor	Illumina HiSeq	e496b84b-9adf-462a-8d8f-7b336fa12626	Brain	62	5E92A5D5-77A4-401A-ADE3-E01C95302EC0	640AFBF7-7886-4A29-9505-DCF36B611A05	TCGA-06-0190-01A-01D-1491-08	HG19_Broad_variant	TCGA-06-0190	TCGA-GBM	317	s14094	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1491-08	FALSE
13722.58cfa82ee4b0c9d6adf6aea8	58cfa82ee4b0c9d6adf6aea8	G39020.TCGA-BR-8373-01A-11D-2340-08.3.filtered.	WGS	G39020.TCGA-BR-8373-01A-11D-2340-08.3	G39020.TCGA-BR-8373-01A-11D-2340-08.3.bam	188.7	NA	0.05	58cfa82ee4b0c9d6adf6aea8	G39020.TCGA-BR-8373-01A-11D-2340-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8373-01A	60879669-96C2-4710-82E0-0AE9D0E5B242	Primary Tumor	Illumina HiSeq	cbbdb4e0-d400-45ef-bb4f-790b2cc9cb87	Stomach	65	4370B4F3-4FD7-4558-BF59-DAAE486BADC3	1F2A8889-4374-4037-BB56-0F20733380E3	TCGA-BR-8373-01A-11D-2340-08	HG19_Broad_variant	TCGA-BR-8373	TCGA-STAD	NA	s15094	Broad Institute of MIT and Harvard	Asterand	Ukraine	NO	T4a	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIIA	2340-08	FALSE
13722.58cfa82ee4b0c9d6adf6aab8	58cfa82ee4b0c9d6adf6aab8	G23079.TCGA_CR_6482_01A_11D_2268_08.2.filtered.	WGS	G23079.TCGA_CR_6482_01A_11D_2268_08.2	G23079.TCGA_CR_6482_01A_11D_2268_08.2.bam	68.7	1.9	0.14	58cfa82ee4b0c9d6adf6aab8	G23079.TCGA_CR_6482_01A_11D_2268_08.2.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6482-01A	468649E7-1525-4B8A-8AB5-DDB27DB5F022	Primary Tumor	Illumina HiSeq	47cd6984-3399-4fc7-a843-09a97b33bf4b	Head and Neck	62	92173F97-B46A-4950-8CD8-6729AB9522C5	7158C9FD-A633-4FEF-AA23-BD285F2A87A8	TCGA-CR-6482-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-6482	TCGA-HNSC	NA	s15866	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6aea6	58cfa82ee4b0c9d6adf6aea6	G49537.TCGA-EM-A2OW-01A-11D-A202-08.1.filtered.	WGS	G49537.TCGA-EM-A2OW-01A-11D-A202-08.1	G49537.TCGA-EM-A2OW-01A-11D-A202-08.1.bam	36.94	NA	0.08	58cfa82ee4b0c9d6adf6aea6	G49537.TCGA-EM-A2OW-01A-11D-A202-08.1.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A2OW-01A	A65EC434-9AE0-453F-B440-08BF25558FD1	Primary Tumor	Illumina HiSeq	c5097aad-061c-40d4-aa81-a97fe09d13f6	Thyroid	37	4D6A2D9E-EC25-4040-A696-2D8D5D5C392E	17A66D24-DE77-4F2A-A8AD-D2C6A69E7671	TCGA-EM-A2OW-01A-11D-A202-08	HG19_Broad_variant	TCGA-EM-A2OW	TCGA-THCA	NA	s12504	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T1b	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A202-08	TRUE
13722.58cfa82ee4b0c9d6adf6aed0	58cfa82ee4b0c9d6adf6aed0	G48125.TCGA-13-1491-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-13-1491-01A-01D-A312-08.2	G48125.TCGA-13-1491-01A-01D-A312-08.2.bam	295.97	1.9	0.07	58cfa82ee4b0c9d6adf6aed0	G48125.TCGA-13-1491-01A-01D-A312-08.2.bam	Dead	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-1491-01A	C8FEBEEF-8E7E-459E-88CB-8086692DC559	Primary Tumor	Illumina HiSeq	f59b5a81-22df-4a33-86dd-2e648ee08701	Ovary	55	A082B848-0867-4BB4-96BA-008645D9053C	129DE5B2-D9B0-4762-9EF8-72D98231FB50	TCGA-13-1491-01A-01D-A312-08	HG19_Broad_variant	TCGA-13-1491	TCGA-OV	1595	s17167	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6aebf	58cfa82ee4b0c9d6adf6aebf	G49537.TCGA-DE-A0Y3-01B-11D-A10S-08.2.filtered.	WGS	G49537.TCGA-DE-A0Y3-01B-11D-A10S-08.2	G49537.TCGA-DE-A0Y3-01B-11D-A10S-08.2.bam	60.48	2.03	0.07	58cfa82ee4b0c9d6adf6aebf	G49537.TCGA-DE-A0Y3-01B-11D-A10S-08.2.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DE-A0Y3-01B	C31B3ADF-3FC6-4A72-83B0-BBC0F295B5E7	Primary Tumor	Illumina HiSeq	3c0140ae-22a1-4eff-8981-313aa5dd5315	Thyroid	60	3AE03B86-1473-409C-8118-A91A73A36F60	7DFCFE29-3900-4D7B-8067-60C51584B0B1	TCGA-DE-A0Y3-01B-11D-A10S-08	HG19_Broad_variant	TCGA-DE-A0Y3	TCGA-THCA	NA	s12219	Broad Institute of MIT and Harvard	University of North Carolina	United States	NO	T4a	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IVC	A10S-08	TRUE
13722.58cfa82ee4b0c9d6adf6aeea	58cfa82ee4b0c9d6adf6aeea	G49537.TCGA-EM-A3FR-01A-11D-A21Z-08.1.filtered.	WGS	G49537.TCGA-EM-A3FR-01A-11D-A21Z-08.1	G49537.TCGA-EM-A3FR-01A-11D-A21Z-08.1.bam	45.93	NA	0.08	58cfa82ee4b0c9d6adf6aeea	G49537.TCGA-EM-A3FR-01A-11D-A21Z-08.1.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3FR-01A	2B84CFBC-7CF6-4CB1-A1E3-BA85DAFB89F4	Primary Tumor	Illumina HiSeq	edb95f67-9483-47e8-9b1f-0aad36f1a1ac	Thyroid	55	319E3498-D5FB-4142-A09F-ABA779DBC094	4BAE2F08-DA75-4991-ACB8-5BA9912F9131	TCGA-EM-A3FR-01A-11D-A21Z-08	HG19_Broad_variant	TCGA-EM-A3FR	TCGA-THCA	NA	s11983	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A21Z-08	TRUE
13722.58cfa82ee4b0c9d6adf6aee2	58cfa82ee4b0c9d6adf6aee2	G49537.TCGA-ET-A2N1-01A-11D-A18F-08.2.filtered.	WGS	G49537.TCGA-ET-A2N1-01A-11D-A18F-08.2	G49537.TCGA-ET-A2N1-01A-11D-A18F-08.2.bam	49.49	NA	0.08	58cfa82ee4b0c9d6adf6aee2	G49537.TCGA-ET-A2N1-01A-11D-A18F-08.2.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A2N1-01A	E74B8474-F74A-498D-8848-6AA97D38D2D8	Primary Tumor	Illumina HiSeq	f2cf3084-f780-42f8-b97c-c1d5483a1dd9	Thyroid	47	1EFC40AF-FEDF-4BC3-BE59-1E31A87BAA15	7ED3E66E-F784-483F-AC37-1300736584A4	TCGA-ET-A2N1-01A-11D-A18F-08	HG19_Broad_variant	TCGA-ET-A2N1	TCGA-THCA	NA	s12625	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A18F-08	FALSE
13722.58cfa82ee4b0c9d6adf6af26	58cfa82ee4b0c9d6adf6af26	G48125.TCGA-24-1562-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-24-1562-01A-01D-A312-08.2	G48125.TCGA-24-1562-01A-01D-A312-08.2.bam	222.67	1.9	0.07	58cfa82ee4b0c9d6adf6af26	G48125.TCGA-24-1562-01A-01D-A312-08.2.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1562-01A	4C18D9CF-4AF4-4A86-8B1C-F78795FBBD7E	Primary Tumor	Illumina HiSeq	b0fd1893-f409-4444-b014-3667fdc22720	Ovary	67	A323F2F5-B250-40A6-A318-084A3933E829	E9D98643-01EE-40C3-A617-E004559625CD	TCGA-24-1562-01A-01D-A312-08	HG19_Broad_variant	TCGA-24-1562	TCGA-OV	1384	s18022	Broad Institute of MIT and Harvard	Washington University	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6af2a	58cfa82ee4b0c9d6adf6af2a	G39020.TCGA-HU-8608-01A-11D-2394-08.2.filtered.	WGS	G39020.TCGA-HU-8608-01A-11D-2394-08.2	G39020.TCGA-HU-8608-01A-11D-2394-08.2.bam	200	NA	0.05	58cfa82ee4b0c9d6adf6af2a	G39020.TCGA-HU-8608-01A-11D-2394-08.2.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-8608-01A	C6316FB5-99A7-4ADF-832F-DCE44DDCD3AA	Primary Tumor	Illumina HiSeq	58876087-e158-4469-af68-c91fe264ca8e	Stomach	70	E70FE3AD-F9FA-4097-B472-86606C241D26	A2EE5DDE-4342-4E78-88C5-3C9A8E10CBF5	TCGA-HU-8608-01A-11D-2394-08	HG19_Broad_variant	TCGA-HU-8608	TCGA-STAD	NA	s15298	Broad Institute of MIT and Harvard	National Cancer Center Korea	Korea South	NO	T4a	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIB	2394-08	TRUE
13722.58cfa82ee4b0c9d6adf6af4a	58cfa82ee4b0c9d6adf6af4a	G47088.TCGA-66-2793-01A-01D-1267-08.1.filtered.	WGS	G47088.TCGA-66-2793-01A-01D-1267-08.1	G47088.TCGA-66-2793-01A-01D-1267-08.1.bam	195.33	1.9	0.16	58cfa82ee4b0c9d6adf6af4a	G47088.TCGA-66-2793-01A-01D-1267-08.1.bam	Dead	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2793-01A	9AF6ED4E-8CDC-4F49-84E9-BA1053B5B3CA	Primary Tumor	Illumina HiSeq	ca861e94-4779-4f5f-b97c-4310ed2d7702	Lung	68	DAA128EB-BF5A-4C2C-A7DC-E6E06B6AEB85	7DC5F8BA-0080-43D3-8426-BD527A970761	TCGA-66-2793-01A-01D-1267-08	HG19_Broad_variant	TCGA-66-2793	TCGA-LUSC	306	s10158	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T4	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIB	1267-08	FALSE
13722.58cfa82ee4b0c9d6adf6af3a	58cfa82ee4b0c9d6adf6af3a	G48125.TCGA-13-0912-01A-01D-A312-08.3.filtered.	WGS	G48125.TCGA-13-0912-01A-01D-A312-08.3	G48125.TCGA-13-0912-01A-01D-A312-08.3.bam	120.67	1.9	0.08	58cfa82ee4b0c9d6adf6af3a	G48125.TCGA-13-0912-01A-01D-A312-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0912-01A	58D34254-4F5B-40A4-9E9F-7160062FB2A4	Primary Tumor	Illumina HiSeq	5e598e0f-da1d-4e41-9a69-4ab15597c460	Ovary	58	BFC06061-2299-4785-9943-67F5EC9EBE3F	95FC38AC-2B36-4C46-ABBF-8D2D52FF9626	TCGA-13-0912-01A-01D-A312-08	HG19_Broad_variant	TCGA-13-0912	TCGA-OV	NA	s17801	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6af1c	58cfa82ee4b0c9d6adf6af1c	G39020.TCGA-FP-7998-01A-11D-2201-08.2.filtered.	WGS	G39020.TCGA-FP-7998-01A-11D-2201-08.2	G39020.TCGA-FP-7998-01A-11D-2201-08.2.bam	278.7	NA	0.05	58cfa82ee4b0c9d6adf6af1c	G39020.TCGA-FP-7998-01A-11D-2201-08.2.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-FP-7998-01A	B2E2D35C-7A79-4165-97A5-82D5C37D94F2	Primary Tumor	Illumina HiSeq	d124dc46-96b0-4101-b8a6-3e4ebf4862c9	Stomach	77	0A95BD32-539E-43F3-9694-A7D033A6FA84	172C9864-C26D-4E9B-947A-E8CE761E996D	TCGA-FP-7998-01A-11D-2201-08	HG19_Broad_variant	TCGA-FP-7998	TCGA-STAD	NA	s15369	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T4a	N3a	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIC	2201-08	FALSE
13722.58cfa82ee4b0c9d6adf6af4c	58cfa82ee4b0c9d6adf6af4c	G47088.TCGA-18-4721-01A-01D-1441-08.2.filtered.	WGS	G47088.TCGA-18-4721-01A-01D-1441-08.2	G47088.TCGA-18-4721-01A-01D-1441-08.2.bam	305.7	1.9	0.05	58cfa82ee4b0c9d6adf6af4c	G47088.TCGA-18-4721-01A-01D-1441-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-18-4721-01A	19F0CB8C-2E57-4310-967F-A9890F1605DB	Primary Tumor	Illumina HiSeq	cc99a2ed-feab-46b5-86eb-27fa81408f7c	Lung	74	1BAC4FF6-E35B-40F6-BBE4-705AB672D102	D2AB2555-7288-47A4-A80C-BF62D65B67B8	TCGA-18-4721-01A-01D-1441-08	HG19_Broad_variant	TCGA-18-4721	TCGA-LUSC	NA	s10078	Broad Institute of MIT and Harvard	Princess Margaret Hospital (Canada)	Canada	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	1441-08	FALSE
13722.58cfa82ee4b0c9d6adf6af7e	58cfa82ee4b0c9d6adf6af7e	G48125.TCGA-25-1632-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-25-1632-01A-01D-A312-08.2	G48125.TCGA-25-1632-01A-01D-A312-08.2.bam	432.97	1.9	0.08	58cfa82ee4b0c9d6adf6af7e	G48125.TCGA-25-1632-01A-01D-A312-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-1632-01A	C435627C-159D-4A6D-A819-30ABAC24BF4D	Primary Tumor	Illumina HiSeq	541a0820-9b52-430b-9fca-5eaaeb06eb4a	Ovary	68	ED9C97D8-4DF2-4ED3-B455-4955D72901A8	FF3FE4A3-7D19-4D4D-81B6-AAA41BA5BF39	TCGA-25-1632-01A-01D-A312-08	HG19_Broad_variant	TCGA-25-1632	TCGA-OV	1799	s17406	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6af78	58cfa82ee4b0c9d6adf6af78	G39020.TCGA-EQ-5647-01A-01D-1600-08.2.filtered.	WGS	G39020.TCGA-EQ-5647-01A-01D-1600-08.2	G39020.TCGA-EQ-5647-01A-01D-1600-08.2.bam	255.7	1.87	0.05	58cfa82ee4b0c9d6adf6af78	G39020.TCGA-EQ-5647-01A-01D-1600-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-EQ-5647-01A	2D291FA3-F0FD-4BC1-91A6-783863714190	Primary Tumor	Illumina HiSeq	c688688d-4440-4ff2-b58b-0b2fcf8591f7	Stomach	86	400FED84-FE61-4F7A-9DCC-6C32131106CD	FECCEE20-A62D-4152-B832-B9FDACA87A61	TCGA-EQ-5647-01A-01D-1600-08	HG19_Broad_variant	TCGA-EQ-5647	TCGA-STAD	19	s15040	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T4	N3	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1600-08	TRUE
13722.58cfa82ee4b0c9d6adf6af6c	58cfa82ee4b0c9d6adf6af6c	G48125.TCGA-13-0906-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-13-0906-01A-01D-A312-08.2	G48125.TCGA-13-0906-01A-01D-A312-08.2.bam	35.67	1.9	0.08	58cfa82ee4b0c9d6adf6af6c	G48125.TCGA-13-0906-01A-01D-A312-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0906-01A	E43D3769-E25F-4FB7-9080-EA26DEFAF094	Primary Tumor	Illumina HiSeq	aee22c2b-6ab3-4982-b343-b10b89c4b98b	Ovary	50	A0C48680-3CAF-49BD-B495-C9FD3A9CBE76	42AF8F74-FD4B-486D-BC11-DB53CC471D62	TCGA-13-0906-01A-01D-A312-08	HG19_Broad_variant	TCGA-13-0906	TCGA-OV	NA	s17760	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6af68	58cfa82ee4b0c9d6adf6af68	G47088.TCGA-22-5492-01A-01D-1632-08.1.filtered.	WGS	G47088.TCGA-22-5492-01A-01D-1632-08.1	G47088.TCGA-22-5492-01A-01D-1632-08.1.bam	871.7	1.9	0.05	58cfa82ee4b0c9d6adf6af68	G47088.TCGA-22-5492-01A-01D-1632-08.1.bam	Dead	FEMALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-22-5492-01A	422A46B2-A67C-4A7E-923F-9B651CED96F8	Primary Tumor	Illumina HiSeq	ee7c69ad-64c9-44bd-8856-35ef192a2b61	Lung	73	8A0B8A54-D4F7-4911-A692-6731D089EBA2	ABC94013-71F5-4AC6-88A4-01B4EF9F9D2F	TCGA-22-5492-01A-01D-1632-08	HG19_Broad_variant	TCGA-22-5492	TCGA-LUSC	506	s10253	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	United States	NO	T2a	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1632-08	FALSE
13722.58cfa82ee4b0c9d6adf6af04	58cfa82ee4b0c9d6adf6af04	G39020.TCGA-HU-8245-01A-11D-2340-08.4.filtered.	WGS	G39020.TCGA-HU-8245-01A-11D-2340-08.4	G39020.TCGA-HU-8245-01A-11D-2340-08.4.bam	209.7	NA	0.05	58cfa82ee4b0c9d6adf6af04	G39020.TCGA-HU-8245-01A-11D-2340-08.4.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-8245-01A	4E9D13DA-438D-4B5E-8E86-67432B5E9471	Primary Tumor	Illumina HiSeq	6acf61a8-ac0b-43fa-8b56-db959ad7b3f5	Stomach	72	5CD8D6FC-F68E-4C14-93B0-BABE544C7A63	61CAD26A-CBC6-4977-83B9-DC61E49F2861	TCGA-HU-8245-01A-11D-2340-08	HG19_Broad_variant	TCGA-HU-8245	TCGA-STAD	NA	s14680	Broad Institute of MIT and Harvard	National Cancer Center Korea	Korea South	NO	T3	N0	Stomach Intestinal Adenocarcinoma Papillary Type	Stage IIA	2340-08	FALSE
13722.58cfa82ee4b0c9d6adf6afb0	58cfa82ee4b0c9d6adf6afb0	G48125.TCGA-24-1544-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-24-1544-01A-01D-A312-08.2	G48125.TCGA-24-1544-01A-01D-A312-08.2.bam	141.97	1.9	0.08	58cfa82ee4b0c9d6adf6afb0	G48125.TCGA-24-1544-01A-01D-A312-08.2.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1544-01A	21F6BF91-DFC6-4A59-8B76-88A0F95C7B47	Primary Tumor	Illumina HiSeq	d293d826-e945-45a9-8e15-cc375fcf4063	Ovary	71	CF7B9151-6479-41AF-986C-D9DB10E33CA6	052665D1-AB75-4F40-BE5A-B88154C8BEED	TCGA-24-1544-01A-01D-A312-08	HG19_Broad_variant	TCGA-24-1544	TCGA-OV	820	s17761	Broad Institute of MIT and Harvard	Washington University	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6affa	58cfa82ee4b0c9d6adf6affa	G48125.TCGA-13-0727-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-13-0727-01A-01D-A312-08.2	G48125.TCGA-13-0727-01A-01D-A312-08.2.bam	36.64	1.9	0.08	58cfa82ee4b0c9d6adf6affa	G48125.TCGA-13-0727-01A-01D-A312-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0727-01A	90F4B65C-CFD4-4066-A5B9-842885C172E2	Primary Tumor	Illumina HiSeq	e58e09a0-fb52-490e-baf9-19502ff4232d	Ovary	71	6FCD7BB8-6CB0-4797-A5B5-D3EC4911A279	16DF7888-2480-4394-8856-D57A6EF371D2	TCGA-13-0727-01A-01D-A312-08	HG19_Broad_variant	TCGA-13-0727	TCGA-OV	462	s17116	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6aeee	58cfa82ee4b0c9d6adf6aeee	G49537.TCGA-FE-A233-01A-11D-A33C-08.1.filtered.	WGS	G49537.TCGA-FE-A233-01A-11D-A33C-08.1	G49537.TCGA-FE-A233-01A-11D-A33C-08.1.bam	92.7	2.05	0.09	58cfa82ee4b0c9d6adf6aeee	G49537.TCGA-FE-A233-01A-11D-A33C-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A233-01A	E70FEAFD-1390-4F4C-A635-DA65C1A7DAEB	Primary Tumor	Illumina HiSeq	d7f3aea8-ea8e-4400-b8b3-cc40582e70cd	Thyroid	18	76A6F76D-F33E-4B4A-B0EE-FB863345F194	473FE833-FCC6-485E-93D2-95E662C3EF53	TCGA-FE-A233-01A-11D-A33C-08	HG19_Broad_variant	TCGA-FE-A233	TCGA-THCA	NA	s12224	Broad Institute of MIT and Harvard	Ohio State University	United States	NO	T2	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A33C-08	FALSE
13722.58cfa82ee4b0c9d6adf6aed4	58cfa82ee4b0c9d6adf6aed4	G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1.filtered.	WGS	G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1	G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1.bam	53.65	NA	0.07	58cfa82ee4b0c9d6adf6aed4	G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A2CP-01A	2F59F12D-CA0C-4AC6-9718-98A6D455AF46	Primary Tumor	Illumina HiSeq	3bca46e2-dbce-4b1c-8aec-37cc8615d471	Thyroid	26	043765F1-FFBD-4AC9-B0AE-733C3643083D	B8CD6882-BE27-4742-BC63-3227D31BF704	TCGA-EM-A2CP-01A-11D-A17V-08	HG19_Broad_variant	TCGA-EM-A2CP	TCGA-THCA	NA	s12095	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A17V-08	TRUE
13722.58cfa82de4b0c9d6adf6a72e	58cfa82de4b0c9d6adf6a72e	G13226.TCGA-21-1078-01A-01D-1521-08.1.filtered.	WGS	G13226.TCGA-21-1078-01A-01D-1521-08.1	G13226.TCGA-21-1078-01A-01D-1521-08.1.bam	586.7	1.8	0.05	58cfa82de4b0c9d6adf6a72e	G13226.TCGA-21-1078-01A-01D-1521-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-21-1078-01A	0AB8D063-62B4-4D47-82AA-E3351A60029D	Primary Tumor	Illumina HiSeq	646caf62-8b1b-43c0-a9c6-471110de099c	Lung	77	EFACAC80-9428-4482-9AEA-6B57FD172D49	8CF9B32D-3D6F-4898-8C7A-89511B754021	TCGA-21-1078-01A-01D-1521-08	HG19_Broad_variant	TCGA-21-1078	TCGA-LUSC	474	s10248	Broad Institute of MIT and Harvard	Fox Chase Cancer Center	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1521-08	TRUE
13722.58cfa82de4b0c9d6adf6a742	58cfa82de4b0c9d6adf6a742	G14580.TCGA-64-1678-01A-01D-1040-01.2.filtered.	WGS	G14580.TCGA-64-1678-01A-01D-1040-01.2	G14580.TCGA-64-1678-01A-01D-1040-01.2.bam	482.23	1.9	0.15	58cfa82de4b0c9d6adf6a742	G14580.TCGA-64-1678-01A-01D-1040-01.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-64-1678-01A	F77CF4D3-9829-4FD3-95A1-B29AED9E94B8	Primary Tumor	Illumina HiSeq	3abe422b-51c0-4fb1-932d-f9e07cdb2150	Lung	70	0A2D9FAD-C5DF-46C1-BF96-529C7C92DFBA	53BB7112-3E38-45FE-A9C4-1B0871BABF4A	TCGA-64-1678-01A-01D-1040-01	HG19_Broad_variant	TCGA-64-1678	TCGA-LUAD	NA	s11207	Broad Institute of MIT and Harvard	Fox Chase	United States	NO	T2b	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIA	1040-01	FALSE
13722.58cfa82de4b0c9d6adf6a74a	58cfa82de4b0c9d6adf6a74a	G13227.TCGA-43-3394-01A-01D-1553-08.1.filtered.	WGS	G13227.TCGA-43-3394-01A-01D-1553-08.1	G13227.TCGA-43-3394-01A-01D-1553-08.1.bam	532.37	1.9	0.05	58cfa82de4b0c9d6adf6a74a	G13227.TCGA-43-3394-01A-01D-1553-08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-43-3394-01A	CE8612AB-3149-4A6A-B424-29C0C21C9B8B	Primary Tumor	Illumina HiSeq	bc49e74a-6128-4677-93fa-776314b3caef	Lung	52	D8F165AF-1DF5-4876-ABF8-7596E52A3BC3	EFE4D5DD-FFFB-41DF-AB86-BE06CC16646F	TCGA-43-3394-01A-01D-1553-08	HG19_Broad_variant	TCGA-43-3394	TCGA-LUSC	NA	s10073	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T2a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1553-08	FALSE
13722.58cfa82de4b0c9d6adf6a759	58cfa82de4b0c9d6adf6a759	G13230.TCGA-60-2713-01A-01D-1522-08.3.filtered.	WGS	G13230.TCGA-60-2713-01A-01D-1522-08.3	G13230.TCGA-60-2713-01A-01D-1522-08.3.bam	661.3	1.9	0.05	58cfa82de4b0c9d6adf6a759	G13230.TCGA-60-2713-01A-01D-1522-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2713-01A	E58E8850-154F-4695-BEE0-005C76410327	Primary Tumor	Illumina HiSeq	34149172-2cd5-402b-a1c6-c4fd3919f717	Lung	64	88A9B60F-89DD-4C2B-B13B-5EF5E10B94AB	79EB7BBA-F0D8-462C-ADD7-20A2FB7843E1	TCGA-60-2713-01A-01D-1522-08	HG19_Broad_variant	TCGA-60-2713	TCGA-LUSC	NA	s10074	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1522-08	TRUE
13722.58cfa82de4b0c9d6adf6a74e	58cfa82de4b0c9d6adf6a74e	G13229.TCGA-56-1622-01A-01D-1521-08.1.filtered.	WGS	G13229.TCGA-56-1622-01A-01D-1521-08.1	G13229.TCGA-56-1622-01A-01D-1521-08.1.bam	338.7	1.9	0.05	58cfa82de4b0c9d6adf6a74e	G13229.TCGA-56-1622-01A-01D-1521-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-56-1622-01A	3EDF933A-BE1A-46E8-BFB0-ACDFF30E64A0	Primary Tumor	Illumina HiSeq	7fdda717-3cf6-4e4d-a2c7-8b7691ce09b2	Lung	58	4083DE2F-3FF5-487B-A27B-783D51C4F853	0BBC7EDE-5022-4084-925C-D65BAAF7ABC2	TCGA-56-1622-01A-01D-1521-08	HG19_Broad_variant	TCGA-56-1622	TCGA-LUSC	881	s10071	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1521-08	TRUE
13722.58cfa82de4b0c9d6adf6a778	58cfa82de4b0c9d6adf6a778	G14849.TCGA-44-2659-01A-01D-1931-08.5.filtered.	WGS	G14849.TCGA-44-2659-01A-01D-1931-08.5	G14849.TCGA-44-2659-01A-01D-1931-08.5.bam	82.96	1.9	0.15	58cfa82de4b0c9d6adf6a778	G14849.TCGA-44-2659-01A-01D-1931-08.5.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-2659-01A	BF15F7AD-9D92-473B-91D1-F24AA373AB97	Primary Tumor	Illumina HiSeq	bcdd7201-d7f2-45f5-bbaf-e0ca63b987c4	Lung	65	42208BA8-F465-4D62-9ED9-5DBFAA525913	2BDE43E2-FD4E-413E-ADC7-C50BCA75D358	TCGA-44-2659-01A-01D-1931-08	HG19_Broad_variant	TCGA-44-2659	TCGA-LUAD	NA	s10626	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T1	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a776	58cfa82de4b0c9d6adf6a776	G14853.TCGA-05-4420-01A-01D-1931-08.1.filtered.	WGS	G14853.TCGA-05-4420-01A-01D-1931-08.1	G14853.TCGA-05-4420-01A-01D-1931-08.1.bam	651.3	1.9	0.16	58cfa82de4b0c9d6adf6a776	G14853.TCGA-05-4420-01A-01D-1931-08.1.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4420-01A	3D2AA654-1B5F-4EB4-A1C2-AF31F5760069	Primary Tumor	Illumina HiSeq	aa05f7cb-814c-4ddf-a639-50291fa19a95	Lung	41	4B202550-9744-4C6C-AD17-97F764EA3F18	DE614A3E-1C0D-49C7-A2F1-28BC58E6E5C7	TCGA-05-4420-01A-01D-1931-08	HG19_Broad_variant	TCGA-05-4420	TCGA-LUAD	NA	s11315	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a77c	58cfa82de4b0c9d6adf6a77c	G14852.TCGA-49-4510-01A-01D-1931-08.3.filtered.	WGS	G14852.TCGA-49-4510-01A-01D-1931-08.3	G14852.TCGA-49-4510-01A-01D-1931-08.3.bam	177.53	1.9	0.14	58cfa82de4b0c9d6adf6a77c	G14852.TCGA-49-4510-01A-01D-1931-08.3.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4510-01A	F77B6930-A1CE-446E-A15D-C018CBBECFEE	Primary Tumor	Illumina HiSeq	25c363b3-3a56-4365-8fec-10ccb8618909	Lung	51	9A479D32-13A4-46C2-B26D-34CB6051A891	3E680217-92C1-4C6F-BF67-CA64E469B4A4	TCGA-49-4510-01A-01D-1931-08	HG19_Broad_variant	TCGA-49-4510	TCGA-LUAD	896	s11212	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a77a	58cfa82de4b0c9d6adf6a77a	G12520.TCGA-60-2711-01A-01D-0963-08.1.filtered.	WGS	G12520.TCGA-60-2711-01A-01D-0963-08.1	G12520.TCGA-60-2711-01A-01D-0963-08.1.bam	620.3	1.9	0.15	58cfa82de4b0c9d6adf6a77a	G12520.TCGA-60-2711-01A-01D-0963-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2711-01A	1F11DE87-A5FE-49FD-80C1-E279B2BC69DE	Primary Tumor	Illumina HiSeq	53773d17-2e17-4544-845d-b784120af48d	Lung	64	8A3A376A-A4DB-4D4F-85CE-A894A2AA60BB	D54CA81C-1BCC-41EA-B17A-9F7249EBE9C1	TCGA-60-2711-01A-01D-0963-08	HG19_Broad_variant	TCGA-60-2711	TCGA-LUSC	NA	s10496	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	0963-08	FALSE
13722.58cfa82ee4b0c9d6adf6a7cf	58cfa82ee4b0c9d6adf6a7cf	G25249.TCGA-CR-7391-01A-11D-2334-08.1.filtered.	WGS	G25249.TCGA-CR-7391-01A-11D-2334-08.1	G25249.TCGA-CR-7391-01A-11D-2334-08.1.bam	85.7	NA	0.05	58cfa82ee4b0c9d6adf6a7cf	G25249.TCGA-CR-7391-01A-11D-2334-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7391-01A	832316EE-08AB-412B-9E4D-8A57FF84BC11	Primary Tumor	Illumina HiSeq	ef4db578-e4b8-4047-b761-df26ecf7a41e	Head and Neck	36	54B7DB2E-F0DD-469D-81BB-4E2A86EBEA9D	C121DE15-78F7-4698-91BF-FD0485C466C2	TCGA-CR-7391-01A-11D-2334-08	HG19_Broad_variant	TCGA-CR-7391	TCGA-HNSC	NA	s15862	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	2334-08	FALSE
13722.58cfa82ee4b0c9d6adf6a7d6	58cfa82ee4b0c9d6adf6a7d6	G23064.TCGA_CR_6472_01A_11D_2268_08.1.filtered.	WGS	G23064.TCGA_CR_6472_01A_11D_2268_08.1	G23064.TCGA_CR_6472_01A_11D_2268_08.1.bam	118	1.9	0.15	58cfa82ee4b0c9d6adf6a7d6	G23064.TCGA_CR_6472_01A_11D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6472-01A	0956BC67-DD55-4C54-A56A-F22F2856662A	Primary Tumor	Illumina HiSeq	8bf4b442-c0d0-4794-b87d-990df38dfce7	Head and Neck	59	76095F05-CD2B-4973-800A-10FE58EE1609	5193A482-6ED9-4504-BD7C-C8B9E4103577	TCGA-CR-6472-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-6472	TCGA-HNSC	NA	s15603	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6a876	58cfa82ee4b0c9d6adf6a876	G26391.TCGA-26-5135-01A-01D-1486-08.1.filtered.	WGS	G26391.TCGA-26-5135-01A-01D-1486-08.1	G26391.TCGA-26-5135-01A-01D-1486-08.1.bam	443.73	1.9	0.05	58cfa82ee4b0c9d6adf6a876	G26391.TCGA-26-5135-01A-01D-1486-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-26-5135-01A	69D56F2D-6924-409B-9D1E-C8D69B400270	Primary Tumor	Illumina HiSeq	1fec68bf-4fbd-4cbf-bf2e-e540dd2bc143	Brain	72	8CFB4C3F-B25F-412C-91C7-997C64EA2D75	2CE48F01-2F61-49D9-A56A-7438BF4A37D7	TCGA-26-5135-01A-01D-1486-08	HG19_Broad_variant	TCGA-26-5135	TCGA-GBM	270	s14173	Broad Institute of MIT and Harvard	University of Florida	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1486-08	FALSE
13722.58cfa82ee4b0c9d6adf6a89a	58cfa82ee4b0c9d6adf6a89a	G35154.TCGA-HT-8104-01A-11D-A461-08.2.filtered.	WGS	G35154.TCGA-HT-8104-01A-11D-A461-08.2	G35154.TCGA-HT-8104-01A-11D-A461-08.2.bam	129.6	NA	0.08	58cfa82ee4b0c9d6adf6a89a	G35154.TCGA-HT-8104-01A-11D-A461-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-8104-01A	5DE6FD84-ED02-4C27-9947-DB57F05FAF6D	Primary Tumor	Illumina HiSeq	85f4a2b5-246f-41da-9777-57d2ceaf1b70	Brain	51	13845BA9-5FC0-408A-8CA9-AC32511765B7	3139DEFD-0311-4F2A-9AD4-A9903F481832	TCGA-HT-8104-01A-11D-A461-08	HG19_Broad_variant	TCGA-HT-8104	TCGA-LGG	NA	s8334	Broad Institute of MIT and Harvard	Case Western - St Joes	United States	NO	Not available	Not available	Astrocytoma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a81a	58cfa82ee4b0c9d6adf6a81a	G23062.TCGA_BA_4077_01B_01D_2268_08.2.filtered.	WGS	G23062.TCGA_BA_4077_01B_01D_2268_08.2	G23062.TCGA_BA_4077_01B_01D_2268_08.2.bam	246.33	1.9	0.15	58cfa82ee4b0c9d6adf6a81a	G23062.TCGA_BA_4077_01B_01D_2268_08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4077-01B	4BFBCE2B-9D0B-4E8A-950F-FD8E0BA3E05A	Primary Tumor	Illumina HiSeq	6533e56c-b5b8-4c85-862b-a5526c5c2e0a	Head and Neck	45	327BBCA7-FA25-4A92-BE27-21A4C184C760	268D9CDB-CCCF-491A-A9BB-2E3D6B85951F	TCGA-BA-4077-01B-01D-2268-08	HG19_Broad_variant	TCGA-BA-4077	TCGA-HNSC	1134	s16017	Broad Institute of MIT and Harvard	UNC	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8da	58cfa82ee4b0c9d6adf6a8da	G25786.TCGA-78-7146-01A-11D-2036-08.2.filtered.	WGS	G25786.TCGA-78-7146-01A-11D-2036-08.2	G25786.TCGA-78-7146-01A-11D-2036-08.2.bam	113.7	NA	0.05	58cfa82ee4b0c9d6adf6a8da	G25786.TCGA-78-7146-01A-11D-2036-08.2.bam	Dead	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-78-7146-01A	FF9DEF3D-17E5-4EF6-B74E-933F11ED6F00	Primary Tumor	Illumina HiSeq	17e2078c-ad94-4ecc-ba36-9a8e9e4e237e	Lung	71	98A8D751-4EFD-442E-A242-0FE399C2586F	7692E684-4AF2-4892-80AD-1F417B6B38FA	TCGA-78-7146-01A-11D-2036-08	HG19_Broad_variant	TCGA-78-7146	TCGA-LUAD	173	s11108	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T2	N2	Lung Adenocarcinoma Mixed Subtype	Stage IIIA	2036-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8b8	58cfa82ee4b0c9d6adf6a8b8	G35154.TCGA-DU-7304-01A-12D-A461-08.4.filtered.	WGS	G35154.TCGA-DU-7304-01A-12D-A461-08.4	G35154.TCGA-DU-7304-01A-12D-A461-08.4.bam	97.7	NA	0.08	58cfa82ee4b0c9d6adf6a8b8	G35154.TCGA-DU-7304-01A-12D-A461-08.4.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7304-01A	D61710C1-8AC3-44E3-B567-66288A6AB731	Primary Tumor	Illumina HiSeq	7b4cd316-b4cc-4a73-a4ad-767a6c64ac4d	Brain	43	12B638EF-AEB6-43C4-B9B8-C8A6F077D579	8340C88F-B6DB-4CB7-8E44-A9CDF5E167EE	TCGA-DU-7304-01A-12D-A461-08	HG19_Broad_variant	TCGA-DU-7304	TCGA-LGG	709	s8534	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a89c	58cfa82ee4b0c9d6adf6a89c	G25775.TCGA-44-6148-01A-11D-1753-08.1.filtered.	WGS	G25775.TCGA-44-6148-01A-11D-1753-08.1	G25775.TCGA-44-6148-01A-11D-1753-08.1.bam	164.4	1.9	0.05	58cfa82ee4b0c9d6adf6a89c	G25775.TCGA-44-6148-01A-11D-1753-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-6148-01A	8994C8C4-9EA0-46CB-B4A5-0055D7DA5BFA	Primary Tumor	Illumina HiSeq	85617ab0-26a0-468d-b153-3e62d6b86c64	Lung	60	C0FE5FFE-C0A3-4E62-AA55-2BC18788E505	9C7B3AC8-1352-49CD-8A8C-DF6B19F6FD64	TCGA-44-6148-01A-11D-1753-08	HG19_Broad_variant	TCGA-44-6148	TCGA-LUAD	NA	s11320	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T1b	N0	Lung Mucinous Adenocarcinoma	Stage IA	1753-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8e2	58cfa82ee4b0c9d6adf6a8e2	G35154.TCGA-DU-5870-01A-11D-A461-08.3.filtered.	WGS	G35154.TCGA-DU-5870-01A-11D-A461-08.3	G35154.TCGA-DU-5870-01A-11D-A461-08.3.bam	55.6	1.9	0.08	58cfa82ee4b0c9d6adf6a8e2	G35154.TCGA-DU-5870-01A-11D-A461-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-5870-01A	EB42625E-FBBB-4BEE-BBE9-315B3CA2138A	Primary Tumor	Illumina HiSeq	781639a0-ea42-4e90-8e48-2dd0de69143f	Brain	34	25E75875-4A84-4C29-9030-0E0922BD6567	8EFA4E9E-F222-4CCB-BF34-32443183BD7F	TCGA-DU-5870-01A-11D-A461-08	HG19_Broad_variant	TCGA-DU-5870	TCGA-LGG	NA	s8318	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a90a	58cfa82ee4b0c9d6adf6a90a	G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1.filtered.	WGS	G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1	G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1.bam	47.84	NA	0.08	58cfa82ee4b0c9d6adf6a90a	G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3N6-01A	8C1DD7F7-B74A-4FA2-B6A7-86F0348D2567	Primary Tumor	Illumina HiSeq	d881868c-a616-4a4c-bbb7-4fbda95e1323	Bladder	43	6CD6D1F4-D8E4-47F9-812F-EB7FEC925F8D	D4615CA0-B5C7-4A5C-8593-BD50034A78AE	TCGA-FD-A3N6-01A-11D-A21A-08	HG19_Broad_variant	TCGA-FD-A3N6	TCGA-BLCA	NA	s2849	Broad Institute of MIT and Harvard	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6a910	58cfa82ee4b0c9d6adf6a910	G35154.TCGA-CS-6186-01A-12D-A461-08.2.filtered.	WGS	G35154.TCGA-CS-6186-01A-12D-A461-08.2	G35154.TCGA-CS-6186-01A-12D-A461-08.2.bam	324.7	NA	0.08	58cfa82ee4b0c9d6adf6a910	G35154.TCGA-CS-6186-01A-12D-A461-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-6186-01A	9EE6E821-3AF2-42D7-9D14-F0CA455F338C	Primary Tumor	Illumina HiSeq	946c11c5-c3b6-4bd4-a20f-dbf1f726c1fa	Brain	58	5F73FA4E-FC7D-4FC0-8436-2241E57B9B69	A3CA8731-C86A-498D-B3FB-3923AD286BA3	TCGA-CS-6186-01A-12D-A461-08	HG19_Broad_variant	TCGA-CS-6186	TCGA-LGG	538	s8098	Broad Institute of MIT and Harvard	Thomas Jefferson University	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8fd	58cfa82ee4b0c9d6adf6a8fd	G26370.TCGA-27-1831-01A-01D-1494-08.1.filtered.	WGS	G26370.TCGA-27-1831-01A-01D-1494-08.1	G26370.TCGA-27-1831-01A-01D-1494-08.1.bam	564.7	1.93	0.05	58cfa82ee4b0c9d6adf6a8fd	G26370.TCGA-27-1831-01A-01D-1494-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-27-1831-01A	F45F4A30-6B4C-4F15-9140-959D6A25A45F	Primary Tumor	Illumina HiSeq	c2dc8176-a9d4-4f93-877b-c6d55f074569	Brain	66	9BB49615-6F5E-471C-B68B-866E6199CEB7	9880C3C9-5685-42A7-8FE9-7585EA1A1D37	TCGA-27-1831-01A-01D-1494-08	HG19_Broad_variant	TCGA-27-1831	TCGA-GBM	505	s14091	Broad Institute of MIT and Harvard	Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6a960	58cfa82ee4b0c9d6adf6a960	G35154.TCGA-DU-6404-01A-11D-A461-08.3.filtered.	WGS	G35154.TCGA-DU-6404-01A-11D-A461-08.3	G35154.TCGA-DU-6404-01A-11D-A461-08.3.bam	202.6	1.9	0.07	58cfa82ee4b0c9d6adf6a960	G35154.TCGA-DU-6404-01A-11D-A461-08.3.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6404-01A	C0D47E0F-4918-4E06-9DB6-201671B1259C	Primary Tumor	Illumina HiSeq	e8c73506-ba8e-44dc-87cd-4305bdb6b7f9	Brain	24	1F5A0C14-D1C1-4E88-BC19-ABFAFFF97445	E24BC524-4F82-4FC8-AA20-0B64C9B74762	TCGA-DU-6404-01A-11D-A461-08	HG19_Broad_variant	TCGA-DU-6404	TCGA-LGG	4068	s8104	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a95e	58cfa82ee4b0c9d6adf6a95e	G35154.TCGA-DU-6397-01A-11D-A461-08.3.filtered.	WGS	G35154.TCGA-DU-6397-01A-11D-A461-08.3	G35154.TCGA-DU-6397-01A-11D-A461-08.3.bam	140.6	1.9	0.07	58cfa82ee4b0c9d6adf6a95e	G35154.TCGA-DU-6397-01A-11D-A461-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6397-01A	E695B780-17F4-4E71-9120-7C6BCAFAA3A7	Primary Tumor	Illumina HiSeq	24c6f54a-e7a2-4148-8335-045e3c74096e	Brain	45	AEB67AEA-F2AA-4181-8E25-7653341A0B61	77909413-9323-4916-BB9F-A8E578342333	TCGA-DU-6397-01A-11D-A461-08	HG19_Broad_variant	TCGA-DU-6397	TCGA-LGG	1401	s8113	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a911	58cfa82ee4b0c9d6adf6a911	G16921.TCGA-BP-4977-01A-01D-2048-08.1.filtered.	WGS	G16921.TCGA-BP-4977-01A-01D-2048-08.1	G16921.TCGA-BP-4977-01A-01D-2048-08.1.bam	26.1	1.9	0.16	58cfa82ee4b0c9d6adf6a911	G16921.TCGA-BP-4977-01A-01D-2048-08.1.bam	Alive	MALE	WHITE	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4977-01A	CC353686-E2B6-46A1-8095-48E2BC44B11F	Primary Tumor	Illumina HiSeq	eb47b3fe-95b7-490e-99d4-9e326b44d448	Kidney	57	35C747C0-38BB-4D2E-A428-8E24106ADFAB	1E046AB9-FA4C-4C15-8D78-ED0048C80EBF	TCGA-BP-4977-01A-01D-2048-08	HG19_Broad_variant	TCGA-BP-4977	TCGA-KIRC	NA	s8831	Broad Institute of MIT and Harvard	MSKCC	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2048-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9ae	58cfa82ee4b0c9d6adf6a9ae	G16919.TCGA-A3-3308-01A-01D-2048-08.1.filtered.	WGS	G16919.TCGA-A3-3308-01A-01D-2048-08.1	G16919.TCGA-A3-3308-01A-01D-2048-08.1.bam	591.9	1.9	0.17	58cfa82ee4b0c9d6adf6a9ae	G16919.TCGA-A3-3308-01A-01D-2048-08.1.bam	Alive	FEMALE	WHITE	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3308-01A	3CBCA837-F5A7-4A87-8F02-C59EAC232D5A	Primary Tumor	Illumina HiSeq	6208ef74-033a-4d92-ad2e-96de84ea4784	Kidney	77	0B935ADB-0E19-4FCC-9BB0-B9D95872BCEF	EFD9E8D3-7803-4996-85D3-8A9449B3C1AC	TCGA-A3-3308-01A-01D-2048-08	HG19_Broad_variant	TCGA-A3-3308	TCGA-KIRC	NA	s9441	Broad Institute of MIT and Harvard	International Genomics Consortium	None	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage III	2048-08	FALSE
13722.58cfa82ee4b0c9d6adf6a922	58cfa82ee4b0c9d6adf6a922	G26380.TCGA-06-0744-01A-01D-1492-08.1.filtered.	WGS	G26380.TCGA-06-0744-01A-01D-1492-08.1	G26380.TCGA-06-0744-01A-01D-1492-08.1.bam	108.57	1.91	0.05	58cfa82ee4b0c9d6adf6a922	G26380.TCGA-06-0744-01A-01D-1492-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0744-01A	5613F5F6-086D-470B-8F77-6DCB7F8625B7	Primary Tumor	Illumina HiSeq	fec78208-6a76-43eb-9c8c-a3d7c5d55fed	Brain	66	C01952D4-AE81-48E2-8818-0E438E66B516	914421D2-898E-433E-BB66-B1710EAAE2C7	TCGA-06-0744-01A-01D-1492-08	HG19_Broad_variant	TCGA-06-0744	TCGA-GBM	NA	s14138	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1492-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9a6	58cfa82ee4b0c9d6adf6a9a6	G25789.TCGA-78-7535-01A-11D-2063-08.1.filtered.	WGS	G25789.TCGA-78-7535-01A-11D-2063-08.1	G25789.TCGA-78-7535-01A-11D-2063-08.1.bam	314.3	NA	0.05	58cfa82ee4b0c9d6adf6a9a6	G25789.TCGA-78-7535-01A-11D-2063-08.1.bam	Dead	MALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-78-7535-01A	46592B7B-6968-42A6-83AF-0917C9F4A9A5	Primary Tumor	Illumina HiSeq	c7601721-da6e-403a-9b43-7971f6513153	Lung	45	C0A8C73C-35BA-4724-B13A-9A9986AF36C0	FA8844F8-C4B6-487A-8187-E30C12A7A453	TCGA-78-7535-01A-11D-2063-08	HG19_Broad_variant	TCGA-78-7535	TCGA-LUAD	949	s10759	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	2063-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9c4	58cfa82ee4b0c9d6adf6a9c4	G23076.TCGA_CV_5443_01A_01D_2268_08.1.filtered.	WGS	G23076.TCGA_CV_5443_01A_01D_2268_08.1	G23076.TCGA_CV_5443_01A_01D_2268_08.1.bam	385	1.9	0.15	58cfa82ee4b0c9d6adf6a9c4	G23076.TCGA_CV_5443_01A_01D_2268_08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5443-01A	180036A2-3B56-405E-A1FE-D5932517B6C7	Primary Tumor	Illumina HiSeq	9e76f187-2863-42f5-9540-da82b815d6c0	Head and Neck	63	746322C7-FE75-4B9F-9309-93E9CFA4CB5A	D4B80307-ABBD-48BB-B52C-6DCD409699A2	TCGA-CV-5443-01A-01D-2268-08	HG19_Broad_variant	TCGA-CV-5443	TCGA-HNSC	NA	s15742	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	None	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6a9d5	58cfa82ee4b0c9d6adf6a9d5	G25788.TCGA-55-7281-01A-11D-2036-08.1.filtered.	WGS	G25788.TCGA-55-7281-01A-11D-2036-08.1	G25788.TCGA-55-7281-01A-11D-2036-08.1.bam	196.7	NA	0.05	58cfa82ee4b0c9d6adf6a9d5	G25788.TCGA-55-7281-01A-11D-2036-08.1.bam	Alive	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-55-7281-01A	659668E8-F0D9-4FF2-BBC8-9246F2EF49AB	Primary Tumor	Illumina HiSeq	19c6ac35-62fd-4db0-8641-22abc19d0b52	Lung	70	AFEC3B25-C3F7-4E48-8FB0-6FB4DD581081	D5443922-FEA5-4FF0-BD6E-8CE04E1951D8	TCGA-55-7281-01A-11D-2036-08	HG19_Broad_variant	TCGA-55-7281	TCGA-LUAD	NA	s11213	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T1b	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	2036-08	TRUE
13722.58cfa82ee4b0c9d6adf6a9e7	58cfa82ee4b0c9d6adf6a9e7	G25771.TCGA-05-4395-01A-01D-2364-08.1.filtered.	WGS	G25771.TCGA-05-4395-01A-01D-2364-08.1	G25771.TCGA-05-4395-01A-01D-2364-08.1.bam	385.2	1.9	0.05	58cfa82ee4b0c9d6adf6a9e7	G25771.TCGA-05-4395-01A-01D-2364-08.1.bam	Dead	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4395-01A	762DEA8A-5B41-4058-979A-B7876ED13D7E	Primary Tumor	Illumina HiSeq	e32c5a48-a697-44eb-8628-35528945fdf2	Lung	76	9DED6605-39A3-4C0F-AD2E-7F6863960DBE	BCE88385-4A1B-4A8C-920C-060F6A2675D4	TCGA-05-4395-01A-01D-2364-08	HG19_Broad_variant	TCGA-05-4395	TCGA-LUAD	0	s11216	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T4	N2	Lung Adenocarcinoma Mixed Subtype	Stage IIIB	2364-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa04	58cfa82ee4b0c9d6adf6aa04	G25250.TCGA-CR-6470-01A-11D-2334-08.1.filtered.	WGS	G25250.TCGA-CR-6470-01A-11D-2334-08.1	G25250.TCGA-CR-6470-01A-11D-2334-08.1.bam	137.7	1.9	0.05	58cfa82ee4b0c9d6adf6aa04	G25250.TCGA-CR-6470-01A-11D-2334-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6470-01A	CD032DDB-55F2-4C77-8DCF-E4E630F7DE6F	Primary Tumor	Illumina HiSeq	1a71c849-3daa-48f9-b309-4c340a01def2	Head and Neck	38	AFB7EA63-2959-4E53-95EA-7A032DCB5A8B	02C6A893-49C5-49D1-8EB1-195021E70D52	TCGA-CR-6470-01A-11D-2334-08	HG19_Broad_variant	TCGA-CR-6470	TCGA-HNSC	NA	s16019	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2334-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa06	58cfa82ee4b0c9d6adf6aa06	G23074.TCGA_CN_4741_01A_01D_2268_08.1.filtered.	WGS	G23074.TCGA_CN_4741_01A_01D_2268_08.1	G23074.TCGA_CN_4741_01A_01D_2268_08.1.bam	215.7	1.9	0.14	58cfa82ee4b0c9d6adf6aa06	G23074.TCGA_CN_4741_01A_01D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4741-01A	277B02E9-DED5-4980-845D-AF53690000AC	Primary Tumor	Illumina HiSeq	b508fa53-d86f-4e56-9703-6cdb7095ed0b	Head and Neck	75	03C9108A-5139-4BAC-9641-C7DBBEDEF420	F652367A-D6C9-4A0A-AADE-1AB988BE3BE6	TCGA-CN-4741-01A-01D-2268-08	HG19_Broad_variant	TCGA-CN-4741	TCGA-HNSC	NA	s15745	Broad Institute of MIT and Harvard	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa44	58cfa82ee4b0c9d6adf6aa44	G25251.TCGA-CR-7404-01A-11D-2334-08.1.filtered.	WGS	G25251.TCGA-CR-7404-01A-11D-2334-08.1	G25251.TCGA-CR-7404-01A-11D-2334-08.1.bam	181.7	NA	0.05	58cfa82ee4b0c9d6adf6aa44	G25251.TCGA-CR-7404-01A-11D-2334-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7404-01A	D189A6C6-210F-4957-B500-457D5CE3F867	Primary Tumor	Illumina HiSeq	f8742c2f-2e32-467e-9347-f0dd0959da6b	Head and Neck	53	A39131B9-E7C7-4385-A1B9-D8A0A0950337	83ECA7B5-45BB-44C0-8AFE-36F8988D0078	TCGA-CR-7404-01A-11D-2334-08	HG19_Broad_variant	TCGA-CR-7404	TCGA-HNSC	NA	s15602	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	2334-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa4a	58cfa82ee4b0c9d6adf6aa4a	G35154.TCGA-HT-A61B-01A-11D-A461-08.2.filtered.	WGS	G35154.TCGA-HT-A61B-01A-11D-A461-08.2	G35154.TCGA-HT-A61B-01A-11D-A461-08.2.bam	20.91	NA	0.08	58cfa82ee4b0c9d6adf6aa4a	G35154.TCGA-HT-A61B-01A-11D-A461-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-A61B-01A	CF2A1B98-5693-4C04-9167-F85E69A88A4A	Primary Tumor	Illumina HiSeq	95493209-d334-4fbe-aeef-683bf27cdf09	Brain	22	32C901F6-B277-4870-B3F4-7A7CE53F124E	46C0DD13-2F72-4396-9F7A-07ACB44D1D57	TCGA-HT-A61B-01A-11D-A461-08	HG19_Broad_variant	TCGA-HT-A61B	TCGA-LGG	NA	s8747	Broad Institute of MIT and Harvard	Case Western - St Joes	United States	NO	Not available	Not available	Astrocytoma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa3c	58cfa82ee4b0c9d6adf6aa3c	G23081.TCGA_CV_6961_01A_21D_2268_08.2.filtered.	WGS	G23081.TCGA_CV_6961_01A_21D_2268_08.2	G23081.TCGA_CV_6961_01A_21D_2268_08.2.bam	52.7	1.9	0.14	58cfa82ee4b0c9d6adf6aa3c	G23081.TCGA_CV_6961_01A_21D_2268_08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6961-01A	4075717B-2240-4842-A00A-0C4DBCB910C4	Primary Tumor	Illumina HiSeq	4b9344a0-a7c6-453a-b184-87e94c97920a	Head and Neck	61	BE0A6A2B-A306-4AC6-8BF8-EA6AF16EAA5A	DFA20D2D-1BA3-476A-B4B9-21D21470BEE2	TCGA-CV-6961-01A-21D-2268-08	HG19_Broad_variant	TCGA-CV-6961	TCGA-HNSC	76	s15744	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa4c	58cfa82ee4b0c9d6adf6aa4c	G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2.filtered.	WGS	G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2	G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2.bam	12.75	NA	0.07	58cfa82ee4b0c9d6adf6aa4c	G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2.bam	Dead	FEMALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-TQ-A8XE-01A	135A149A-D153-465E-AA58-06D47BB18E00	Primary Tumor	Illumina HiSeq	3bc46ccf-d9f8-41bd-a003-42e547c7d758	Brain	42	7C60D0DE-B913-4454-BF9F-C554810911B5	4AAEBADF-13D2-4865-8AB5-CC989D80A261	TCGA-TQ-A8XE-01A-11D-A36O-08	HG19_Broad_variant	TCGA-TQ-A8XE	TCGA-LGG	954	s8339	Broad Institute of MIT and Harvard	University of Sao Paulo	Brazil	NO	Not available	Not available	Oligodendroglioma	Not available	A36O-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa72	58cfa82ee4b0c9d6adf6aa72	G26387.TCGA-19-2620-01A-01D-1495-08.2.filtered.	WGS	G26387.TCGA-19-2620-01A-01D-1495-08.2	G26387.TCGA-19-2620-01A-01D-1495-08.2.bam	648.1	1.9	0.05	58cfa82ee4b0c9d6adf6aa72	G26387.TCGA-19-2620-01A-01D-1495-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-19-2620-01A	352768F9-3CE1-419C-BEEF-6515C78F5D7A	Primary Tumor	Illumina HiSeq	57c2175a-25d3-4859-9eab-ecf3563510e9	Brain	70	2ED6BBB4-C2FB-42BF-A0B6-8687A73B3B7B	6DE41AC1-229B-40B9-A494-5588C284351D	TCGA-19-2620-01A-01D-1495-08	HG19_Broad_variant	TCGA-19-2620	TCGA-GBM	148	s14368	Broad Institute of MIT and Harvard	Case Western	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1495-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa50	58cfa82ee4b0c9d6adf6aa50	G23069.TCGA_CR_6480_01A_11D_2268_08.2.filtered.	WGS	G23069.TCGA_CR_6480_01A_11D_2268_08.2	G23069.TCGA_CR_6480_01A_11D_2268_08.2.bam	158.7	1.9	0.15	58cfa82ee4b0c9d6adf6aa50	G23069.TCGA_CR_6480_01A_11D_2268_08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6480-01A	BA9D4568-71A8-41FC-A2BE-0BF784E36D6A	Primary Tumor	Illumina HiSeq	cf0a07e0-8d0a-4c16-8d48-7efb9bf38f8a	Head and Neck	53	0C6B4631-381E-4B73-AC9E-62BBC1849FF4	EF673D3D-2031-4036-BA25-4BC7EF04075B	TCGA-CR-6480-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-6480	TCGA-HNSC	NA	s16166	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa78	58cfa82ee4b0c9d6adf6aa78	G32451.TCGA-BT-A20T-01A-11D-A14W-08.1.filtered.	WGS	G32451.TCGA-BT-A20T-01A-11D-A14W-08.1	G32451.TCGA-BT-A20T-01A-11D-A14W-08.1.bam	59.68	2.07	0.09	58cfa82ee4b0c9d6adf6aa78	G32451.TCGA-BT-A20T-01A-11D-A14W-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20T-01A	096B4F32-10C1-4737-A0DD-CAE04C54EE33	Primary Tumor	Illumina HiSeq	7d40d139-a746-424d-9f90-d5d3da5e98cb	Bladder	63	52F538EF-B05D-4C76-9976-CE6D49158016	301D6CE3-4099-4C1D-8E50-C04B7CE91450	TCGA-BT-A20T-01A-11D-A14W-08	HG19_Broad_variant	TCGA-BT-A20T	TCGA-BLCA	453	s2674	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A14W-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa7a	58cfa82ee4b0c9d6adf6aa7a	G26390.TCGA-06-0214-01A-02D-1491-08.1.filtered.	WGS	G26390.TCGA-06-0214-01A-02D-1491-08.1	G26390.TCGA-06-0214-01A-02D-1491-08.1.bam	20	1.89	0.05	58cfa82ee4b0c9d6adf6aa7a	G26390.TCGA-06-0214-01A-02D-1491-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0214-01A	9853C6BB-A42C-4698-ABE5-F3C897EBC8F6	Primary Tumor	Illumina HiSeq	b4e7ab91-7a2f-4f62-baa3-1ade0467836e	Brain	66	A86189C2-BFF1-4DBE-B4AC-C886478E6FFC	08AC57EC-0036-4134-A9BB-F22EAA27AB0D	TCGA-06-0214-01A-02D-1491-08	HG19_Broad_variant	TCGA-06-0214	TCGA-GBM	457	s13926	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1491-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa4d	58cfa82ee4b0c9d6adf6aa4d	G26368.TCGA-19-2629-01A-01D-1495-08.1.filtered.	WGS	G26368.TCGA-19-2629-01A-01D-1495-08.1	G26368.TCGA-19-2629-01A-01D-1495-08.1.bam	169.1	1.9	0.05	58cfa82ee4b0c9d6adf6aa4d	G26368.TCGA-19-2629-01A-01D-1495-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-19-2629-01A	E17A6048-7A72-42C0-AD3F-97CBFF02BC9F	Primary Tumor	Illumina HiSeq	f54e5ef9-adae-4612-98af-8247a3499567	Brain	60	B89A4D5D-EE24-4052-B454-B67169328737	56FFAA35-814C-4C0B-B3C6-D4514D34FEC2	TCGA-19-2629-01A-01D-1495-08	HG19_Broad_variant	TCGA-19-2629	TCGA-GBM	737	s14367	Broad Institute of MIT and Harvard	Case Western	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1495-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab16	58cfa82ee4b0c9d6adf6ab16	G25783.TCGA-55-6986-01A-11D-1945-08.2.filtered.	WGS	G25783.TCGA-55-6986-01A-11D-1945-08.2	G25783.TCGA-55-6986-01A-11D-1945-08.2.bam	62	NA	0.05	58cfa82ee4b0c9d6adf6ab16	G25783.TCGA-55-6986-01A-11D-1945-08.2.bam	Alive	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-55-6986-01A	028E99E9-5B9A-4954-BB6E-6D4709A3CEA8	Primary Tumor	Illumina HiSeq	ee88a53a-b82b-4bd8-b13b-da8f5da9e39c	Lung	74	9622C370-68D0-48DA-A7E0-5EB4765B6F27	5A7F3C88-EF02-4E97-8009-5622245B6A09	TCGA-55-6986-01A-11D-1945-08	HG19_Broad_variant	TCGA-55-6986	TCGA-LUAD	NA	s11106	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2	N0	Lung Bronchioloalveolar Carcinoma Nonmucinous	Stage IB	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6aac9	58cfa82ee4b0c9d6adf6aac9	G25778.TCGA-05-4396-01A-21D-1855-08.2.filtered.	WGS	G25778.TCGA-05-4396-01A-21D-1855-08.2	G25778.TCGA-05-4396-01A-21D-1855-08.2.bam	301.7	1.9	0.05	58cfa82ee4b0c9d6adf6aac9	G25778.TCGA-05-4396-01A-21D-1855-08.2.bam	Dead	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4396-01A	9F81C602-8AFA-4588-B0B6-6E5A1A128D5A	Primary Tumor	Illumina HiSeq	80ae7a4a-81b6-4887-b708-cbff2cae5d94	Lung	76	4D85772B-287E-4790-B1E8-CD1C0E88AD48	0176CF1D-0760-4769-A493-277F4BB7585E	TCGA-05-4396-01A-21D-1855-08	HG19_Broad_variant	TCGA-05-4396	TCGA-LUAD	303	s11215	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T4	N1	Lung Adenocarcinoma Mixed Subtype	Stage IIIB	1855-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab02	58cfa82ee4b0c9d6adf6ab02	G23071.TCGA_CV_7100_01A_11D_2268_08.1.filtered.	WGS	G23071.TCGA_CV_7100_01A_11D_2268_08.1	G23071.TCGA_CV_7100_01A_11D_2268_08.1.bam	335.7	NA	0.14	58cfa82ee4b0c9d6adf6ab02	G23071.TCGA_CV_7100_01A_11D_2268_08.1.bam	Dead	MALE	WHITE	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7100-01A	90A8D2CB-1F31-45F9-8575-EED3CB9A7798	Primary Tumor	Illumina HiSeq	4e9d6eec-9af8-4de3-b449-1d56dd8ba30f	Head and Neck	66	08C3093D-4100-4BFC-92FC-A11F1393868F	FECCC27E-5C2E-4339-8746-0945FEE93C1E	TCGA-CV-7100-01A-11D-2268-08	HG19_Broad_variant	TCGA-CV-7100	TCGA-HNSC	274	s16312	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T2	N1	Head and Neck Squamous Cell Carcinoma	Stage III	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab88	58cfa82ee4b0c9d6adf6ab88	G37566.TCGA-CH-5750-01A-11D-1576-08.2.filtered.	WGS	G37566.TCGA-CH-5750-01A-11D-1576-08.2	G37566.TCGA-CH-5750-01A-11D-1576-08.2.bam	300.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab88	G37566.TCGA-CH-5750-01A-11D-1576-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5750-01A	DC40CF49-B208-4F59-B5F0-CFBDD02970B2	Primary Tumor	Illumina HiSeq	84c3a2f5-0cac-4bc2-8734-3269860bd2c0	Prostate	72	0386D0E9-7BD8-467F-BA97-A379C1D67A83	E1B169C3-44E0-43E5-9EE3-2DF7A678A5EA	TCGA-CH-5750-01A-11D-1576-08	HG19_Broad_variant	TCGA-CH-5750	TCGA-PRAD	NA	s3580	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1576-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab9c	58cfa82ee4b0c9d6adf6ab9c	G25777.TCGA-67-6215-01A-11D-1753-08.1.filtered.	WGS	G25777.TCGA-67-6215-01A-11D-1753-08.1	G25777.TCGA-67-6215-01A-11D-1753-08.1.bam	292.4	1.9	0.05	58cfa82ee4b0c9d6adf6ab9c	G25777.TCGA-67-6215-01A-11D-1753-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-67-6215-01A	DBD5B0DE-94C9-45DD-AFB3-6820A7ECACA2	Primary Tumor	Illumina HiSeq	70835707-2b01-4434-88b9-57b2c434b88e	Lung	52	3BA5F6B9-6458-44E2-A0AA-B5C7E5FCD632	68C2A355-862C-4657-B296-5776ED8447B0	TCGA-67-6215-01A-11D-1753-08	HG19_Broad_variant	TCGA-67-6215	TCGA-LUAD	NA	s10633	Broad Institute of MIT and Harvard	St Joseph's Medical Center (MD)	United States	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1753-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab99	58cfa82ee4b0c9d6adf6ab99	G26397.TCGA-19-5960-01A-11D-1696-08.2.filtered.	WGS	G26397.TCGA-19-5960-01A-11D-1696-08.2	G26397.TCGA-19-5960-01A-11D-1696-08.2.bam	513.03	1.9	0.05	58cfa82ee4b0c9d6adf6ab99	G26397.TCGA-19-5960-01A-11D-1696-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-19-5960-01A	93ED7A2B-B0CB-4A84-871F-5C34A0B6A640	Primary Tumor	Illumina HiSeq	264b0e2f-a66b-477b-90af-7dd319a8d4b8	Brain	56	86C6A232-F5AB-47CD-B91B-4CAD6AA1D0F1	B8151614-B08F-49A3-AB6F-2E780F765A17	TCGA-19-5960-01A-11D-1696-08	HG19_Broad_variant	TCGA-19-5960	TCGA-GBM	NA	s14347	Broad Institute of MIT and Harvard	Case Western	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1696-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab8a	58cfa82ee4b0c9d6adf6ab8a	G26372.TCGA-26-5132-01A-01D-1486-08.2.filtered.	WGS	G26372.TCGA-26-5132-01A-01D-1486-08.2	G26372.TCGA-26-5132-01A-01D-1486-08.2.bam	568.73	1.9	0.05	58cfa82ee4b0c9d6adf6ab8a	G26372.TCGA-26-5132-01A-01D-1486-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-26-5132-01A	2C5FA2D4-8E35-42E4-8BCA-9FB3371A19C8	Primary Tumor	Illumina HiSeq	68345c45-66a1-48a6-a6a5-ed29b8525b04	Brain	74	AC7EA2F0-A526-4B9A-8E81-2736EA38F53B	D1132127-1250-43AF-9C16-425798A3D1A7	TCGA-26-5132-01A-01D-1486-08	HG19_Broad_variant	TCGA-26-5132	TCGA-GBM	NA	s13890	Broad Institute of MIT and Harvard	University of Florida	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1486-08	FALSE
13722.58cfa82ee4b0c9d6adf6abb0	58cfa82ee4b0c9d6adf6abb0	G26366.TCGA-06-0686-01A-01D-1492-08.2.filtered.	WGS	G26366.TCGA-06-0686-01A-01D-1492-08.2	G26366.TCGA-06-0686-01A-01D-1492-08.2.bam	420.57	1.91	0.05	58cfa82ee4b0c9d6adf6abb0	G26366.TCGA-06-0686-01A-01D-1492-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0686-01A	C931F3BD-74C5-4EBD-BC0F-C7C6BECD25AB	Primary Tumor	Illumina HiSeq	4d80b67a-08f2-45cf-84b2-9aabce938c2f	Brain	53	7AF6D7A5-B550-42D9-983A-241EC76FD7F4	2C71D542-1653-4D97-8752-F2FD05C7E75D	TCGA-06-0686-01A-01D-1492-08	HG19_Broad_variant	TCGA-06-0686	TCGA-GBM	NA	s14344	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1492-08	FALSE
13722.58cfa82ee4b0c9d6adf6abc4	58cfa82ee4b0c9d6adf6abc4	G37566.TCGA-EJ-5506-01A-01D-1576-08.1.filtered.	WGS	G37566.TCGA-EJ-5506-01A-01D-1576-08.1	G37566.TCGA-EJ-5506-01A-01D-1576-08.1.bam	238.7	1.9	0.05	58cfa82ee4b0c9d6adf6abc4	G37566.TCGA-EJ-5506-01A-01D-1576-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5506-01A	E5E4D3B6-8E58-4DCF-8F67-A00E656A8E27	Primary Tumor	Illumina HiSeq	b7db243f-ae86-4f3d-b5f1-38ba6363bd78	Prostate	67	9EBDA113-B0FC-4233-87AC-DAD0E7D033DE	9F5E6063-D19E-4F56-B3F9-5C2260D3BFC9	TCGA-EJ-5506-01A-01D-1576-08	HG19_Broad_variant	TCGA-EJ-5506	TCGA-PRAD	NA	s3757	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type	Not available	1576-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac20	58cfa82ee4b0c9d6adf6ac20	G37566.TCGA-CH-5789-01A-11D-1576-08.1.filtered.	WGS	G37566.TCGA-CH-5789-01A-11D-1576-08.1	G37566.TCGA-CH-5789-01A-11D-1576-08.1.bam	148.7	1.9	0.05	58cfa82ee4b0c9d6adf6ac20	G37566.TCGA-CH-5789-01A-11D-1576-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5789-01A	BE5411DC-3CAA-4B25-9B94-CE463E8E52B4	Primary Tumor	Illumina HiSeq	93287c07-09e0-4643-b170-08b49803c218	Prostate	61	3C42EB4B-DB63-4F81-8D28-A439E932C716	B68C5EC2-0875-4D77-B4B7-738D2B2F313C	TCGA-CH-5789-01A-11D-1576-08	HG19_Broad_variant	TCGA-CH-5789	TCGA-PRAD	NA	s3761	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1576-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac1c	58cfa82ee4b0c9d6adf6ac1c	G37566.TCGA-HC-7079-01A-11D-1961-08.2.filtered.	WGS	G37566.TCGA-HC-7079-01A-11D-1961-08.2	G37566.TCGA-HC-7079-01A-11D-1961-08.2.bam	133	NA	0.05	58cfa82ee4b0c9d6adf6ac1c	G37566.TCGA-HC-7079-01A-11D-1961-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7079-01A	10FBE481-F111-4F88-AE45-4D67CB265567	Primary Tumor	Illumina HiSeq	75a8bf78-150a-4c1f-99fa-41db038cf5a5	Prostate	51	190EF71A-5B5D-4009-B707-68F10147CB65	7F1CA00A-84BA-4B26-A1A5-4D83C363AC69	TCGA-HC-7079-01A-11D-1961-08	HG19_Broad_variant	TCGA-HC-7079	TCGA-PRAD	NA	s3924	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1961-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac1e	58cfa82ee4b0c9d6adf6ac1e	G37566.TCGA-G9-7522-01A-11D-2260-08.1.filtered.	WGS	G37566.TCGA-G9-7522-01A-11D-2260-08.1	G37566.TCGA-G9-7522-01A-11D-2260-08.1.bam	146.7	NA	0.05	58cfa82ee4b0c9d6adf6ac1e	G37566.TCGA-G9-7522-01A-11D-2260-08.1.bam	Alive	MALE	Not available	Not available	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-7522-01A	87959988-BB25-47EE-AFC1-9AF92592BBE7	Primary Tumor	Illumina HiSeq	07b2c012-7fce-49d8-a6b8-6d5eb4907508	Prostate	49	10BFE256-C4A2-4D88-B907-56F86EF63DE9	F54442D1-80FA-4678-AC94-C3AD03BC37FB	TCGA-G9-7522-01A-11D-2260-08	HG19_Broad_variant	TCGA-G9-7522	TCGA-PRAD	NA	s3923	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2260-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac27	58cfa82ee4b0c9d6adf6ac27	G37566.TCGA-HC-7737-01A-11D-2114-08.3.filtered.	WGS	G37566.TCGA-HC-7737-01A-11D-2114-08.3	G37566.TCGA-HC-7737-01A-11D-2114-08.3.bam	205.3	NA	0.05	58cfa82ee4b0c9d6adf6ac27	G37566.TCGA-HC-7737-01A-11D-2114-08.3.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	Not available	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7737-01A	73F875CB-BCFC-43BA-AB97-4E94CAF836D4	Primary Tumor	Illumina HiSeq	855b7ac8-18b6-4ec4-9471-8d12a802bf46	Prostate	55	47B6E89A-EA86-475A-9F1D-02001069C895	DCF98ACC-736B-4AF6-BDCA-A320A413165A	TCGA-HC-7737-01A-11D-2114-08	HG19_Broad_variant	TCGA-HC-7737	TCGA-PRAD	NA	s3407	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2c	N1	Prostate Adenocarcinoma Acinar Type	Not available	2114-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac9a	58cfa82ee4b0c9d6adf6ac9a	G41960.TCGA-91-6847-01A-11D-1945-08.1.filtered.	WGS	G41960.TCGA-91-6847-01A-11D-1945-08.1	G41960.TCGA-91-6847-01A-11D-1945-08.1.bam	528.7	1.9	0.05	58cfa82ee4b0c9d6adf6ac9a	G41960.TCGA-91-6847-01A-11D-1945-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-91-6847-01A	97831D28-AB41-4C18-BFC2-C4C6BC757D13	Primary Tumor	Illumina HiSeq	7d8d3882-a579-44c1-b63d-eabff64671d1	Lung	62	96A05D4B-3731-4B98-B38F-A6B33CD6ED96	020FAB36-C7DE-4933-B2BF-DC7B019A1326	TCGA-91-6847-01A-11D-1945-08	HG19_Broad_variant	TCGA-91-6847	TCGA-LUAD	NA	s10635	Broad Institute of MIT and Harvard	ABS - IUPUI	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac88	58cfa82ee4b0c9d6adf6ac88	G47088.TCGA-34-5240-01A-01D-1441-08.1.filtered.	WGS	G47088.TCGA-34-5240-01A-01D-1441-08.1	G47088.TCGA-34-5240-01A-01D-1441-08.1.bam	715.7	1.9	0.05	58cfa82ee4b0c9d6adf6ac88	G47088.TCGA-34-5240-01A-01D-1441-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-34-5240-01A	E7D1B042-5B1C-4C29-B501-A5EF4810ECD2	Primary Tumor	Illumina HiSeq	8c136698-e283-46dc-83d9-44916f08fe6b	Lung	73	49395D22-CD07-4AB7-BDF3-CFA56687BA43	4C3840DF-9824-40DB-879E-6D24ADC8C155	TCGA-34-5240-01A-01D-1441-08	HG19_Broad_variant	TCGA-34-5240	TCGA-LUSC	NA	s10361	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N1	Lung Basaloid Squamous Cell Carcinoma	Stage IIB	1441-08	FALSE
13722.58cfa82ee4b0c9d6adf6acac	58cfa82ee4b0c9d6adf6acac	G37566.TCGA-HC-7740-01A-11D-2114-08.2.filtered.	WGS	G37566.TCGA-HC-7740-01A-11D-2114-08.2	G37566.TCGA-HC-7740-01A-11D-2114-08.2.bam	31.3	NA	0.05	58cfa82ee4b0c9d6adf6acac	G37566.TCGA-HC-7740-01A-11D-2114-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7740-01A	91E249A6-B0B0-487E-9FAD-0E9F5798DCAE	Primary Tumor	Illumina HiSeq	dd2df8bb-8035-4f08-b3d4-d9ee910fd0ea	Prostate	59	54D1CF0E-5D54-486C-A863-733B5EDC5986	7303F9FE-88BB-48BA-B9B4-EBF9E4770C1C	TCGA-HC-7740-01A-11D-2114-08	HG19_Broad_variant	TCGA-HC-7740	TCGA-PRAD	NA	s3762	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2114-08	FALSE
13722.58cfa82ee4b0c9d6adf6accb	58cfa82ee4b0c9d6adf6accb	G39020.TCGA-D7-6815-01A-11D-1882-08.1.filtered.	WGS	G39020.TCGA-D7-6815-01A-11D-1882-08.1	G39020.TCGA-D7-6815-01A-11D-1882-08.1.bam	457	1.9	0.05	58cfa82ee4b0c9d6adf6accb	G39020.TCGA-D7-6815-01A-11D-1882-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6815-01A	53086E20-A727-40D6-B42D-8030109B5130	Primary Tumor	Illumina HiSeq	6265f1bc-c42b-4073-b83d-4f13fbe9da6c	Stomach	70	B5F3D9A1-46B5-4A63-8F7D-9C993FE9340D	9536F736-63BC-4099-BD54-740F5910F4A8	TCGA-D7-6815-01A-11D-1882-08	HG19_Broad_variant	TCGA-D7-6815	TCGA-STAD	NA	s14682	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T2	N2	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IIB	1882-08	FALSE
13722.58cfa82ee4b0c9d6adf6acd3	58cfa82ee4b0c9d6adf6acd3	G39020.TCGA-D7-6528-01A-11D-1800-08.2.filtered.	WGS	G39020.TCGA-D7-6528-01A-11D-1800-08.2	G39020.TCGA-D7-6528-01A-11D-1800-08.2.bam	303.4	1.9	0.05	58cfa82ee4b0c9d6adf6acd3	G39020.TCGA-D7-6528-01A-11D-1800-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6528-01A	35496E4E-598F-4FFC-B11E-8EDAEB676079	Primary Tumor	Illumina HiSeq	afbd806d-5a24-4b55-ba74-c8fef8aba22c	Stomach	70	DF817250-9A2C-42E8-AD90-0D9E13FE37B3	153A64EE-6322-4F2E-B3DF-77EF7D3A4CF0	TCGA-D7-6528-01A-11D-1800-08	HG19_Broad_variant	TCGA-D7-6528	TCGA-STAD	NA	s15232	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IB	1800-08	TRUE
13722.58cfa82ee4b0c9d6adf6acdb	58cfa82ee4b0c9d6adf6acdb	G39020.TCGA-D7-6519-01A-11D-1800-08.2.filtered.	WGS	G39020.TCGA-D7-6519-01A-11D-1800-08.2	G39020.TCGA-D7-6519-01A-11D-1800-08.2.bam	266.4	1.9	0.05	58cfa82ee4b0c9d6adf6acdb	G39020.TCGA-D7-6519-01A-11D-1800-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6519-01A	E37CAE9E-0656-4B89-B326-739A5CC859E0	Primary Tumor	Illumina HiSeq	8f8b5fc2-7fb8-4a30-968b-375bf038514e	Stomach	64	FA7426E1-FCFB-4B08-AD50-1D9E903A81FB	A2E67393-50D7-4BCC-9BBD-C695086A936A	TCGA-D7-6519-01A-11D-1800-08	HG19_Broad_variant	TCGA-D7-6519	TCGA-STAD	NA	s14683	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T2	N1	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIB	1800-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad0e	58cfa82ee4b0c9d6adf6ad0e	G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2.filtered.	WGS	G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2	G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2.bam	76.27	1.91	0.08	58cfa82ee4b0c9d6adf6ad0e	G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AE-01A	493A4FF2-37A5-4B79-928D-83DBFE534556	Primary Tumor	Illumina HiSeq	2722f260-d3b4-4088-860d-7a5070921255	Bladder	84	67865453-D515-4D63-84E8-CFB2686A211D	ABD2D959-D5ED-4EB3-9759-67EB1AA23325	TCGA-DK-A1AE-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1AE	TCGA-BLCA	NA	s2688	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad66	58cfa82ee4b0c9d6adf6ad66	G35154.TCGA-HT-A5R7-01A-11D-A461-08.2.filtered.	WGS	G35154.TCGA-HT-A5R7-01A-11D-A461-08.2	G35154.TCGA-HT-A5R7-01A-11D-A461-08.2.bam	17.75	NA	0.08	58cfa82ee4b0c9d6adf6ad66	G35154.TCGA-HT-A5R7-01A-11D-A461-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-A5R7-01A	7E41BABA-7EF6-4030-B595-D95CD96336B5	Primary Tumor	Illumina HiSeq	c239bee2-d22d-4390-be44-ed4be0395f57	Brain	33	7BA53D9A-FE20-487A-B4BB-84451E207755	C71F8C39-653F-42F2-AD3E-439CF86A0738	TCGA-HT-A5R7-01A-11D-A461-08	HG19_Broad_variant	TCGA-HT-A5R7	TCGA-LGG	NA	s8119	Broad Institute of MIT and Harvard	Case Western - St Joes	United States	NO	Not available	Not available	Astrocytoma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad7c	58cfa82ee4b0c9d6adf6ad7c	G26401.TCGA-15-1444-01A-02D-1696-08.1.filtered.	WGS	G26401.TCGA-15-1444-01A-02D-1696-08.1	G26401.TCGA-15-1444-01A-02D-1696-08.1.bam	294.03	1.9	0.05	58cfa82ee4b0c9d6adf6ad7c	G26401.TCGA-15-1444-01A-02D-1696-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-15-1444-01A	4C42DC4E-66B7-40BF-9FBE-B92543248198	Primary Tumor	Illumina HiSeq	15eb38d5-3d01-48d9-bea4-3b6868b9dee9	Brain	21	07DA260D-EF04-4A23-BDAD-5CEB98A673CA	CBD4D4E7-F1C4-446C-8DBC-CE06C872EC14	TCGA-15-1444-01A-02D-1696-08	HG19_Broad_variant	TCGA-15-1444	TCGA-GBM	1537	s14141	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	None	NO	Not available	Not available	Glioblastoma Multiforme (GBM)	Not available	1696-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac7c	58cfa82ee4b0c9d6adf6ac7c	G41960.TCGA-50-6591-01A-11D-1753-08.3.filtered.	WGS	G41960.TCGA-50-6591-01A-11D-1753-08.3	G41960.TCGA-50-6591-01A-11D-1753-08.3.bam	351.4	1.8	0.05	58cfa82ee4b0c9d6adf6ac7c	G41960.TCGA-50-6591-01A-11D-1753-08.3.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-6591-01A	9B132E4F-7E35-4CC5-8711-43AD62B906D0	Primary Tumor	Illumina HiSeq	3d4858b4-9af4-47f2-84d2-6618c7a21581	Lung	63	0791E7AA-E97C-4DD0-9615-09EC7090F684	BF7462A2-394F-4838-BCB6-4D0126FA48B1	TCGA-50-6591-01A-11D-1753-08	HG19_Broad_variant	TCGA-50-6591	TCGA-LUAD	119	s10637	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IV	1753-08	TRUE
13722.58cfa82ee4b0c9d6adf6af6a	58cfa82ee4b0c9d6adf6af6a	G41960.TCGA-55-6972-01A-11D-1945-08.1.filtered.	WGS	G41960.TCGA-55-6972-01A-11D-1945-08.1	G41960.TCGA-55-6972-01A-11D-1945-08.1.bam	520.7	NA	0.05	58cfa82ee4b0c9d6adf6af6a	G41960.TCGA-55-6972-01A-11D-1945-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-6972-01A	C4D1E105-28B7-48DF-ABEF-FBE09782FDB2	Primary Tumor	Illumina HiSeq	30f0b521-90e2-41a2-9dcc-97b6702a46fc	Lung	72	38C83B40-FBA4-48D4-AD6E-93768CB6139F	46693A2B-5105-4770-A9E1-031DFEDEB694	TCGA-55-6972-01A-11D-1945-08	HG19_Broad_variant	TCGA-55-6972	TCGA-LUAD	NA	s11113	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2	N0	Lung Papillary Adenocarcinoma	Stage IB	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6b0c4	58cfa82ee4b0c9d6adf6b0c4	G8891.TCGA-66-2756-01A-01D-1180-08.1.filtered.	WGS	G8891.TCGA-66-2756-01A-01D-1180-08.1	G8891.TCGA-66-2756-01A-01D-1180-08.1.bam	184.3	1.9	0.15	58cfa82ee4b0c9d6adf6b0c4	G8891.TCGA-66-2756-01A-01D-1180-08.1.bam	Alive	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2756-01A	43ABE847-4BA7-466E-8283-5D7B80B999A7	Primary Tumor	Illumina HiSeq	2cc59bf0-d2ce-42b3-a587-574633628139	Lung	68	D80486CD-F054-4527-A886-CF9446381B9F	25224AA0-CFDD-48EC-92E5-8F3992A3E574	TCGA-66-2756-01A-01D-1180-08	HG19_Broad_variant	TCGA-66-2756	TCGA-LUSC	NA	s10261	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T4	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIB	1180-08	FALSE
13722.58cfa82ee4b0c9d6adf6af76	58cfa82ee4b0c9d6adf6af76	G41960.TCGA-50-5930-01A-11D-1753-08.3.filtered.	WGS	G41960.TCGA-50-5930-01A-11D-1753-08.3	G41960.TCGA-50-5930-01A-11D-1753-08.3.bam	181.4	2	0.05	58cfa82ee4b0c9d6adf6af76	G41960.TCGA-50-5930-01A-11D-1753-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5930-01A	368E23F0-E573-4547-BF5A-14080BAF737B	Primary Tumor	Illumina HiSeq	7ef1f666-79cc-4c94-90b9-49c32631ba72	Lung	47	3E30DBD1-10BF-4450-8D19-6F44D3284E02	BD3E88B3-B37C-4641-85FA-D8125BA324CA	TCGA-50-5930-01A-11D-1753-08	HG19_Broad_variant	TCGA-50-5930	TCGA-LUAD	282	s10638	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N2	Lung Adenocarcinoma Mixed Subtype	Stage IIIA	1753-08	TRUE
13722.58cfa82de4b0c9d6adf6a712	58cfa82de4b0c9d6adf6a712	G14854.TCGA-38-4628-01A-01D-1931-08.5.filtered.	WGS	G14854.TCGA-38-4628-01A-01D-1931-08.5	G14854.TCGA-38-4628-01A-01D-1931-08.5.bam	32.52	1.9	0.13	58cfa82de4b0c9d6adf6a712	G14854.TCGA-38-4628-01A-01D-1931-08.5.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-38-4628-01A	CC4BD56A-25C5-4C48-B583-AC3AEB778CA6	Primary Tumor	Illumina HiSeq	2fb6e0f6-487d-4404-9958-6ca019a21395	Lung	65	A74F6423-B5D3-4AE2-B61F-3EE04B1073BF	C437535B-2ACC-4236-BEAE-94E2C1336830	TCGA-38-4628-01A-01D-1931-08	HG19_Broad_variant	TCGA-38-4628	TCGA-LUAD	1492	s10627	Broad Institute of MIT and Harvard	UNC	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a720	58cfa82de4b0c9d6adf6a720	G13232.TCGA-60-2726-01A-01D-1522-08.2.filtered.	WGS	G13232.TCGA-60-2726-01A-01D-1522-08.2	G13232.TCGA-60-2726-01A-01D-1522-08.2.bam	741.3	1.9	0.05	58cfa82de4b0c9d6adf6a720	G13232.TCGA-60-2726-01A-01D-1522-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2726-01A	3D1F4059-2220-45B4-A4D2-B14F76CEC96A	Primary Tumor	Illumina HiSeq	f4213e44-6813-4ccc-a6aa-9213ff594b0b	Lung	56	91A60807-2D0F-474E-B02F-18FEA788B319	A96EDDFC-3AFB-4BF8-A440-C91778113FBD	TCGA-60-2726-01A-01D-1522-08	HG19_Broad_variant	TCGA-60-2726	TCGA-LUSC	358	s10250	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIA	1522-08	TRUE
13722.58cfa82ee4b0c9d6adf6abe7	58cfa82ee4b0c9d6adf6abe7	G32538.TCGA-EM-A2CU-01A-12D-A17V-08.4.filtered.	WGS	G32538.TCGA-EM-A2CU-01A-12D-A17V-08.4	G32538.TCGA-EM-A2CU-01A-12D-A17V-08.4.bam	27.26	NA	0.08	58cfa82ee4b0c9d6adf6abe7	G32538.TCGA-EM-A2CU-01A-12D-A17V-08.4.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A2CU-01A	667EB7F6-1D36-49BB-9D7B-C9D167B64619	Primary Tumor	Illumina HiSeq	ef836a6f-dd3c-40ed-af7d-87b77a209877	Thyroid	47	5F75F169-6835-4B42-AF77-AB64CBFB5EF3	788FBFAA-51BF-42A4-AFA6-5B87ED04C2D5	TCGA-EM-A2CU-01A-12D-A17V-08	HG19_Broad_variant	TCGA-EM-A2CU	TCGA-THCA	NA	s12341	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T2	N1a	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A17V-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac7e	58cfa82ee4b0c9d6adf6ac7e	G47088.TCGA-85-8052-01A-11D-2244-08.3.filtered.	WGS	G47088.TCGA-85-8052-01A-11D-2244-08.3	G47088.TCGA-85-8052-01A-11D-2244-08.3.bam	56.03	NA	0.05	58cfa82ee4b0c9d6adf6ac7e	G47088.TCGA-85-8052-01A-11D-2244-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-85-8052-01A	395BABB3-3F5D-4E71-A675-AF4443F23028	Primary Tumor	Illumina HiSeq	541bd2eb-5c99-4a8c-a9d3-c05c470d15f8	Lung	53	9248B38E-EC7B-4C7C-BCB0-E942CE3C4847	43AA4123-0FE2-4071-8A81-CBDD0410B917	TCGA-85-8052-01A-11D-2244-08	HG19_Broad_variant	TCGA-85-8052	TCGA-LUSC	NA	s10498	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T3	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIB	2244-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac7a	58cfa82ee4b0c9d6adf6ac7a	G39020.TCGA-IN-7806-01A-11D-2053-08.3.filtered.	WGS	G39020.TCGA-IN-7806-01A-11D-2053-08.3	G39020.TCGA-IN-7806-01A-11D-2053-08.3.bam	341.7	NA	0.05	58cfa82ee4b0c9d6adf6ac7a	G39020.TCGA-IN-7806-01A-11D-2053-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-IN-7806-01A	87C217D4-66F4-46CA-8244-7856CE658FD3	Primary Tumor	Illumina HiSeq	65b3a7db-195a-47e8-804b-a1d4a5df79aa	Stomach	50	9B864C79-BF5C-4430-86E8-D8479ED90D25	576A1741-8C65-40DA-9F0F-B2CA805D70F3	TCGA-IN-7806-01A-11D-2053-08	HG19_Broad_variant	TCGA-IN-7806	TCGA-STAD	NA	s15297	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3	N1	Stomach  Adenocarcinoma  Diffuse Type	Stage IIB	2053-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac9c	58cfa82ee4b0c9d6adf6ac9c	G47088.TCGA-21-1083-01A-01D-1521-08.3.filtered.	WGS	G47088.TCGA-21-1083-01A-01D-1521-08.3	G47088.TCGA-21-1083-01A-01D-1521-08.3.bam	532	1.9	0.05	58cfa82ee4b0c9d6adf6ac9c	G47088.TCGA-21-1083-01A-01D-1521-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-21-1083-01A	0398EAE1-7216-4595-80A5-6B117D96E070	Primary Tumor	Illumina HiSeq	365def90-a1fd-45b6-a3ab-749e13d4833d	Lung	75	300CB22F-ACB4-4ACD-8D64-FE8DCDF64801	FB0C6353-A90C-45E2-9355-7CD16CF756FF	TCGA-21-1083-01A-01D-1521-08	HG19_Broad_variant	TCGA-21-1083	TCGA-LUSC	1315	s9978	Broad Institute of MIT and Harvard	Fox Chase Cancer Center	United States	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	1521-08	TRUE
13722.58cfa82ee4b0c9d6adf6acec	58cfa82ee4b0c9d6adf6acec	G49537.TCGA-DE-A3KN-01A-11D-A20C-08.2.filtered.	WGS	G49537.TCGA-DE-A3KN-01A-11D-A20C-08.2	G49537.TCGA-DE-A3KN-01A-11D-A20C-08.2.bam	47.57	NA	0.08	58cfa82ee4b0c9d6adf6acec	G49537.TCGA-DE-A3KN-01A-11D-A20C-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DE-A3KN-01A	085FFCDC-8600-42E2-852A-506465F716A2	Primary Tumor	Illumina HiSeq	62705306-2ad4-4287-ac8d-ca27cf525430	Thyroid	49	620B21C9-AC06-4154-A941-2532C775C6D8	07A7C634-BD9A-4FC2-B9FE-87B060EC3D1F	TCGA-DE-A3KN-01A-11D-A20C-08	HG19_Broad_variant	TCGA-DE-A3KN	TCGA-THCA	NA	s11984	Broad Institute of MIT and Harvard	University of North Carolina	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IVA	A20C-08	FALSE
13722.58cfa82ee4b0c9d6adf6acef	58cfa82ee4b0c9d6adf6acef	G49537.TCGA-DJ-A4UT-01A-11D-A257-08.1.filtered.	WGS	G49537.TCGA-DJ-A4UT-01A-11D-A257-08.1	G49537.TCGA-DJ-A4UT-01A-11D-A257-08.1.bam	37.91	NA	0.08	58cfa82ee4b0c9d6adf6acef	G49537.TCGA-DJ-A4UT-01A-11D-A257-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A4UT-01A	ACB80B76-2394-4250-8687-60E40E16E83B	Primary Tumor	Illumina HiSeq	3f6de736-5ec7-4e27-85a6-a39f216ce0bf	Thyroid	32	4D6855A8-076D-4F95-B6CE-2B250CE3087D	64A17D5B-8F40-4CCF-8F2F-E68C5FE6B1FF	TCGA-DJ-A4UT-01A-11D-A257-08	HG19_Broad_variant	TCGA-DJ-A4UT	TCGA-THCA	NA	s11980	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T1a	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A257-08	FALSE
13722.58cfa82ee4b0c9d6adf6acf8	58cfa82ee4b0c9d6adf6acf8	G49537.TCGA-EL-A3T9-01A-21D-A22D-08.2.filtered.	WGS	G49537.TCGA-EL-A3T9-01A-21D-A22D-08.2	G49537.TCGA-EL-A3T9-01A-21D-A22D-08.2.bam	33.29	NA	0.08	58cfa82ee4b0c9d6adf6acf8	G49537.TCGA-EL-A3T9-01A-21D-A22D-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3T9-01A	8A233B01-2959-467F-8950-02BE16309156	Primary Tumor	Illumina HiSeq	2ef29dae-4708-441b-ab7f-4f8ef4462a47	Thyroid	69	5297F55C-3A46-47ED-8ACC-03333AC26473	D692ECD0-2433-426B-9AF2-A30C44A80F7C	TCGA-EL-A3T9-01A-21D-A22D-08	HG19_Broad_variant	TCGA-EL-A3T9	TCGA-THCA	174	s12499	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T4	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage IV	A22D-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad00	58cfa82ee4b0c9d6adf6ad00	G49537.TCGA-E8-A418-01A-11D-A23M-08.1.filtered.	WGS	G49537.TCGA-E8-A418-01A-11D-A23M-08.1	G49537.TCGA-E8-A418-01A-11D-A23M-08.1.bam	30.97	NA	0.08	58cfa82ee4b0c9d6adf6ad00	G49537.TCGA-E8-A418-01A-11D-A23M-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-E8-A418-01A	EBBD54AD-7B97-4081-AD11-7F7F3CE74EEF	Primary Tumor	Illumina HiSeq	dcbb2120-b24f-4bc5-a07f-706d58345c05	Thyroid	75	979CBB75-28D9-4D33-8083-077C25BDDFD6	63EA274B-D42B-4787-9C54-8EE95EA376EC	TCGA-E8-A418-01A-11D-A23M-08	HG19_Broad_variant	TCGA-E8-A418	TCGA-THCA	NA	s12088	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T4a	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage IVA	A23M-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad02	58cfa82ee4b0c9d6adf6ad02	G49537.TCGA-E8-A416-01A-11D-A23M-08.2.filtered.	WGS	G49537.TCGA-E8-A416-01A-11D-A23M-08.2	G49537.TCGA-E8-A416-01A-11D-A23M-08.2.bam	16.01	NA	0.08	58cfa82ee4b0c9d6adf6ad02	G49537.TCGA-E8-A416-01A-11D-A23M-08.2.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-E8-A416-01A	86B82345-6F4D-44FD-A9DB-6F107DE62F53	Primary Tumor	Illumina HiSeq	d49de1af-8dd9-4fdb-8a60-87bd8894395b	Thyroid	51	AF7B5868-2C11-4C74-8033-E914C987ECE6	C8381701-31CB-465A-BDF2-1B8132BE7A14	TCGA-E8-A416-01A-11D-A23M-08	HG19_Broad_variant	TCGA-E8-A416	TCGA-THCA	NA	s12623	Broad Institute of MIT and Harvard	Asterand	Vietnam	NO	T1b	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23M-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad1c	58cfa82ee4b0c9d6adf6ad1c	G49537.TCGA-BJ-A45K-01A-11D-A23U-08.3.filtered.	WGS	G49537.TCGA-BJ-A45K-01A-11D-A23U-08.3	G49537.TCGA-BJ-A45K-01A-11D-A23U-08.3.bam	27.47	NA	0.08	58cfa82ee4b0c9d6adf6ad1c	G49537.TCGA-BJ-A45K-01A-11D-A23U-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A45K-01A	8CFB88F6-7B37-4F1E-882B-3A368B604167	Primary Tumor	Illumina HiSeq	9a38b46c-3b59-40ad-9d22-d0d153c211a1	Thyroid	33	29B4816D-4CFB-45F0-BCD2-6B948245F3A4	77EBE6D2-6537-49D3-849D-FE93E2CF52AF	TCGA-BJ-A45K-01A-11D-A23U-08	HG19_Broad_variant	TCGA-BJ-A45K	TCGA-THCA	NA	s12615	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23U-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad12	58cfa82ee4b0c9d6adf6ad12	G49537.TCGA-DE-A2OL-01A-11D-A18F-08.2.filtered.	WGS	G49537.TCGA-DE-A2OL-01A-11D-A18F-08.2	G49537.TCGA-DE-A2OL-01A-11D-A18F-08.2.bam	71.37	NA	0.08	58cfa82ee4b0c9d6adf6ad12	G49537.TCGA-DE-A2OL-01A-11D-A18F-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DE-A2OL-01A	77BB90F0-E923-4E28-BB88-4D6B420E0B5C	Primary Tumor	Illumina HiSeq	60e1b538-0f36-45ea-892a-a8b64734f42b	Thyroid	44	6CBA95AD-2702-4F50-8B1E-BECDAF014B83	FC812906-D3B6-4210-A842-96F095280CBF	TCGA-DE-A2OL-01A-11D-A18F-08	HG19_Broad_variant	TCGA-DE-A2OL	TCGA-THCA	NA	s12350	Broad Institute of MIT and Harvard	University of North Carolina	United States	NO	T2	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A18F-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad18	58cfa82ee4b0c9d6adf6ad18	G49537.TCGA-EM-A2OV-01A-11D-A202-08.1.filtered.	WGS	G49537.TCGA-EM-A2OV-01A-11D-A202-08.1	G49537.TCGA-EM-A2OV-01A-11D-A202-08.1.bam	24.95	NA	0.08	58cfa82ee4b0c9d6adf6ad18	G49537.TCGA-EM-A2OV-01A-11D-A202-08.1.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EM-A2OV-01A	55E03FFC-F006-4EC8-8E5D-A738FF091F8A	Primary Tumor	Illumina HiSeq	6c8370c6-102f-4bde-84ce-bf930800ac6a	Thyroid	64	1183BCB5-50A7-4CC0-A94C-732636B7EE7D	2DFE70FD-2650-49C0-B6EB-67DF585D063B	TCGA-EM-A2OV-01A-11D-A202-08	HG19_Broad_variant	TCGA-EM-A2OV	TCGA-THCA	NA	s12347	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A202-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad1f	58cfa82ee4b0c9d6adf6ad1f	G39020.TCGA-BR-8486-01A-31D-2394-08.2.filtered.	WGS	G39020.TCGA-BR-8486-01A-31D-2394-08.2	G39020.TCGA-BR-8486-01A-31D-2394-08.2.bam	280	NA	0.05	58cfa82ee4b0c9d6adf6ad1f	G39020.TCGA-BR-8486-01A-31D-2394-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8486-01A	B8A1C8C7-3945-4D84-8F58-3A1A1EB10730	Primary Tumor	Illumina HiSeq	09ea179f-e2fc-479c-9b04-7c3ae8034874	Stomach	90	65FA5F32-8747-41B7-8287-061587DC22DE	6A7CDAF6-211E-4EB8-A70E-1153D69C45E4	TCGA-BR-8486-01A-31D-2394-08	HG19_Broad_variant	TCGA-BR-8486	TCGA-STAD	NA	s14678	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T1b	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IA	2394-08	TRUE
13722.58cfa82ee4b0c9d6adf6adac	58cfa82ee4b0c9d6adf6adac	G39020.TCGA-CD-8529-01A-11D-2340-08.2.filtered.	WGS	G39020.TCGA-CD-8529-01A-11D-2340-08.2	G39020.TCGA-CD-8529-01A-11D-2340-08.2.bam	200.7	NA	0.05	58cfa82ee4b0c9d6adf6adac	G39020.TCGA-CD-8529-01A-11D-2340-08.2.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-8529-01A	5B7E557A-6AEE-4077-B3CD-C96179E643AE	Primary Tumor	Illumina HiSeq	65281f4c-9277-4d03-8566-75feb73c114d	Stomach	65	EB18C784-32F7-4570-A661-E4DF8F55378C	931B24DA-5D6D-4C2D-8DE9-EF32D6EB8565	TCGA-CD-8529-01A-11D-2340-08	HG19_Broad_variant	TCGA-CD-8529	TCGA-STAD	NA	s14958	Broad Institute of MIT and Harvard	ILSbio	Vietnam	NO	T4	N0	Stomach Intestinal Adenocarcinoma Mucinous Type	Stage IV	2340-08	FALSE
13722.58cfa82ee4b0c9d6adf6add6	58cfa82ee4b0c9d6adf6add6	G39020.TCGA-BR-8690-01A-11D-2394-08.4.filtered.	WGS	G39020.TCGA-BR-8690-01A-11D-2394-08.4	G39020.TCGA-BR-8690-01A-11D-2394-08.4.bam	390	NA	0.05	58cfa82ee4b0c9d6adf6add6	G39020.TCGA-BR-8690-01A-11D-2394-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8690-01A	337819D2-5281-4B41-9583-A476924BC837	Primary Tumor	Illumina HiSeq	4a0c62bb-6857-41e2-8933-37b5cb32f6b7	Stomach	54	0F7EBFFA-D119-45D6-8AF1-2048ECA173E7	EDC8839F-FA6B-41E0-AD49-F688073730BD	TCGA-BR-8690-01A-11D-2394-08	HG19_Broad_variant	TCGA-BR-8690	TCGA-STAD	NA	s14390	Broad Institute of MIT and Harvard	Asterand	Ukraine	NO	T3	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIIB	2394-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad25	58cfa82ee4b0c9d6adf6ad25	G49538.TCGA-19-1389-01A-01D-2319-08.1.filtered.	WGS	G49538.TCGA-19-1389-01A-01D-2319-08.1	G49538.TCGA-19-1389-01A-01D-2319-08.1.bam	233.3	1.9	0.05	58cfa82ee4b0c9d6adf6ad25	G49538.TCGA-19-1389-01A-01D-2319-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-19-1389-01A	309005A2-93A8-4566-B8D3-6B9310144266	Primary Tumor	Illumina HiSeq	4af17e02-7d17-41c3-9ee7-32c7c1d5e163	Brain	51	A20EB141-2F2C-44E4-BBC2-5BC9F58F5644	359452A5-29CD-4D2B-BB78-E60FD790A35E	TCGA-19-1389-01A-01D-2319-08	HG19_Broad_variant	TCGA-19-1389	TCGA-GBM	141	s14062	Broad Institute of MIT and Harvard	Case Western	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	2319-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae16	58cfa82ee4b0c9d6adf6ae16	G49837.TCGA-94-7943-01A-11D-A320-08.2.filtered.	WGS	G49837.TCGA-94-7943-01A-11D-A320-08.2	G49837.TCGA-94-7943-01A-11D-A320-08.2.bam	203	NA	0.08	58cfa82ee4b0c9d6adf6ae16	G49837.TCGA-94-7943-01A-11D-A320-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-94-7943-01A	AECF85CC-058C-46F3-9CDC-3573AC3B8438	Primary Tumor	Illumina HiSeq	f0eef218-f0af-4e9d-8f67-cdfc840480bc	Lung	80	E447DA47-227D-4956-9F46-AD1F81B73EBA	7731EF7F-25BD-42F5-9A20-BE249306A711	TCGA-94-7943-01A-11D-A320-08	HG19_Broad_variant	TCGA-94-7943	TCGA-LUSC	NA	s10509	Broad Institute of MIT and Harvard	Washington University - Emory	United States	NO	T1b	NX	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ade4	58cfa82ee4b0c9d6adf6ade4	G49837.TCGA-66-2789-01A-01D-A320-08.2.filtered.	WGS	G49837.TCGA-66-2789-01A-01D-A320-08.2	G49837.TCGA-66-2789-01A-01D-A320-08.2.bam	379.94	1.8	0.07	58cfa82ee4b0c9d6adf6ade4	G49837.TCGA-66-2789-01A-01D-A320-08.2.bam	Dead	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2789-01A	87AC0AD4-8C9D-409E-9A86-1D201D01769D	Primary Tumor	Illumina HiSeq	52b8139f-9275-441d-b6ee-e7d29d66fc68	Lung	73	A633A5CA-C207-45BE-8903-93527DE31C22	9623D295-C23D-4F2F-827C-69F767A26F1F	TCGA-66-2789-01A-01D-A320-08	HG19_Broad_variant	TCGA-66-2789	TCGA-LUSC	123	s10164	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T1	N3	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad92	58cfa82ee4b0c9d6adf6ad92	G39020.TCGA-D7-6527-01A-11D-1800-08.2.filtered.	WGS	G39020.TCGA-D7-6527-01A-11D-1800-08.2	G39020.TCGA-D7-6527-01A-11D-1800-08.2.bam	84.4	1.9	0.05	58cfa82ee4b0c9d6adf6ad92	G39020.TCGA-D7-6527-01A-11D-1800-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6527-01A	CB622CD6-776D-4681-8A67-4ADDD61C66B8	Primary Tumor	Illumina HiSeq	869f3603-32f9-4e4d-a862-211f1bb624b8	Stomach	62	8461CE68-3A6F-4343-8977-78448123F373	DC537FCF-D910-4C4B-8AF9-E7DA429F2633	TCGA-D7-6527-01A-11D-1800-08	HG19_Broad_variant	TCGA-D7-6527	TCGA-STAD	NA	s15229	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T2	N1	Stomach Intestinal Adenocarcinoma Papillary Type	Stage II	1800-08	TRUE
13722.58cfa82ee4b0c9d6adf6ae7c	58cfa82ee4b0c9d6adf6ae7c	G49538.TCGA-06-0171-01A-02D-A33C-08.2.filtered.	WGS	G49538.TCGA-06-0171-01A-02D-A33C-08.2	G49538.TCGA-06-0171-01A-02D-A33C-08.2.bam	117.7	1.92	0.07	58cfa82ee4b0c9d6adf6ae7c	G49538.TCGA-06-0171-01A-02D-A33C-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0171-01A	01A92062-967A-4900-8DC7-A5ECD3B3F8E2	Primary Tumor	Illumina HiSeq	9b5a849c-703d-4d9c-81f4-6bd061fd21a8	Brain	65	6081351A-7D07-41FB-A99E-43587223BFCC	18901F76-660B-4CC6-AF1B-1B6F5D62204D	TCGA-06-0171-01A-02D-A33C-08	HG19_Broad_variant	TCGA-06-0171	TCGA-GBM	399	s13947	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	A33C-08	FALSE
13722.58cfa82ee4b0c9d6adf6aeaa	58cfa82ee4b0c9d6adf6aeaa	G49537.TCGA-ET-A4KN-01A-11D-A257-08.1.filtered.	WGS	G49537.TCGA-ET-A4KN-01A-11D-A257-08.1	G49537.TCGA-ET-A4KN-01A-11D-A257-08.1.bam	32.52	NA	0.07	58cfa82ee4b0c9d6adf6aeaa	G49537.TCGA-ET-A4KN-01A-11D-A257-08.1.bam	Alive	FEMALE	WHITE	Not available	Thyroid Carcinoma	Aligned reads	TCGA-ET-A4KN-01A	7629F864-A009-4AA9-BF7E-2D99E00D294E	Primary Tumor	Illumina HiSeq	82a795da-f726-45af-a15f-a778695d466a	Thyroid	51	E01D507C-8E8E-45C6-B4EF-193177A382C4	178D0486-CB0D-4979-8BDF-BB3FE99149BD	TCGA-ET-A4KN-01A-11D-A257-08	HG19_Broad_variant	TCGA-ET-A4KN	TCGA-THCA	NA	s12619	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage III	A257-08	FALSE
13722.58cfa82ee4b0c9d6adf6aea0	58cfa82ee4b0c9d6adf6aea0	G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1.filtered.	WGS	G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1	G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1.bam	37.07	NA	0.08	58cfa82ee4b0c9d6adf6aea0	G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FY-A2QD-01A	B0CB6ED7-3D9F-4D5E-8DF5-EDCC921C43B4	Primary Tumor	Illumina HiSeq	102342da-d9ce-4eb4-8c20-dda6ce072830	Thyroid	61	08D3CB3B-9A80-4034-B06D-B37DD38C8B9B	E7335A24-E5FC-4558-9EBA-511C5A802320	TCGA-FY-A2QD-01A-11D-A19J-08	HG19_Broad_variant	TCGA-FY-A2QD	TCGA-THCA	NA	s12226	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Not available	A19J-08	FALSE
13722.58cfa82ee4b0c9d6adf6aedb	58cfa82ee4b0c9d6adf6aedb	G49537.TCGA-DJ-A2Q1-01A-22D-A19J-08.1.filtered.	WGS	G49537.TCGA-DJ-A2Q1-01A-22D-A19J-08.1	G49537.TCGA-DJ-A2Q1-01A-22D-A19J-08.1.bam	27.76	NA	0.09	58cfa82ee4b0c9d6adf6aedb	G49537.TCGA-DJ-A2Q1-01A-22D-A19J-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A2Q1-01A	E35B2928-8784-45D0-A71A-A2DF161542FA	Primary Tumor	Illumina HiSeq	0cac59ec-55cb-4769-ba6d-92c08a076186	Thyroid	44	D1361CB2-6758-4A8C-AE97-8AD5192572FC	007AAB66-2F07-459D-8952-3041D6EA24A8	TCGA-DJ-A2Q1-01A-22D-A19J-08	HG19_Broad_variant	TCGA-DJ-A2Q1	TCGA-THCA	NA	s11981	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T1b	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A19J-08	FALSE
13722.58cfa82ee4b0c9d6adf6aeb6	58cfa82ee4b0c9d6adf6aeb6	G49537.TCGA-EM-A2CN-01A-11D-A19J-08.2.filtered.	WGS	G49537.TCGA-EM-A2CN-01A-11D-A19J-08.2	G49537.TCGA-EM-A2CN-01A-11D-A19J-08.2.bam	65.79	NA	0.09	58cfa82ee4b0c9d6adf6aeb6	G49537.TCGA-EM-A2CN-01A-11D-A19J-08.2.bam	Alive	MALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A2CN-01A	4AED5116-D27B-4911-B310-05C2248B861F	Primary Tumor	Illumina HiSeq	2dc0d4bf-c927-40fc-bc8e-fbdc5e1da355	Thyroid	62	4548D9EE-668F-495B-845F-8B9FC798EA38	5C02D399-07AF-4573-A568-BC1B256BC8F8	TCGA-EM-A2CN-01A-11D-A19J-08	HG19_Broad_variant	TCGA-EM-A2CN	TCGA-THCA	NA	s12089	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage IVC	A19J-08	FALSE
13722.58cfa82ee4b0c9d6adf6af3e	58cfa82ee4b0c9d6adf6af3e	G47088.TCGA-22-5485-01A-01D-1632-08.2.filtered.	WGS	G47088.TCGA-22-5485-01A-01D-1632-08.2	G47088.TCGA-22-5485-01A-01D-1632-08.2.bam	342.7	1.9	0.05	58cfa82ee4b0c9d6adf6af3e	G47088.TCGA-22-5485-01A-01D-1632-08.2.bam	Dead	FEMALE	WHITE	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-22-5485-01A	305F72A8-069B-410B-BBE4-4ECB761C748D	Primary Tumor	Illumina HiSeq	c56332b3-4ccb-4b34-80c3-ffa0b28c5690	Lung	58	ABC3A25F-D5BC-469E-8C3E-8E6F5B129E8F	448AF8B4-E071-48B0-A65B-B4AD17AFDC0C	TCGA-22-5485-01A-01D-1632-08	HG19_Broad_variant	TCGA-22-5485	TCGA-LUSC	916	s10593	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	United States	NO	T1a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	1632-08	FALSE
13722.58cfa82ee4b0c9d6adf6af4e	58cfa82ee4b0c9d6adf6af4e	G49537.TCGA-EL-A4K6-01A-12D-A257-08.2.filtered.	WGS	G49537.TCGA-EL-A4K6-01A-12D-A257-08.2	G49537.TCGA-EL-A4K6-01A-12D-A257-08.2.bam	55.8	NA	0.08	58cfa82ee4b0c9d6adf6af4e	G49537.TCGA-EL-A4K6-01A-12D-A257-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A4K6-01A	4FC8E011-4433-4537-B03F-457A3A70240F	Primary Tumor	Illumina HiSeq	3fa6f792-4048-42a5-990b-a50e3e20fa7a	Thyroid	75	BB98FF62-4CD8-46D6-9A85-8439265BE40B	66EB4833-1B87-4FD9-A53D-26DC7AD6DE29	TCGA-EL-A4K6-01A-12D-A257-08	HG19_Broad_variant	TCGA-EL-A4K6	TCGA-THCA	NA	s12498	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T4	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage IV	A257-08	FALSE
13722.58cfa82ee4b0c9d6adf6aec4	58cfa82ee4b0c9d6adf6aec4	G49537.TCGA-DJ-A13R-01A-11D-A10S-08.1.filtered.	WGS	G49537.TCGA-DJ-A13R-01A-11D-A10S-08.1	G49537.TCGA-DJ-A13R-01A-11D-A10S-08.1.bam	78.88	1.95	0.08	58cfa82ee4b0c9d6adf6aec4	G49537.TCGA-DJ-A13R-01A-11D-A10S-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13R-01A	3E787A0E-B5D2-401E-B1E5-077376090B3A	Primary Tumor	Illumina HiSeq	af5f8467-77af-435f-b962-db1a207085e3	Thyroid	50	27B0FF79-4213-4B57-B6E0-A393B8983D20	3F039593-91D1-43CB-A06B-41E92F7E8D20	TCGA-DJ-A13R-01A-11D-A10S-08	HG19_Broad_variant	TCGA-DJ-A13R	TCGA-THCA	NA	s12503	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A10S-08	TRUE
13722.58cfa82ee4b0c9d6adf6af6e	58cfa82ee4b0c9d6adf6af6e	G39020.TCGA-F1-6875-01A-11D-2053-08.3.filtered.	WGS	G39020.TCGA-F1-6875-01A-11D-2053-08.3	G39020.TCGA-F1-6875-01A-11D-2053-08.3.bam	583.7	NA	0.05	58cfa82ee4b0c9d6adf6af6e	G39020.TCGA-F1-6875-01A-11D-2053-08.3.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-F1-6875-01A	283776CD-32E8-4A79-BED1-1411C9D3A9E0	Primary Tumor	Illumina HiSeq	b6dcf3d5-80e4-40e1-a164-4697d1de7670	Stomach	79	4E5FDD56-C807-4493-A331-359577C31514	EA1CAC20-88C1-4257-9CDB-D2890EB2E123	TCGA-F1-6875-01A-11D-2053-08	HG19_Broad_variant	TCGA-F1-6875	TCGA-STAD	2197	s14461	Broad Institute of MIT and Harvard	UNC	United States	NO	T2	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IA	2053-08	FALSE
13722.58cfa82ee4b0c9d6adf6b004	58cfa82ee4b0c9d6adf6b004	G49537.TCGA-EM-A3FL-01A-11D-A21A-08.2.filtered.	WGS	G49537.TCGA-EM-A3FL-01A-11D-A21A-08.2	G49537.TCGA-EM-A3FL-01A-11D-A21A-08.2.bam	8.35	NA	0.08	58cfa82ee4b0c9d6adf6b004	G49537.TCGA-EM-A3FL-01A-11D-A21A-08.2.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3FL-01A	CFDD2155-57A9-499C-92E1-FB82B577B050	Primary Tumor	Illumina HiSeq	477abd20-1834-4af2-8091-7566a4d68578	Thyroid	63	56E31332-09FB-4305-8EE8-ADC568B393F3	1BBB522D-E224-4B3F-9E10-3A47D06B2B05	TCGA-EM-A3FL-01A-11D-A21A-08	HG19_Broad_variant	TCGA-EM-A3FL	TCGA-THCA	NA	s12225	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T1b	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6afc7	58cfa82ee4b0c9d6adf6afc7	G49537.TCGA-DJ-A13L-01A-11D-A21Z-08.1.filtered.	WGS	G49537.TCGA-DJ-A13L-01A-11D-A21Z-08.1	G49537.TCGA-DJ-A13L-01A-11D-A21Z-08.1.bam	32.87	NA	0.08	58cfa82ee4b0c9d6adf6afc7	G49537.TCGA-DJ-A13L-01A-11D-A21Z-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13L-01A	C7A2F394-3E3F-4C90-9F1E-F2BE3E5B0D6B	Primary Tumor	Illumina HiSeq	56cad7af-d64e-4a7f-9d2e-206cbb921c3f	Thyroid	85	AB13FB1A-8B7F-4D84-84A9-C4F7EE59CAF8	1924D200-6929-4EEF-8A7F-317F8FBAB915	TCGA-DJ-A13L-01A-11D-A21Z-08	HG19_Broad_variant	TCGA-DJ-A13L	TCGA-THCA	NA	s12501	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage I	A21Z-08	TRUE
13722.58cfa82ee4b0c9d6adf6ade1	58cfa82ee4b0c9d6adf6ade1	G39020.TCGA-BR-8682-01A-11D-2394-08.3.filtered.	WGS	G39020.TCGA-BR-8682-01A-11D-2394-08.3	G39020.TCGA-BR-8682-01A-11D-2394-08.3.bam	231	NA	0.05	58cfa82ee4b0c9d6adf6ade1	G39020.TCGA-BR-8682-01A-11D-2394-08.3.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8682-01A	D5EFCDE2-21E6-4071-9AA4-3C5688A45B3F	Primary Tumor	Illumina HiSeq	36f56254-f585-4353-89b4-00cb5cfa20eb	Stomach	52	4E6BBC3C-BB9E-46C0-8B22-60F9725DB516	EA2055D1-7B8B-4AAF-9A70-8802F4DEEF9B	TCGA-BR-8682-01A-11D-2394-08	HG19_Broad_variant	TCGA-BR-8682	TCGA-STAD	NA	s15038	Broad Institute of MIT and Harvard	Asterand	Vietnam	NO	T4a	N0	Stomach Intestinal Adenocarcinoma Mucinous Type	Stage IIB	2394-08	TRUE
13722.58cfa82ee4b0c9d6adf6aaa8	58cfa82ee4b0c9d6adf6aaa8	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3.filtered.	WGS	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3.bam	59.04	1.91	0.08	58cfa82ee4b0c9d6adf6aaa8	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A5-01A	904A8757-E0C5-41EF-B583-C8F170CAAAC1	Primary Tumor	Illumina HiSeq	bc2dfa86-f2b0-4747-beb4-8940c4a6c000	Bladder	79	A9EF3EC5-B1C1-481F-89CF-1729FAB50173	448FE471-3F4E-4DC8-A4E0-6F147DC93ABE	TCGA-DK-A1A5-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A5	TCGA-BLCA	65	s3253	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab36	58cfa82ee4b0c9d6adf6ab36	G32557.TCGA-ER-A19T-01A-11D-A19A-08.3.filtered.	WGS	G32557.TCGA-ER-A19T-01A-11D-A19A-08.3	G32557.TCGA-ER-A19T-01A-11D-A19A-08.3.bam	76.29	NA	0.09	58cfa82ee4b0c9d6adf6ab36	G32557.TCGA-ER-A19T-01A-11D-A19A-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A19T-01A	B85B14D7-3B5A-4800-AF12-622EC03B9FE5	Primary Tumor	Illumina HiSeq	7967a744-2db3-4cec-86e2-524388a325e5	Skin	51	11E2F891-251A-4813-AA90-E944F350C54D	D1942D67-3C90-474E-9164-E76DDF9E335A	TCGA-ER-A19T-01A-11D-A19A-08	HG19_Broad_variant	TCGA-ER-A19T	TCGA-SKCM	270	s7307	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T4a	N3	Not available	Stage IV	A19A-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa51	58cfa82ee4b0c9d6adf6aa51	G35155.TCGA-CR-5243-01A-01D-1512-08.2.filtered.	WGS	G35155.TCGA-CR-5243-01A-01D-1512-08.2	G35155.TCGA-CR-5243-01A-01D-1512-08.2.bam	348.7	1.9	0.05	58cfa82ee4b0c9d6adf6aa51	G35155.TCGA-CR-5243-01A-01D-1512-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-5243-01A	E37F479F-CA05-45E4-AC6D-A974BED6E7F8	Primary Tumor	Illumina HiSeq	9b40a7ed-a315-4294-ade6-8b2194292f0b	Head and Neck	51	D89D46EA-9A7A-4FD8-B11E-9C9CA4780119	297E8B35-5B8B-4D5B-B812-86165F949A20	TCGA-CR-5243-01A-01D-1512-08	HG19_Broad_variant	TCGA-CR-5243	TCGA-HNSC	NA	s15873	Broad Institute of MIT and Harvard	Vanderbilt University	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	1512-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa64	58cfa82ee4b0c9d6adf6aa64	G35155.TCGA-CN-5373-01A-01D-1434-08.2.filtered.	WGS	G35155.TCGA-CN-5373-01A-01D-1434-08.2	G35155.TCGA-CN-5373-01A-01D-1434-08.2.bam	165.7	1.9	0.05	58cfa82ee4b0c9d6adf6aa64	G35155.TCGA-CN-5373-01A-01D-1434-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5373-01A	546F01D5-AED5-4FB8-91C0-0FD5E0FDE935	Primary Tumor	Illumina HiSeq	25d55985-95b6-4558-b42e-5c32684d89b0	Head and Neck	55	9D73D061-F1E1-47BA-929D-FEEB6C191279	00988676-1E9B-4E00-B4AA-A8F86C21B206	TCGA-CN-5373-01A-01D-1434-08	HG19_Broad_variant	TCGA-CN-5373	TCGA-HNSC	NA	s15872	Broad Institute of MIT and Harvard	University of Pittsburgh	None	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	1434-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab12	58cfa82ee4b0c9d6adf6ab12	G35155.TCGA-CQ-6220-01A-11D-1912-08.2.filtered.	WGS	G35155.TCGA-CQ-6220-01A-11D-1912-08.2	G35155.TCGA-CQ-6220-01A-11D-1912-08.2.bam	342.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab12	G35155.TCGA-CQ-6220-01A-11D-1912-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6220-01A	96D0CEFE-7949-4736-A7DC-1E4FA94765EC	Primary Tumor	Illumina HiSeq	34bb201c-76f4-432d-b2d3-a46d882b205d	Head and Neck	69	E0E75203-3982-40B2-A057-FAA8433DFB7A	65E67EDA-16A4-4DFD-94A9-546C76D94A02	TCGA-CQ-6220-01A-11D-1912-08	HG19_Broad_variant	TCGA-CQ-6220	TCGA-HNSC	985	s15748	Broad Institute of MIT and Harvard	University Health Network, Toronto	Canada	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	1912-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab7e	58cfa82ee4b0c9d6adf6ab7e	G35155.TCGA-CQ-5323-01A-01D-1683-08.2.filtered.	WGS	G35155.TCGA-CQ-5323-01A-01D-1683-08.2	G35155.TCGA-CQ-5323-01A-01D-1683-08.2.bam	481	1.9	0.05	58cfa82ee4b0c9d6adf6ab7e	G35155.TCGA-CQ-5323-01A-01D-1683-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5323-01A	DEEFDD62-4D35-40C9-AD4C-0B593F35CFF7	Primary Tumor	Illumina HiSeq	a8f7b17a-acda-474e-be1c-c3a584542451	Head and Neck	82	3AC5396D-B92F-41D5-A3F0-603AA52AAFA3	892067EF-C465-46EA-8F91-10636DD0081B	TCGA-CQ-5323-01A-01D-1683-08	HG19_Broad_variant	TCGA-CQ-5323	TCGA-HNSC	NA	s15874	Broad Institute of MIT and Harvard	University Health Network, Toronto	Canada	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	1683-08	FALSE
13722.58cfa82ee4b0c9d6adf6aba6	58cfa82ee4b0c9d6adf6aba6	G35155.TCGA-CR-6471-01A-11D-1870-08.2.filtered.	WGS	G35155.TCGA-CR-6471-01A-11D-1870-08.2	G35155.TCGA-CR-6471-01A-11D-1870-08.2.bam	90.7	1.9	0.05	58cfa82ee4b0c9d6adf6aba6	G35155.TCGA-CR-6471-01A-11D-1870-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6471-01A	EDA29281-E803-4217-8603-D6A388408611	Primary Tumor	Illumina HiSeq	280b365a-3459-4fa2-9daa-644b077065dd	Head and Neck	58	4F845FB4-4724-455F-88F2-09DE7259A484	C087E87F-867C-45DD-8645-5AB774E4827C	TCGA-CR-6471-01A-11D-1870-08	HG19_Broad_variant	TCGA-CR-6471	TCGA-HNSC	1202	s15607	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T4a	N1	Head and Neck Squamous Cell Carcinoma	Stage IVA	1870-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab1c	58cfa82ee4b0c9d6adf6ab1c	G35155.TCGA-CV-7406-01A-11D-2078-08.2.filtered.	WGS	G35155.TCGA-CV-7406-01A-11D-2078-08.2	G35155.TCGA-CV-7406-01A-11D-2078-08.2.bam	161.7	NA	0.05	58cfa82ee4b0c9d6adf6ab1c	G35155.TCGA-CV-7406-01A-11D-2078-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7406-01A	2C6D6C93-FB6D-47F7-A868-5E9A82C75D4C	Primary Tumor	Illumina HiSeq	378f5b8c-a067-4ecf-af73-b546498381c4	Head and Neck	49	39D9F003-89E6-4349-B060-F5A604789FB3	8C9EFFA8-ACB6-4DB0-874A-8F0DF386924C	TCGA-CV-7406-01A-11D-2078-08	HG19_Broad_variant	TCGA-CV-7406	TCGA-HNSC	1748	s15486	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2078-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab8d	58cfa82ee4b0c9d6adf6ab8d	G35155.TCGA-DQ-7591-01A-11D-2078-08.2.filtered.	WGS	G35155.TCGA-DQ-7591-01A-11D-2078-08.2	G35155.TCGA-DQ-7591-01A-11D-2078-08.2.bam	482.7	NA	0.05	58cfa82ee4b0c9d6adf6ab8d	G35155.TCGA-DQ-7591-01A-11D-2078-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-7591-01A	3EF779CF-772E-445E-93C8-E1094EA8B878	Primary Tumor	Illumina HiSeq	17aee7fb-ed6f-46de-8dc7-ad13153b83a3	Head and Neck	62	FB144A86-0EB9-4754-BD74-8BA4BFFE7666	4068A2FC-452D-4B2C-88D8-72D30097527B	TCGA-DQ-7591-01A-11D-2078-08	HG19_Broad_variant	TCGA-DQ-7591	TCGA-HNSC	NA	s15871	Broad Institute of MIT and Harvard	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	2078-08	FALSE
13722.58cfa82ee4b0c9d6adf6abe9	58cfa82ee4b0c9d6adf6abe9	G35155.TCGA-CR-6481-01A-11D-1870-08.2.filtered.	WGS	G35155.TCGA-CR-6481-01A-11D-1870-08.2	G35155.TCGA-CR-6481-01A-11D-1870-08.2.bam	88.7	1.9	0.05	58cfa82ee4b0c9d6adf6abe9	G35155.TCGA-CR-6481-01A-11D-1870-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6481-01A	9A76BD98-1D2B-4D0F-9772-883520FF6210	Primary Tumor	Illumina HiSeq	577ba651-2ad3-4e83-a94c-547efbe03ebe	Head and Neck	47	04652163-A674-446F-9E86-607DE19E4C34	5E7D2531-81C1-48BB-9C0A-1867D1F83F92	TCGA-CR-6481-01A-11D-1870-08	HG19_Broad_variant	TCGA-CR-6481	TCGA-HNSC	NA	s15869	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available	1870-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac6c	58cfa82ee4b0c9d6adf6ac6c	G35155.TCGA-HD-7754-01A-11D-2078-08.2.filtered.	WGS	G35155.TCGA-HD-7754-01A-11D-2078-08.2	G35155.TCGA-HD-7754-01A-11D-2078-08.2.bam	471.73	NA	0.05	58cfa82ee4b0c9d6adf6ac6c	G35155.TCGA-HD-7754-01A-11D-2078-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-HD-7754-01A	10F53522-9AE7-47B9-80AA-B4B481561465	Primary Tumor	Illumina HiSeq	58f7e425-aa07-404f-afe5-6a47488d4296	Head and Neck	69	ADB496A1-07EB-45B9-8690-00184143300E	233ECDC4-0B42-4533-8908-64AC7D3AC33B	TCGA-HD-7754-01A-11D-2078-08	HG19_Broad_variant	TCGA-HD-7754	TCGA-HNSC	NA	s16167	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	2078-08	FALSE
13722.58cfa82ee4b0c9d6adf6abf5	58cfa82ee4b0c9d6adf6abf5	G35155.TCGA-CR-7368-01A-11D-2129-08.2.filtered.	WGS	G35155.TCGA-CR-7368-01A-11D-2129-08.2	G35155.TCGA-CR-7368-01A-11D-2129-08.2.bam	250.7	NA	0.05	58cfa82ee4b0c9d6adf6abf5	G35155.TCGA-CR-7368-01A-11D-2129-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7368-01A	27C28C89-F4E7-4AEC-A806-C0DA7756E47F	Primary Tumor	Illumina HiSeq	71be6814-d02e-4639-9836-25de17a1ec0f	Head and Neck	54	0C4C4B41-05AC-48CE-B5C0-A639FFAFC411	4B194AB3-D213-4A7A-BE46-909B4F0C7291	TCGA-CR-7368-01A-11D-2129-08	HG19_Broad_variant	TCGA-CR-7368	TCGA-HNSC	NA	s15875	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T4a	N1	Head and Neck Squamous Cell Carcinoma	Stage IVA	2129-08	FALSE
